Rules and Regulations of the State of Georgia
 

JavaScript Is Not Enabled alert

You need to have JavaScript enabled in your browser to utilise the full functionality of this website.

How to enable JavaScript in your browser






firefox Mozilla Firefox

  1. In the address bar, type about:config and press Enter.
  2. Click "I'll be careful, I promise" if a warning message appears.
  3. In the search box, search for javascript.enabled
  4. Toggle the "javascript.enabled" preference (right-click and select "Toggle" or double-click the preference) to change the value from "false" to "true".
  5. Click on the "Reload current page" button of the web browser to refresh the page.
  • 1. In the address bar, type about:config and press Enter.
  • 2. Click "I'll be careful, I promise" if a warning message appears.
  • 3. In the search box, search for javascript.enabled
  • 4. Toggle the "javascript.enabled" preference (right-click and select "Toggle" or double-click the preference) to change the value from "false" to "true".
  • 5. Click on the "Reload current page" button of the web browser to refresh the page.




ie Internet Explorer

  1. On web browser menu click "Tools" icon and select "Internet Options".
  2. In the "Internet Options" window select the "Security" tab.
  3. On the "Security" tab click on the "Custom level..." button.
  4. When the "Security Settings - Internet Zone" dialog window opens, look for the "Scripting" section.
  5. In the "Active Scripting" item select "Enable".
  6. When the "Warning!" window pops out asking "Are you sure you want to change the settings for this zone?" select "Yes".
  7. In the "Internet Options" window click on the "OK" button to close it.
  8. Click on the "Refresh" button of the web browser to refresh the page.
  • 1. ie9 01
  • 2. ie9 02
  • 3. ie9 03
  • 4. ie9 04
  • 5. ie9 05
  • 6. ie9 06
  • 7. ie9 07
  • 8. ie9 08
 Internet Explorer < 9
  1. On web browser menu click "Tools" and select "Internet Options"
  2. In the "Internet Options" window select the "Security" tab.
  3. On the "Security" tab click on the "Custom level..." button.
  4. When the "Security Settings - Internet Zone" dialog window opens, look for the "Scripting" section.
  5. In the "Active Scripting" item select "Enable".
  6. When the "Warning!" window pops out asking "Are you sure you want to change the settings for this zone?" select "Yes".
  7. In the "Internet Options" window click on the "OK" button to close it.
  8. Click on the "Refresh" button of the web browser to refresh the page.
  • 1. ie 01
  • 2. ie 02
  • 3. ie 03
  • 4. ie 04
  • 5. ie 05
  • 6. ie 06
  • 7. ie 07
  • 8. ie 08




chrome Google Chrome

  1. On the web browser menu click on the "Customize and control Google Chrome" and select "Settings".
  2. In the "Settings" section click on the "Show advanced settings..."
  3. Under the the "Privacy" click on the "Content settings...".
  4. When the dialog window opens, look for the "JavaScript" section and select "Allow all sites to run JavaScript (recommended)".
  5. Click on the "OK" button to close it.
  6. Close the "Settings" tab.
  7. Click on the "Reload this page" button of the web browser to refresh the page.
  • 1. chrome 01
  • 2. chrome 02
  • 3. chrome 03
  • 4. chrome 04
  • 5. chrome 05
  • 6. chrome 06
  • 7. chrome 07




opera Opera

  • 1. a) Click on "Menu", hover mouse on the "Settings" then hover mouse on the "Quick preferences" and mark the "Enable Javascript" checkbox.
  • 1. b) If "Menu bar" is shown click on the "Tools", hover mouse on the "Quick preferences" and mark the "Enable Javascript" checkbox.
1. a) opera10 a 1. b) opera10 b




safari Apple Safari

  1. On the web browser menu click on the "Edit" and select "Preferences".
  2. In the "Preferences" window select the "Security" tab.
  3. In the "Security" tab section "Web content" mark the "Enable JavaScript" checkbox.
  4. Click on the "Reload the current page" button of the web browser to refresh the page.
  • 1. safari 01
  • 2. safari 02
  • 3. safari 03
  • 4. safari 04
<xmp>.</xmp> <form name="form1" method="post" action="../nllxml/georgiacodesGetcv.aspx?urlRedirected=yes&amp;data=admin&amp;lookingfor=391-3-17" id="form1"> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="/wEPDwUKLTY5ODkwOTM2Nw8WAh4Ec3BhbQIJFgJmD2QWAgIFDw8WAh4EVGV4dAUFNCArIDVkZGTwx7DJbJ2XVOi61RI7wn4R7m87Mw==" /> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="EEBB6393" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEWCALq+sLUDALniKOhBALV5cpNAoa5iIEFAoznisYGAsrv5u0MAsrv4u0MAsrv3u0M0AdMvBtvqr9/5LSKlVWHtHeA9Eg=" /> <div class='popup'> <div class='cnt223'> <div style="margin-bottom:6px;"> <img alt="Rules and Regulations of the State of Georgia" src="/images/new.gif"/> </div> <div class="header"> Terms and Conditions of Agreement for Access to Rules and Regulations of the State of Georgia Website </div> <div class="scroll"> <p>(Note: certain features of this site have been disabled for the general public to prevent digital piracy. If you are an entitled government entity pursuant the Georgia Administrative Procedures Act, <a target="_new" href="http://links.casemakerlegal.com/states/GA/books/Code_of_Georgia/browse?ci=25id=gasos&amp;codesec=50-13-7&amp;title=50&amp;#50-13-7(d)">O.C.G.A.§ 50-13-7(d)</a> contact the State of Georgia's Administrative Procedures Division at 678-364-3785 to enable these features for your location.)</p> <p>To access this website, you must agree to the following: </p> <p> These terms of use are a contract between you and/or your employer (if any), and Lawriter, LLC. </p> <p> You agree that you will not copy, print, or download anything from this website for any commercial use. </p> <p> You agree not to use any web crawler, scraper, or other robot or automated program or device to obtain data from the website.</p> <p> You agree that you will not sell, will not license, and will not otherwise make available in exchange for anything of value, anything that you download, print, or copy from this site.</p> <p> You agree that you will not copy, print, or download any portion of the regulations posted on this site exceeding a single chapter of regulations for sale, license, or other transfer to a third party, except that you may quote a reasonable portion of the regulations in the course of rendering professional advice.</p> <p> If you violate this agreement, or if you access or use this website in violation of this agreement, you agree that Lawriter will suffer damages of at least $20,000. </p> <p> THIS WEBSITE AND ITS CONTENT ARE PROVIDED "AS IS." THE STATE OF GEORGIA AND LAWRITER EXPRESSLY DISCLAIM ALL WARRANTIES, INCLUDING THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT AND ARE NOT LIABLE TO ANY PERSON FOR ANY ERRORS IN INACCURACIES CONTAINED IN THIS WEBSITE. </p> <p> If you accept these terms enter the information below and click “I AGREE”.</p> </div> <table border="0" style="width: 810px"> <tr> </tr> <tr> <td style="vertical-align: text-top; width: 243px;"> Full Name:</td> <td style="width: 532px; vertical-align:super;"> <input name="firstName" type="text" id="firstName" class="txt" /> <span id="lbl_fname"><font color="Red"></font></span> </td> </tr> <tr><td style="width: 243px"> Human verification: <b> <span id="lblStopSpam">4 + 5</span>&nbsp;= </b></td><td style="width: 532px"> <input name="captcha" type="text" id="captcha" class="txt" /> <span id="lbl_captcha"><font color="Red"></font></span> &nbsp; <input name="sum" type="hidden" id="sum" value="9" /> </td></tr> </table> <input type="submit" name="Button1" value="I AGREE" id="Button1" disabled="disabled" /> <span id="alrtmsg"><font color="Red"></font></span> <input name="v1" type="hidden" id="v1" /> <input name="v2" type="hidden" id="v2" /> <input name="v3" type="hidden" id="v3" /> <p>Privacy Policy: the above information is for internal use only as related to this agreement and will not be sold or distributed.</p> </div> </div> </form> <html> <head runat="server"> <title>GA - GAC</title> <link href="_files/main.css" media="all" rel="Stylesheet" type="text/css" /> <link href="_files/treeview_old.css" media="all" rel="Stylesheet" type="text/css" /> <link href="/_files/popup.css" media="all" rel="stylesheet" type="text/css" /> <script type="text/javascript" src="/_files/treeview.js"></script> <script type="text/javascript" src="/_files/jquery-1.8.0.min.js"></script> <script type="text/javascript" src="/_files/jquery-1.10.2.js"></script> <script type="text/javascript" src="/_files/popup.js"></script> <script type="text/javascript" src="http://code.jquery.com/jquery-1.8.2.js"></script> <script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.8/jquery.min.js" /> <script type="text/javascript" src="/_files/jquery.popup.js"></script> <script type="text/javascript" src="/_files/jquery.popup.min.js"></script> <script type="text/javascript" src="/_files/ValidateForm.js"></script> <script src="https://code.jquery.com/jquery-1.11.3.js"></script> <link href="/_files/enablejs.css" rel="Stylesheet" type="text/css" /> <link href="/_files/forJavascript.css" rel="Stylesheet" type="text/css" /> <style type="text/css"> .collapse{background-image:url('/images/expcoll_right.png');} .expand{background-image:url('/images/expcoll_down.png');} </style> <script type="text/javascript"> $(document).ready(function(){ $("#History-parent").click(function(){ $("#History-Childs").toggle(); if ($('#History-parent img').hasClass('expand')) { $('#History-parent img').addClass('collapse'); $('#History-parent img').removeClass('expand'); $('#History-parent img').attr('src', '/images/expcoll_right.png'); } else { $('#History-parent img').removeClass('collapse'); $('#History-parent img').addClass('expand'); $('#History-parent img').attr('src', '/images/expcoll_down.png'); } }); $("#History-Childs").hide(); var tocnode=document.getElementById('toc-children'); if (tocnode != null) { if(tocnode.childNodes.length != 0) { document.getElementById("doc-content").style.width="72%"; document.getElementById("toc").style.width="21%"; document.getElementById("toc").style.padding="10px"; } else { document.getElementById('toc').style.display="none"; } } }); function fnsetRDVal(id) { if (id=="y") { document.getElementById("y").value="yes" document.getElementById("n").value="" } else { document.getElementById("n").value="no" document.getElementById("y").value="" } } </script> <script type="text/javascript"> function TermsCon() { var overlay = $('<div id="overlay"></div>'); overlay.show(); overlay.appendTo(document.body); $('.popup2').show(); $('#btnAgree').click(function () { $('.popup2').hide(); $("#overlay").hide(); overlay.appendTo(document.body).remove(); }); $("#btnprint").click(function () { var contents = $("#popupterms").html(); var frame1 = $('<iframe />'); frame1[0].name = "frame1"; frame1.css({ "position": "absolute", "top": "-1000000px" }); $("body").append(frame1); var frameDoc = frame1[0].contentWindow ? frame1[0].contentWindow : frame1[0].contentDocument.document ? frame1[0].contentDocument.document : frame1[0].contentDocument; frameDoc.document.open(); //Create a new HTML document. frameDoc.document.write('<html><head>'); frameDoc.document.write('</head><body>'); //Append the external CSS file. frameDoc.document.write('<link href="_files/popup.css" rel="stylesheet" type="text/css" />'); //Append the DIV contents. frameDoc.document.write(contents); frameDoc.document.write('</body></html>'); frameDoc.document.close(); setTimeout(function () { window.frames["frame1"].focus(); window.frames["frame1"].print(); frame1.remove(); }, 500); }); // alert("Because you do not agree to the Terms and Conditions for Access, you must cease accessing and/or using this website and destroy all material obtained from this website without your agreement."); // $('.popup2').show(); } </script> </head> <body> <div class="popup2"> <div class='cnt2231' id="popupterms"> <div style="margin-bottom: 6px;"> <img alt="Rules and Regulations of the State of Georgia" src="/images/new.gif" /> </div> <div class="header"> Terms and Conditions of Agreement for Access to Rules and Regulations of the State of Georgia Website </div> <div class="scroll"> <p>(Note: certain features of this site have been disabled for the general public to prevent digital piracy. If you are an entitled government entity pursuant the Georgia Administrative Procedures Act, <a target="_new" href="http://links.casemakerlegal.com/states/GA/books/Code_of_Georgia/browse?ci=25id=gasos&amp;codesec=50-13-7&amp;title=50&amp;#50-13-7(d)">O.C.G.A.§ 50-13-7(d)</a> contact the State of Georgia's Administrative Procedures Division at 678-364-3785 to enable these features for your location.)</p> <p>To access this website, you must agree to the following: </p> <p> These terms of use are a contract between you and/or your employer (if any), and Lawriter, LLC. </p> <p> You agree that you will not copy, print, or download anything from this website for any commercial use. </p> <p> You agree not to use any web crawler, scraper, or other robot or automated program or device to obtain data from the website.</p> <p> You agree that you will not sell, will not license, and will not otherwise make available in exchange for anything of value, anything that you download, print, or copy from this site.</p> <p> You agree that you will not copy, print, or download any portion of the regulations posted on this site exceeding a single chapter of regulations for sale, license, or other transfer to a third party, except that you may quote a reasonable portion of the regulations in the course of rendering professional advice.</p> <p> If you violate this agreement, or if you access or use this website in violation of this agreement, you agree that Lawriter will suffer damages of at least $20,000. </p> <p> THIS WEBSITE AND ITS CONTENT ARE PROVIDED "AS IS." THE STATE OF GEORGIA AND LAWRITER EXPRESSLY DISCLAIM ALL WARRANTIES, INCLUDING THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT AND ARE NOT LIABLE TO ANY PERSON FOR ANY ERRORS IN INACCURACIES CONTAINED IN THIS WEBSITE. </p> <p> By accessing and/or using this website, you agree to the terms and conditions above. If you do not agree to the terms and conditions above, you must cease accessing and/or using this website and destroy all material obtained from this website without your agreement. </p> </div> <div class="modal-footer"> <input type="button" name="btnAgree" value="Close" id="btnAgree" class="btn-blue noprint" /> <input type="button" name="btnprint" value="Print" id="btnprint" class="btn-blue noprint" /> </div> </div> </div> <div id="main" class="noprint"> <!--class="noprint"--> <div id="header" class="noprint"> <div class="container"> <div class="terms"> NOTICE OF TERMS OF USE OF THIS WEBSITE. By accessing and/or using this website, you agree to the following <a onclick="javascript:TermsCon();" style="text-decoration: underline">terms and conditions.</a> </div> <div class="content"> <div id="logo"> <!--<a href="../" title="Home"><img alt="Rules and Regulations of the State of Georgia" src="/images/garr_logo.gif" /></a>--> <!--<span id="georgia"><a href="/">Rules and Regulations of the State of Georgia</a></span>--> <a href="../" title="Home"><img alt="Rules and Regulations of the State of Georgia" src="/images/ga_rulesreg.gif" /></a> </div> <div id="links"> <a href="../home.aspx" class="constant" title="home">Home</a> | <a href="../gac/" class="constant" title="home">Browse</a> | <a href="../help.aspx" class="constant" title="help">Help</a> | <a href="http://sos.ga.gov/index.php/General/rules_and_regulations" target="_blank" onclick="void(0);" class="constant" title="Georgia SOS">Go to Georgia SOS</a> </div> </div> </div> <div class="sidebar"> <div id="full-text-search"> <form class="searchform" action="../search.aspx" method="get" onsubmit="javascript:return fncheckqts();"> <span class="searchHierarchy" style="margin-right:10px;" > <em class="mnemonic">H</em>ierarchy Search:&nbsp; <input onclick="fnsetRDVal(id);" id="y" checked="checked" type="radio" name="hierarchysearch" value="yes" />&nbsp;Y <input onclick="fnsetRDVal(id);" id="n" type="radio" name="hierarchysearch" value="" />&nbsp;N </span> <input id="query" name="query" class="searchfield" value="Search GA R&R...." onfocus="if (this.value == 'Search GA R&R....') {this.value = '';}" onblur="if (this.value == '') {this.value = 'Search GA R&R....';}" type="text" /> <input class="searchbutton" value="Go" type="submit" /> <input type="hidden" name="searchvalue" value="Subject 391-3-17 RADIOACTIVE MATERIALS" /> <input type="hidden" id="msg" value="REPLACE_MESSAGE" /> <input type="hidden" name="from" value="gac" /> </form> </div> <!--<div id="full-text-search"> <form id="search" action="../search.aspx" method="get" onsubmit="javascript:return fncheckqts();"> <span class="searchHierarchy" style="margin-right:10px;" > <em class="mnemonic">H</em>ierarchy Search:&nbsp; <input onclick="fnsetRDVal(id);" id="y" checked="checked" type="radio" name="hierarchysearch" value="yes" />&nbsp;Y <input onclick="fnsetRDVal(id);" id="n" type="radio" name="hierarchysearch" value="" />&nbsp;N </span> <label for="query" accesskey="s"> <em class="mnemonic">S</em>earch GA R&R: </label><input type="hidden" name="from" value="gac" /> <input id="query" name="query" type="text" /> <input class="submit" value="Go" type="submit" /> <input type="hidden" id="msg" value="REPLACE_MESSAGE" /> <input type="hidden" name="searchlevel" value="REPLACE_SEARCHLEVEL" /> <input type="hidden" name="searchvalue" value="Subject 391-3-17 RADIOACTIVE MATERIALS" /> </form> </div>--> <div id="searchcitation"> <form class="searchform" action="../search.aspx" method="get" onsubmit="javascript:return fnchecks();"> <div> <input id="section" name="section" class="searchfield" value="Go to Citation...." onfocus="if (this.value == 'Go to Citation....') {this.value = '';}" onblur="if (this.value == '') {this.value = 'Go to Citation....';}" type="text" /> <input class="searchbutton" value="Go" type="submit" /> <input type="hidden" name="from" value="gac" /> </div> </form> </div> </div> <div id="infobar" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:msxsl="urn:schemas-microsoft-com:xslt" xmlns:nll="uuid:{D3B28627-934D-41bc-8B7A-0549A8802FE4}"><a href="javascript:;" accesskey="r" Name="Route" title="Route" class="quickkey"><em class="mnemonic">R</em>oute </a>:<div class="searchtips" style="float:right;margin-right:10px;color: rgb(47, 79, 79);"> <a style="text-decoration:none;color: rgb(47, 79, 79);" title="search tips" name="searchtip" href="../help.aspx#searching" target="_blank"><em class="mnemonic">S</em>earch tips</a></div><ul class="breadcrumb"> <li><a href="/GAC" name="GAC" title="GAC">GA R&amp;R</a></li> <li>&raquo; <a href="/GAC/391" title="391">Department 391</a></li> <li>&raquo; <a href="/GAC/391-3" title="391-3">Chapter 391-3</a></li> <li>&raquo; Subject 391-3-17</li> </ul> </div> </div><div id="doc" class="container" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:msxsl="urn:schemas-microsoft-com:xslt" xmlns:nll="uuid:{D3B28627-934D-41bc-8B7A-0549A8802FE4}"> <div id="doc-content" class="content"> <h1><nllsubject>Subject 391-3-17 RADIOACTIVE MATERIALS</nllsubject></h1> <h2><a href="/GAC/391-3-17-.01" name="391-3-17-.01" title="391-3-17-.01">Rule 391-3-17-.01 General Provisions</a></h2> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(1)">(1)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Scope.</B></span><span class=""> Except as otherwise specifically provided, this Chapter, 391-3-17, applies to all persons who manufacture, produce, receive, possess, use, transfer, own, or acquire any source of radiation; provided, however, that nothing in this Chapter shall apply to any person to the extent such person is subject to regulation by the U.S. Nuclear Regulatory Commission.</span><span class=""><sup>[<a name="fn-FR-391-3-17-.01-1" href="#ftn.fn-FR-391-3-17-.01-1">1</a>]</sup></span><span class=""> Nothing in Rule </span><span class=""> <a title="391-3-17-.03" href="391-3-17-.03">391-3-17-.03</a></span><span class=""> of this Chapter shall be interpreted as limiting the intentional exposure of patients to radiation for the purpose of diagnosis or therapy.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)">(2)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Definitions.</B></span><span class=""> As used in this Chapter, these terms have the definitions set forth below. Additional definitions used only in a certain Rule will be found in that Rule. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "A</span><span class=""><SUB>1</SUB></span><span class="">" means the maximum activity of special form radioactive material permitted in a Type A package. "A</span><span class=""><SUB>2</SUB></span><span class="">" means the maximum activity of radioactive material, other than special form, LSA and SCO material, permitted in a Type A package. These values are either listed in the "Table of A</span><span class=""><SUB>1</SUB></span><span class=""> and A</span><span class=""><SUB>2</SUB></span><span class=""> Values for Radionuclides" of </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=173.435&amp;title=49#" target="_newtab">49 CFR 173.435</a></span><span class=""> or may be derived in accordance with the procedure prescribed in 49 CFR 173.433-173.435.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Absorbed dose" means the energy imparted by ionizing radiation per unit mass of irradiated material. The units of absorbed dose are the rad and the Gray (Gy).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Accelerator-produced radioactive material" means any material made radioactive by a particle accelerator.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Act" means Chapter 13 of the Official Code of Georgia, Annotated, entitled "Radiation Control" as amended.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Activity" means the rate of disintegration or transformation or decay of radioactive material. The units of activity are the Curie (Ci) and the Becquerel (Bq).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Adult" means an individual 18 or more years of age.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Agreement State" means any State with which the U.S. Nuclear Regulatory Commission or the U.S. Atomic Energy Commission has entered into an effective agreement under subsection 274b. of the Atomic Energy Act of 1954, as amended (73 Stat. 689).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Airborne radioactive material" means any radioactive material dispersed in the air in the form of dusts, fumes, particulates, mists, vapors, or gases.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Airborne radioactivity area" means a room, enclosure or operating area in which airborne radioactive materials, composed wholly or partly of licensed materials, exist in concentrations; </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(i)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In excess of the derived air concentrations (DACs) specified in Appendix B, to 10 CFR 20.1001-20.2401, or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(i)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> To such a degree that an individual present in the area without respiratory protective equipment could exceed, during the hours an individual is present in a week, an intake of 0.6 percent of the annual limit on intake (ALI) or 12 DAC-hours.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(j)">(j)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Annually" means once every 12 calendar months or no later than the last day of the same calendar month of the following year.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(k)">(k)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "As low as is reasonably achievable" (ALARA) means making every reasonable effort to maintain exposures to radiation as far below the dose limits in this Chapter as is practical, consistent with the purpose for which the licensed activity is undertaken, taking into account the state of technology, the economics of improvements in relation to the state of technology, the economics of improvements in relation to benefits to the public health and safety, and other societal and socioeconomic considerations, and in relation to utilization of nuclear energy and licensed or registered sources of radiation in the public interest.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(l)">(l)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Background radiation" means radiation from cosmic sources; naturally occurring radioactive materials, including radon, except as a decay product of source or special nuclear material, and including global fallout as it exists in the environment from the testing of nuclear explosive devices or from past nuclear accidents such as Chernobyl that contribute to background radiation and are not under the control of the licensee. "Background radiation" does not include sources of radiation from radioactive materials regulated by the Department.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(m)">(m)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Becquerel" (Bq) means the SI unit of activity. One Becquerel is equal to one disintegration or transformation per second.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(n)">(n)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Bioassay" means the determination of kinds, quantities or concentrations, and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of this Chapter, "radiobioassay" is an equivalent term.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)">(o)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Byproduct material" means: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any radioactive material, except special nuclear material, yielded in or made radioactive by exposure to the radiation incident to the process of producing or utilizing special nuclear material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The tailings or wastes produced by the extraction or concentration of uranium or thorium from ore processed primarily for its source material content, including discrete surface wastes resulting from uranium solution extraction processes. Underground ore bodies depleted by these solution extraction operations do not constitute "byproduct material" within this definition.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any discrete source of radium-226 that is produced, extracted, or converted after extraction, before, on, or after August 8, 2005, for use for a commercial, medical, or research activity; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any material that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)3.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Has been made radioactive by use of a particle accelerator; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)3.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Is produced, extracted, or converted after extraction, before, on, or after August 8, 2005, for use for a commercial, medical, or research activity; and </span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any discrete source of naturally occurring radioactive material, other than source material, that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Nuclear Regulatory Commission, in consultation with the Administrator of the Environmental Protection Agency, the Secretary of Energy, the Secretary of Homeland Security, and the head of any other appropriate Federal agency, determines would pose a threat similar to the threat posed by a discrete source of radium-226 to the public health and safety or the common defense and security; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(o)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Before, on, or after August 8, 2005, is extracted or converted after extraction for use in a commercial, medical, or research activity.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(p)">(p)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Calibration" means the determination of: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(p)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The response or reading of an instrument relative to a series of known radiation values over the range of the instrument, or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(p)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The strength of a source of radiation relative to a standard.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(q)">(q)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "CFR" means the Code of Federal Regulations.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(r)">(r)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Collective dose" means the sum of the individual doses received in a given period of time by a specified population from exposure to a specified source of radiation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(s)">(s)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Committed dose" means the radiation dose that will accumulate over time as a result of retention in the body of radioactive material. Committed dose is a generic term for internal dose and must be calculated by summing the projected dose over the 50 years after intake for all irradiated organs or tissues multiplying the doses to individual organs and tissues by applicable tissue weighting factors.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(t)">(t)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Committed dose equivalent" (H</span><span class=""><SUB>T,50</SUB></span><span class="">) means the dose equivalent to organs or tissues of reference (T) that will be received from an intake of radioactive material by an individual during the 50-year period following the intake.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(u)">(u)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Committed effective dose equivalent" (H</span><span class=""><SUB>E,50</SUB></span><span class="">) is the sum of the products of the weighting factors applicable to each of the body organs or tissues that are irradiated and the committed dose equivalent to each of these organs or tissues (H</span><span class=""><SUB>E,50</SUB></span><span class=""> = [SIGMA] w</span><span class=""><SUB>T,</SUB></span><span class="">H</span><span class=""><SUB>T,50</SUB></span><span class="">).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Consortium" means an association of medical use licensees and a PET radionuclide production facility in the same geographical area that jointly own or share in the operation and maintenance cost of the PET radionuclide production facility that produces PET radionuclides for use in producing radioactive drugs within the consortium for noncommercial distributions among its associated members for medical use. The PET radionuclide production facility within the consortium must be located at an educational institution or a Federal facility or a medical facility.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(w)">(w)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Curie" means a unit of quantity of radioactivity. One Curie (Ci) is that quantity of radioactive material that decays at the rate of 3.7 x 10</span><span class=""><SUP>10</SUP></span><span class=""> transformations per second (tps).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(x)">(x)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Daily" means once every calendar day worked.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(y)">(y)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Deep dose equivalent" (H</span><span class=""><SUB>d</SUB></span><span class="">), which applies to external whole body exposure, means the dose equivalent at a tissue depth of one centimeter (1,000 mg/cm</span><span class=""><SUP>2</SUP></span><span class="">).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(z)">(z)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Department" means the Department of Natural Resources of the State of Georgia.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(aa)">(aa)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Depleted uranium" means the source material uranium in which the isotope uranium-235 is less than 0.711 weight percent of the total uranium present. Depleted uranium does not include special nuclear material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(bb)">(bb)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Derived air concentration" (DAC) means the concentration of a given radionuclide in air which, if breathed by the reference man for a working year of 2,000 hours under conditions of light work (inhalation rate 1.2 cubic meters of air per hour), results in an intake of one ALI. (Annual Limit on Intake defined in Rule .03(2) (d) ) DAC values are given in Table 1, Column 3 of Appendix B to </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=20.1001&amp;title=10#" target="_newtab">10 CFR 20.1001</a></span><span class="">- </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=20.2401&amp;title=10#" target="_newtab">20.2401</a></span><span class="">.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(cc)">(cc)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Discrete source" means a radionuclide that has been processed so that its concentration within a material has been purposely increased for use for commercial, medical, or research activities.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(dd)">(dd)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Dose" is a generic term that means absorbed dose, dose equivalent, effective dose equivalent, committed dose equivalent, committed effective dose equivalent, or total effective dose equivalent.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ee)">(ee)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Dose equivalent" (H</span><span class=""><SUB>T</SUB></span><span class="">) means the product of the absorbed dose in tissue, quality factor, and all other necessary modifying factors at the location of interest. The units of dose equivalent are the rem and Sievert (Sv).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ff)">(ff)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Dose limits" means the permissible upper bounds of radiation doses established in accordance with this Chapter. For purposes of this Chapter, "limits" is an equivalent term.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(gg)">(gg)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Effective dose equivalent" (H</span><span class=""><SUB>E</SUB></span><span class="">) means the sum of the products of the dose equivalent to each organ or tissue (H</span><span class=""><SUB>T</SUB></span><span class="">) and the weighting factor (w</span><span class=""><SUB>T</SUB></span><span class="">) applicable to each of the body organs or tissues that are irradiated (H</span><span class=""><SUB>E</SUB></span><span class=""> = [SIGMA] w</span><span class=""><SUB>T</SUB></span><span class="">H</span><span class=""><SUB>T</SUB></span><span class="">).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(hh)">(hh)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Embryo/fetus" means the developing human organism from conception until the time of birth.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Entrance or access point" means any opening through which an individual or extremity of an individual could gain access to radiation areas or to licensed radioactive materials. This includes entry or exit portals of sufficient size to permit human entry, irrespective of their intended use.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(jj)">(jj)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Explosive material" means any chemical compound, mixture, or device that produces a substantial instantaneous release of gas and heat spontaneously or by contact with sparks or flame.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(kk)">(kk)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Exposure" means being exposed to ionizing radiation or to radioactive material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ll)">(ll)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Exposure rate" means the exposure per unit of time, such as Roentgen per minute or milliroentgen per hour.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(mm)">(mm)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "External dose" means that portion of the dose equivalent received from any source of radiation outside the body.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(nn)">(nn)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Extremity" means hand, elbow, arm below the elbow, foot, knee, and leg below the knee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(oo)">(oo)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Former U.S. Atomic Energy Commission (AEC) or U.S. Nuclear Regulatory Commission (NRC) licensed facilities" means nuclear reactors, nuclear fuel reprocessing plants, uranium enrichment plants, or critical mass experimental facilities where AEC or NRC licenses have been terminated.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(pp)">(pp)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Generally applicable environmental radiation standards" means standards issued by the U.S. Environmental Protection Agency (EPA) under the authority of the Atomic Energy Act of 1954, as amended, that impose limits on radiation exposures, levels, concentrations or quantities of radioactive material, in the general environment outside the boundaries of locations under the control of persons possessing or using radioactive material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(qq)">(qq)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Gray" (Gy) means the SI unit of absorbed dose. One Gray is equal to an absorbed dose of one Joule/kilogram (100 rad).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(rr)">(rr)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Hazardous waste" means those wastes designated as hazardous by U.S. Environmental Protection Agency regulations in 40 CFR Part 261.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ss)">(ss)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Healing arts" means medicine, dentistry, chiropractic, podiatry, osteopathy or veterinary medicine.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(tt)">(tt)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "High radiation area" means an area, accessible to individuals, in which radiation levels from radiation sources external to the body could result in an individual receiving a dose equivalent in excess of 0.1 rem (1 mSv) in one hour at 30 centimeters from any source of radiation or from any surface that the radiation penetrates. For purposes of this Chapter, rooms or areas in which diagnostic x-ray systems are used for healing arts purposes are not considered high radiation areas.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(uu)">(uu)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Human use" means the internal or external administration of radiation or radioactive material to human beings.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(vv)">(vv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Individual" means any human being.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ww)">(ww)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Individual monitoring" means the assessment of:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ww)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Dose equivalent by the use of:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ww)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Individual monitoring devices, or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ww)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Survey data; or</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ww)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Committed effective dose equivalent:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ww)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> By bioassay, or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ww)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> By determination of the time-weighted air concentrations to which an individual has been exposed, that is, DAC-hours [See the definition of DAC-hours in Rule </span><span class=""> <a title="391-3-17-.03(2)(q)" href="391-3-17-.03#391-3-17-.03(2)(q)">391-3-17-.03(2)(q)</a></span><span class=""> ]. </span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(xx)">(xx)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Individual monitoring devices" means devices designed to be worn by a single individual for the assessment of dose equivalent. For purposes of this Chapter, individual monitoring devices and personnel monitoring equipment are equivalent terms. Examples of individual monitoring devices are film badges, thermoluminescent dosimeters (TLDs), optically stimulated luminescent devices, pocket ionization chambers, and personal air sampling devices.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(yy)">(yy)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Inspection" means an official examination or observation including, but not limited to, tests, surveys, and monitoring to determine compliance with Rules, Regulations, Orders, requirements, and conditions of the Department.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(zz)">(zz)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Interlock" means a device arranged or connected such that the occurrence of an event or condition is required before a second event or condition can occur or continue to occur.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(aaa)">(aaa)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Internal dose" means that portion of the dose equivalent received from radioactive material taken into the body.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(bbb)">(bbb)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Lens dose equivalent" (LDE) means the external exposure of the lens of the eye and is taken as the dose equivalent at a tissue depth of 0.3 centimeter (300 mg/cm</span><span class=""><SUP>2</SUP></span><span class="">).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ccc)">(ccc)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "License" means a license issued by the Department in accordance with the Regulations promulgated by the Board.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ddd)">(ddd)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Licensed material" means radioactive material received, possessed, used, transferred or disposed of under a general or specific license issued by the Department.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(eee)">(eee)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Licensee" means any person who is licensed by the Department in accordance with this Chapter and the Act.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(fff)">(fff)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Licensing State" means any state with regulations equivalent to the Suggested State Regulations for Control of Radiation relating to, and an effective program for, the regulatory control of NARM and which has been granted final designation by the Conference of Radiation Control Program Directors, Inc.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ggg)">(ggg)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Limits" [See Dose limits].</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(hhh)">(hhh)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Lost or missing licensed material" means licensed material whose location is unknown. This definition includes licensed material that has been shipped but has not reached its planned destination and whose location cannot be readily traced in the transportation system.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Major processor" means a user processing, handling, or manufacturing radioactive material exceeding Type A quantities as unsealed sources or material, or exceeding four times Type B quantities as sealed sources, but does not include nuclear medicine programs, universities, industrial radiographers, or small industrial programs. Type A and B quantities are defined in Section 71.4 of 10 CFR Part 71.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(jjj)">(jjj)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Management" means the chief executive officer or other individual having the authority to manage, direct, or administer the licensee's activities, or those persons' delegate or delegates.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(kkk)">(kkk)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Member of the public" means any individual except when that individual is receiving an occupational dose.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(lll)">(lll)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Minor" means an individual less than 18 years of age.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(mmm)">(mmm)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Monthly" means once every calendar month, not to exceed an interval of 35 days.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(nnn)">(nnn)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Monitoring" means the measurement of radiation, radioactive material concentrations, surface area activities or quantities of radioactive material and the use of the results of these measurements to evaluate potential exposures and doses. For purposes of this Chapter, "radiation monitoring" and "radiation protection monitoring" are equivalent terms.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ooo)">(ooo)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "NARM" means any naturally-occurring or accelerator-produced radioactive material. It does not include byproduct, source, or special nuclear material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ppp)">(ppp)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Natural radioactivity" means radioactivity of naturally-occurring nuclides.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(qqq)">(qqq)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "NORM" (Naturally-Occurring Radioactive Material) means any nuclide which is radioactive in its natural physical state (i.e., not man-made), but does not include byproduct, source, or special nuclear material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(rrr)">(rrr)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Nuclear Regulatory Commission" (NRC) means the U.S. Nuclear Regulatory Commission or its duly authorized representatives.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(sss)">(sss)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Occupational dose" means the dose received by an individual in the course of employment while engaged in activities licensed by the Department in which the individual's assigned duties involve exposure to licensed and unlicensed sources of radiation whether in the possession of the licensee, or other person. Occupational dose does not include doses received from background radiation, as a patient from medical practices, from exposure from individuals administered radioactive material and released in accordance with Rule </span><span class=""> <a title="391-3-17-.05(37)" href="391-3-17-.05#391-3-17-.05(37)">391-3-17-.05(37)</a></span><span class="">, from voluntary participation in medical research programs, or as a member of the public.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ttt)">(ttt)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Package" means the assembly of components necessary to ensure compliance with packing requirements of DOT regulations together with its radioactive contents as presented for transport.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ttt)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Fissile material package" means a fissile material packaging together with its fissile material contents.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ttt)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Type B package" means a Type B packaging together with its radioactive contents. On approval, a Type B package design is designated by NRC as B(U) unless the package has a maximum normal operating pressure of more than 700 kPa (100 lb/in</span><span class=""><SUP>2</SUP></span><span class="">) gauge or pressure relief device that will allow the release of radioactive material to the environment under the tests specified in 10 CFR 71 (hypothetical accident conditions), in which case it will receive a designation B(M). B(U) refers to the need for unilateral approval of international shipments; B(M) refers to the need for multilateral approval of international shipments. There is no distinction made in how packages with these designations may be used in domestic transportation. To determine their distinction for international transportation, see DOT regulations in 49 CFR 173. A Type B package approved before September 6, 1983, was designated only as Type B. Limitations on its use are specified in </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=71.13&amp;title=10#" target="_newtab">10 CFR 71.13</a></span><span class="">.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(uuu)">(uuu)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Particle accelerator" means any machine capable of accelerating electrons, protons, deuterons, or other charged particles in a vacuum and of discharging the resultant particulate or other radiation into a medium at energies usually in excess of one MeV. For purposes of this definition, "accelerator" is an equivalent term.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(vvv)">(vvv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Person" means any individual, corporation, partnership, firm, association, trust, estate, public or private institution, group, agency, political subdivision of this State, any other state or political subdivision or agency thereof, and any legal successor, representative, agent, or department of the foregoing, but shall not include federal government agencies.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(www)">(www)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Personnel monitoring equipment" [See Individual monitoring devices].</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(xxx)">(xxx)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Pharmacist" means any individual who is licensed to practice Pharmacy in this State by the Georgia State Board of Pharmacy.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(yyy)">(yyy)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Physician" means any person who is licensed to engage in the practice of medicine under the Authority of O.C.G.A. </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Code_of_Georgia/browse?ci=25&amp;id=gasos&amp;codesec=43-34-20&amp;title=43#" target="_newtab">43-34-20</a></span><span class=""> or the limited practice of medicine under O.C.G.A. </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Code_of_Georgia/browse?ci=25&amp;id=gasos&amp;codesec=43-35-1&amp;title=43#" target="_newtab">43-35-1</a></span><span class="">.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(zzz)">(zzz)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Positron Emission Tomography (PET) radionuclide production facility" is defined as a facility operating a cyclotron or accelerator for the purpose of producing PET radionuclides.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(aaaa)">(aaaa)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Principal activities," as used in this Chapter, means activities authorized by the license which are essential to achieving the purpose(s) for which the license was issued or amended. Storage during which no license material is accessed for use or disposal and activities incidental to decontamination or decommissioning are not principal activities.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(bbbb)">(bbbb)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Public dose" means the dose received by a member of the public from radiation and/or radioactive material released by a licensee or from any other source of radiation under the control of a licensee. It does not include occupational dose, doses received from background radiation, doses received as a patient from medical practices, from exposure from individuals administered radioactive material and released in accordance with Rule </span><span class=""> <a title="391-3-17-.05(37)" href="391-3-17-.05#391-3-17-.05(37)">391-3-17-.05(37)</a></span><span class="">, or doses from voluntary participation in medical research programs.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(cccc)">(cccc)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Pyrophoric liquid" means any liquid that ignites spontaneously in dry or moist air at or below 130 </span><span class="">°</span><span class="">F (54.4 </span><span class="">°</span><span class="">C). A pyrophoric solid is any solid material, other than one classed as an explosive, which under normal conditions is liable to cause fires through friction, retained heat from manufac­turing or processing, or which can be ignited readily and, when ignited, burns so vigorously and persistently as to create a serious transportation, handling, or disposal hazard. Included are spontaneously combustible and water-reactive materials.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(dddd)">(dddd)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Qualified expert" means an individual having the knowledge and training to measure ionizing radiation, to evaluate safety techniques, and to advise regarding radiation protection needs, for example, individuals certified in the appropriate field by the American Board of Radiology or the American Board of Health Physics, or those having equivalent qualifications. With reference to the calibration of radiation therapy equipment, an individual having, in addition to the above qualifications, training and experience in the clinical applications of radiation physics to radiation therapy, for example, individuals certified in Therapeutic Radiological Physics or X-Ray and Radium Physics by the American Board of Radiology, or those having equivalent qualifications.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(eeee)">(eeee)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Quality factor" (Q) means the modifying factor, listed in Tables 1 and 2 of this Rule that is used to derive dose equivalent from absorbed dose.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ffff)">(ffff)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Quarterly" means once every three calendar months or no later than the last day of the third month after the initial month.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(gggg)">(gggg)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Rad" means the special unit of absorbed dose. One rad is equal to an absorbed dose of 100 ergs/gram or 0.01 Joule/kilogram (0.01 Gray).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(hhhh)">(hhhh)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Radiation" means alpha particles, beta particles, gamma rays, x- rays, neutrons, high-speed electrons, high-speed protons, and other particles capable of producing ions. For purposes of this Chapter, ionizing radiation is an equivalent term. Radiation, as used in this Chapter, does not include non-ionizing radiation, such as radiowaves, microwaves, visible, infrared, or ultraviolet light.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(iiii)">(iiii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Radiation area" means any area, accessible to individuals, in which radiation levels could result in an individual receiving a dose equivalent in excess of 5 mrem (0.05 mSv) in one hour at 30 centimeters from the source of radiation or from any surface that the radiation penetrates.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(jjjj)">(jjjj)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Radiation machine" means any device capable of producing radiation except those devices with radioactive material as the only source of radiation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(kkkk)">(kkkk)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Radiation Safety Officer" (RSO) means an individual who has the knowledge and responsibility to apply appropriate radiation protection regulations.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(llll)">(llll)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Radioactive material" means any solid, liquid, or gas that emits radiation spontaneously.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(mmmm)">(mmmm)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Radioactivity" means the transformation of unstable atomic nuclei by the emission of radiation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(nnnn)">(nnnn)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Regulations of the U.S. Department of Transportation" means the regulations in 49 CFR Parts 100-189.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(oooo)">(oooo)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Rem" means the special unit of any of the quantities expressed as dose equivalent. The dose equivalent in rem is equal to the absorbed dose in rad multiplied by the quality factor (1 rem = 0.01 Sievert).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(pppp)">(pppp)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Research and development" means </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(pppp)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Theoretical analysis, exploration, or experimentation; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(pppp)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The extension of investigative findings and theories of a scientific or technical nature into practical application for experimental and demonstration purposes, including the experimental production and testing of models, devices, equipment, materials, and processes. Research and development does not include the internal or external administration of radiation or radioactive material to human beings.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(qqqq)">(qqqq)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Restricted area" means any area to which access is limited by the licensee for purposes of protecting individuals against undue risks from exposure to sources of radiation and radioactive material. A restricted area does not include areas used as residential quarters, but separate rooms in a residential building may be set apart as a restricted area.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(rrrr)">(rrrr)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Roentgen" means the special unit of exposure. One Roentgen (R) equals 2.58 x 10</span><span class=""><SUP>-4</SUP></span><span class=""> Coulombs/kilogram of air. </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ssss)">(ssss)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Sealed source" means radioactive material that is permanently bonded or fixed in a capsule or matrix designed to prevent release and dispersal of the radioactive material under the most severe conditions which are likely to be encountered in normal use and handling.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(tttt)">(tttt)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Sealed Source and Device Registry" means the national registry that contains all the registration certificates, generated by both the NRC and the Agreement States, that summarize the radiation safety information for the sealed sources and devices and describe the licensing and use conditions approved for the product.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(uuuu)">(uuuu)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Shallow dose equivalent" (H</span><span class=""><SUB>s</SUB></span><span class="">), which applies to the external exposure of the skin of the whole body or the skin of an extremity, means the dose equivalent at a tissue depth of 0.007 centimeter (7 mg/cm</span><span class=""><SUP>2</SUP></span><span class="">).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(vvvv)">(vvvv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "SI" means an abbreviation of the International System of Units.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(wwww)">(wwww)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Sievert" means the SI unit of any of the quantities expressed as dose equivalent. The dose equivalent in Sievert is equal to the absorbed dose in Gray multiplied by the quality factor (1 Sv = 100 rem).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(xxxx)">(xxxx)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Site boundary" means that line beyond which the land or property is not owned, leased, or otherwise controlled by the licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(yyyy)">(yyyy)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Source material" means</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(yyyy)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Uranium or thorium, or any combination thereof, in any physical or chemical form; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(yyyy)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ores that contain by weight one-twentieth of one percent (0.05 percent) or more of uranium, thorium, or any combination thereof. Source material does not include special nuclear material.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(zzzz)">(zzzz)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Source material milling" means any activity that results in the production of byproduct material as defined by .01(2)(o)2.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(aaaaa)">(aaaaa)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Source of radiation" means any radioactive material or any device or equipment emitting, or capable of producing, radiation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(bbbbb)">(bbbbb)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Special form radioactive material" means radioactive material that satisfies the following conditions: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(bbbbb)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> It is either a single solid piece or is contained in a sealed capsule that can be opened only by destroying the capsule;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(bbbbb)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The piece or capsule has at least one dimension not less than five millimeters (0.197 inch); and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(bbbbb)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> It satisfies the test requirements specified by the U.S. Nuclear Regulatory Commission. A special form encapsulation designed in accordance with the U.S. Nuclear Regulatory Commission requirements in effect on June 30, 1983, and constructed prior to July 1, 1985, may continue to be used. A special form encapsulation either designed or constructed after June 30, 1985, must meet requirements of this definition applicable at the time of its design or construction.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ccccc)">(ccccc)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Special nuclear material" means:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ccccc)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Plutonium, uranium-233, uranium enriched in the isotope 233 or in the isotope 235, and any other material that the U.S. Nuclear Regulatory Commission, pursuant to the provisions of section 51 of the Atomic Energy Act of 1954, as amended, determines to be special nuclear material but does not include source material; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ccccc)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any material artificially enriched by any of the foregoing but does not include source material.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ddddd)">(ddddd)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Special nuclear material in quantities not sufficient to form a critical mass" means uranium enriched in the isotope U-235 in quantities not exceeding 350 grams of contained U-235; uranium-233 in quantities not exceeding 200 grams; plutonium in quantities not exceeding 200 grams; or any combina­tion of them in accordance with the following formula: For each kind of special nuclear material, determine the ratio between the quantity of that special nuclear material and the quantity specified above for the same kind of special nuclear material. The sum of such ratios for all of the kinds of special nuclear material in combination shall not exceed 1. </span><span class=""><P>For example, the following quantities in combination would not exceed the limitation and are within the formula:</P></span><span class=""><P> <P><img class="ImageLink" src="/pdf/ga/admin/2017/391-3-17-1.gif" alt=" image: ga/admin/2017/391-3-17-1.gif"></P> </P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(eeeee)">(eeeee)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Survey" means an evaluation of the radiological conditions and potential hazards incident to the production, use, transfer, release, disposal, or presence of sources of radiation. When appropriate, such evaluation includes, but is not limited to, tests, physical examinations, and measurements of levels of radiation or concentrations of radioactive material present.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(fffff)">(fffff)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Test" means the process of verifying compliance with an applicable regulation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ggggg)">(ggggg)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "This Chapter" means all of the Rules in Chapter 391-3-17.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(hhhhh)">(hhhhh)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Total effective dose equivalent" (TEDE) means the sum of the effective dose equivalent (for external exposures) and the committed effective dose equivalent (for internal exposures). </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(iiiiii)">(iiiiii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "U.S. Department of Energy" means the Department of Energy established by Public Law 95-91, August 4, 1977, 91 Stat. 565, </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/United_States_Code/browse?ci=25&amp;id=gasos&amp;codesec=7101&amp;title=42&amp;getbrowsepage=yes#" target="_newtab">42 U.S.C. 7101</a></span><span class=""> et seq., to the extent that the Department exercises functions formerly vested in the U.S. Atomic Energy Commission, its Chairman, members, officers, and components and transferred to the U.S. Energy Research and Development Administration and to the Administrator thereof pursuant to sections 104(b), (c) and (d) of the Energy Reorganization Act of 1974 ( Public Law 93-438, October 11, 1974, 88 Stat. 1233 at 1237, </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/United_States_Code/browse?ci=25&amp;id=gasos&amp;codesec=5814&amp;title=42#" target="_newtab">42 U.S.C. 5814</a></span><span class="">, effective January 19, 1975) and retransfer­red to the Secretary of Energy pursuant to section 301(a) of the Department of Energy Organization Act ( Public Law 95-91, August 4, 1977, 91 Stat. 565 at 577-578, </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/United_States_Code/browse?ci=25&amp;id=gasos&amp;codesec=7151&amp;title=42#" target="_newtab">42 U.S.C. 7151</a></span><span class="">, effective October 1, 1977). </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(jjjjj)">(jjjjj)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Unrefined and unprocessed ore" means ore in its natural form prior to any processing, such as grinding, roasting, beneficiating, or refining. Processing does not include sieving or encapsulation of ore or preparation of samples for laboratory analysis.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(kkkkk)">(kkkkk)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Unrestricted area" means an area to which access is neither limited nor controlled by the licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(lllll)">(lllll)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Very High Radiation Area" means an area, accessible to individuals, in which radiation levels could result in an individual receiving an absorbed dose in excess of 500 rads (5 Grays) in one hour at one meter from a radiation source or from any surface that the radiation penetrates.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(mmmmm)">(mmmmm)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Waste" means those low-level radioactive wastes containing source, special nuclear, or byproduct material that are acceptable for disposal in a land disposal facility. For the purposes of this definition, low-level waste has the same meaning as radioactive waste not classified as high-level radioactive waste, transuranic waste, spent nuclear fuel, or byproduct material as defined in .01(2)(o)2., 3., and 4.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(nnnnn)">(nnnnn)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Waste handling licensees" mean persons licensed to receive and store radioactive wastes prior to disposal and/or persons licensed to dispose of radioactive waste.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ooooo)">(ooooo)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Weekly" means once every calendar week, not to exceed an interval of ten days.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ppppp)">(ppppp)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Whole body" means, for purposes of external exposure, head, trunk, including male gonads, arms above the elbow, or legs above the knee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(qqqqq)">(qqqqq)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Worker" means an individual engaged in work under a license issued by the Department and controlled by a licensee. If the licensee is an individual rather than one of the other legal entities defined under "person," the radiation exposure limits for the worker also apply to the individual who is the licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(rrrrr)">(rrrrr)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Working level" (WL) means any combination of short-lived radon daughters in one liter of air that will result in the ultimate emission of 1.3 x 10</span><span class=""><SUP>5</SUP></span><span class=""> MeV of potential alpha particle energy. The short-lived radon daughters for radon-222 are: polonium-218, lead-214, bismuth-214, and polonium-214; and for radon-220: polonium-216, lead-212, bismuth-212, and polonium-212.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(sssss)">(sssss)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Working level month" (WLM) means an exposure to one working level for 170 hours. Two thousand working hours per year divided by 12 months per year is approximately equal to 170 hours per month.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(2)(ttttt)">(ttttt)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Year" means the period of time beginning in January used to determine compliance with the provisions of this Chapter. The licensee may change the starting date of the year used to determine compliance by the licensee provided that the change is made at the beginning of the year and that no day is omitted or duplicated in consecutive years.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)">(3)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Exemptions from the Regulatory Requirements.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> General Provision. The Department may, upon application or upon its own initiative, grant such exemptions or exceptions from the requirements of this Chapter as it determines are authorized by law and will not result in undue hazard to public health and safety or property.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> U.S. Department of Energy Contractors and U.S. Nuclear Regulatory Commission Contractors. Any U.S. Department of Energy contractor or subcontractor and any U.S. Nuclear Regulatory Commission contractor or subcontractor of the following categories operating within this State are exempt from this Chapter to the extent that such contractor or subcontractor under his contract receives, possesses, uses, transfers, or acquires sources of radiation: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prime contractors performing work for the U.S. Department of Energy at U.S. government-owned or -controlled sites, including the transportation of sources of radiation to or from such sites and the performance of contract services during temporary interruptions of such transportation;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prime contractors of the U.S. Department of Energy performing research in, or development, manufacture, storage, testing, or transportation of, atomic weapons or components thereof;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prime contractors of the U.S. Department of Energy using or operating nuclear reactors or other nuclear devices in a United States government-owned vehicle or vessel; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any other prime contractor or subcontractor of the U.S. Department of Energy or of the U.S. Nuclear Regulatory Commission when the Department and the Nuclear Regulatory Commission jointly determine: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)(b)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> That the exemption of the prime contractor or subcontractor is authorized by law; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(3)(b)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> That, under the terms of the contract or subcontract, there is adequate assurance that the work thereunder can be accomplished without undue risk to public health and safety.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(4)">(4)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Records.</B></span><span class=""> Each licensee shall maintain records showing the receipt, transfer, and disposal of all sources of radiation. Additional record requirements are specified elsewhere in this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)">(5)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Inspections.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall afford the Department at all reasonable times opportunity to inspect sources of radiation and the premises and facilities wherein such sources of radiation are used or stored.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall make available to the Department for inspection, upon reasonable notice, records maintained pursuant to this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department or its designated representative is authorized under the authority of O.C.G.A. </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Code_of_Georgia/browse?ci=25&amp;id=gasos&amp;codesec=31-5-5&amp;title=31#31-5-5(b)" target="_newtab">31-5-5(b)</a></span><span class=""> to classify as confidential and privileged such documents, reports, and other information and data obtained from persons, firms, corporations, municipalities, counties, and other public authorities and political subdivisions where such matters relate to: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Trade secrets and commercial or financial information furnished to the Department on a privileged or confidential basis. Matters subject to this exemption are those that are customarily held in confidence by the originator. They include, but are not limited to: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)(c)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Information received in confidence, such as trade secrets, inventions, and proprietary data;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)(c)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Technical reports and data, designs, drawings, specifications, formulas, or other types of proprietary information which are furnished to the Department or which are generated or developed by the Department or for the Department under contract.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Personnel and medical files and similar files, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Examples of files exempt from disclosure include, but are not limited to names or identifying information regarding individuals who have received exposure to radiation.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(5)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Discovery of material qualified pursuant to </span><span class=""> <a title="391-3-17-.01" href="391-3-17-.01">391-3-17-.01</a></span><span class=""> (5)(c) shall be subject to the statutory requirements found in O.C.G.A. </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Code_of_Georgia/browse?ci=25&amp;id=gasos&amp;codesec=31-5-5&amp;title=31#" target="_newtab">31-5-5</a></span><span class="">.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(6)">(6)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Tests.</B></span><span class=""> Each licensee shall perform upon instructions from the Department, or shall permit the Department to perform, such reasonable tests as the Department deems appropriate or necessary, including, but not limited to, tests of: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(6)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Sources of radiation;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(6)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Facilities wherein sources of radiation are used or stored;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(6)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Radiation detection and monitoring instruments; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(6)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Other equipment and devices used in connection with utilization or storage of licensed sources of radiation.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(7)">(7)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Additional Requirements.</B></span><span class=""> The Department, by Rule or Regulation, and the Director by Order, may impose upon any licensee such requirements in addition to those established in this Chapter as it deems appropriate or necessary to minimize danger to public health and safety or property.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)">(8)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Violations.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An injunction or other court order may be obtained prohibiting any violation of the provisions of the Act, this Chapter, or any Order issued thereunder in accordance with Rule </span><span class=""> <a title="391-3-17-.11" href="391-3-17-.11">391-3-17-.11</a></span><span class="">. Any person who willfully violates any provision of the Act, this Chapter, or any Order issued thereunder may be guilty of a misdemeanor as provided by law. Violators of this Chapter may also be subject to civil penalties in accordance with O.C.G.A. </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Code_of_Georgia/browse?ci=25&amp;id=gasos&amp;codesec=31-13-15&amp;title=31#" target="_newtab">31-13-15</a></span><span class="">.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any licensee, certificate of registration holder, applicant for a license or certificate of registration, employee of a licensee, certificate of registration holder or applicant; or any contractor (including a supplier or consultant), subcontractor, employee of a contractor or subcontractor of any licensee or certificate of registration holder or applicant for a license or certificate of registration, who knowingly provides to any licensee, applicant, certificate holder, contractor, or subcontractor, any components, equipment, materials, or other goods or services that relate to a licensee's, certificate holder's or applicant's activities in this part, may not: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Engage in deliberate misconduct that causes or would have caused, if not detected, a licensee, certificate of registration holder, or applicant to be in violation of any Rule, Regulation, or Order; or any term, condition, or limitation of any license issued by the Department; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Deliberately submit to the Department, a licensee, certificate of registration holder, an applicant, or a licensee's, certificate holder's or applicant's, contractor or subcontractor, information that the person submitting the information knows to be incomplete or inaccurate in some respect material to the Department.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A person who violates 8(b)1. or 8(b)2. may be subject to enforcement action in accordance with the provisions of Rule .11 of this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For the purposes of 8(b)1., deliberate misconduct by a person means an intentional act or omission that the person knows:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Would cause a licensee, certificate of registration holder or applicant to be in violation of any Rule, Regulation, or Order; or any term, condition, or limitation, of any license issued by the Department; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(8)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Constitutes a violation of a requirement, procedure, instruction, contract, purchase order, or policy of a licensee, certificate of registration holder, applicant, contractor, or subcontractor.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(9)">(9)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Impounding.</B></span><span class=""> The Department shall have the authority in the event of an emergency to impound or order the impounding of radioactive material in the possession of any person who is not equipped to observe or fails to observe the provisions of this Chapter or any Rules issued thereunder.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(9)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Upon a showing that the emergency no longer exists and the owner of the radioactive material has demonstrated that he has achieved and is capable of maintaining compliance with the Act, the terms and conditions of his license, and all Rules, Regulations, and Orders of the Department, the Department may return the impounded radioactive material to its owner.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(9)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In the event an owner cannot demonstrate his ability to achieve and maintain compliance with the Act, the terms and conditions of his license, and all Rules, Regulations, and Orders of the Department, the Department is authorized to seek a court order condemning such radioactive material and providing for its destruction or other disposition for the health and safety of the populace.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(10)">(10)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Severability.</B></span><span class=""> Should any section, paragraph, sentence, clause or phrase of this Chapter be declared unconstitutional or invalid for any reason, the remainder of this Chapter shall not be affected thereby.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)">(11)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Units of Exposure and Dose.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> As used in this Chapter, the unit of Exposure is the Coulomb per kilogram (C/kg). One Roentgen is equal to 2.58 x 10</span><span class=""><SUP>-4</SUP></span><span class=""> Coulomb per kilogram of air.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> As used in this Chapter, the units of dose are:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Gray (Gy) is the SI unit of absorbed dose. One Gray is equal to an absorbed dose of 1 Joule/kilogram (100 rad).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Rad is the special unit of absorbed dose. One rad is equal to an absorbed dose of 100 ergs/gram or 0.01 Joule/kilogram (0.01 Gy).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Rem is the special unit of any of the quantities expressed as dose equivalent. The dose equivalent in rem is equal to the absorbed dose in rad multiplied by the quality factor (1 rem = 0.01 Sv).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Sievert is the SI unit of any of the quantities expressed as dose equivalent. The dose equivalent in Sievert is equal to the absorbed dose in Gray multiplied by the quality factor (1 Sv = 100 rem).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> As used in this Chapter, the quality factors for converting absorbed dose to dose equivalent are shown in Table I. </span><span class=""><P>TABLE I</P></span><span class=""><P>QUALITY FACTORS AND ABSORBED DOSE EQUIVALENCIES</P></span><span class=""><P> <TABLE> <TBODY> <TR> <TD rowspan="1" colspan="1"> <P>TYPE OF RADIATION</P> </TD> <TD rowspan="1" colspan="1"> <P>Quality Factor (Q)</P> </TD> <TD rowspan="1" colspan="1"> <P>Absorbed Dose Equal to a Unit Dose Equivalent <SUP>(a)</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>X, gamma, or beta radiation and high-speed electrons</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Alpha particles, multiple-charged particles, fission fragments and heavy particles of unknown charge</P> </TD> <TD rowspan="1" colspan="1"> <P> 20</P> </TD> <TD rowspan="1" colspan="1"> <P>0.05</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neutrons of unknown energy</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>High-energy protons</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> </TBODY> </TABLE> </P></span><span class=""><P><SUP>(a)</SUP> Absorbed dose in rad equal to 1 rem or the absorbed dose in Gray equal to 1 Sv. </P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(11)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If it is more convenient to measure the neutron fluence rate than to determine the neutron dose equivalent rate in Sievert per hour or rem per hour, as provided in (11)(c) of this Rule, 0.01 Sv (1 rem) of neutron radiation of unknown energies may, for purposes of this Chapter, be assumed to result from a total fluence of 25 million neutrons per square centimeter incident upon the body. If sufficient information exists to estimate the approximate energy distribution of the neutrons, the licensee may use the fluence rate per unit dose equivalent or the appropriate Q value from Table II to convert a measured tissue dose in Gray or rad to dose equivalent in Sievert or rem. </span><span class=""><P>TABLE II</P></span><span class=""><P>MEAN QUALITY FACTORS, Q, AND FLUENCE PER UNIT DOSE EQUIVALENT FOR MONOENERGETIC NEUTRONS</P></span><span class=""><P> <TABLE> <TBODY> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Neutron Energy (MeV)</P> </TD> <TD rowspan="1" colspan="1"> <P>Quality Factor <SUP>(a)</SUP> (Q)</P> </TD> <TD rowspan="1" colspan="1"> <P>Fluence per Unit Dose Equivalent <SUP>(b)</SUP> (neutrons cm<SUP>-2</SUP> rem<SUP>-1</SUP>)</P> </TD> <TD rowspan="1" colspan="1"> <P>Fluence per Unit Dose Equivalent <SUP>(b)</SUP> (neutronscm<SUP>-2</SUP> Sv<SUP>-1</SUP>)</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>(thermal)</P> </TD> <TD rowspan="1" colspan="1"> <P>2.5 x 10<SUP>-8</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> <TD rowspan="1" colspan="1"> <P>980 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>980 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-7</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> <TD rowspan="1" colspan="1"> <P>980 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>980 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> <TD rowspan="1" colspan="1"> <P>810 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>810 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-5</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> <TD rowspan="1" colspan="1"> <P>810 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>810 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-4</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> <TD rowspan="1" colspan="1"> <P>840 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>840 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> <TD rowspan="1" colspan="1"> <P>980 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>980 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-2</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2.5</P> </TD> <TD rowspan="1" colspan="1"> <P>1010 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>1010 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-1</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>7.5</P> </TD> <TD rowspan="1" colspan="1"> <P>170 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>170 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-1</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>11</P> </TD> <TD rowspan="1" colspan="1"> <P>39 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>39 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>11</P> </TD> <TD rowspan="1" colspan="1"> <P>27 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>27 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2.5</P> </TD> <TD rowspan="1" colspan="1"> <P>9</P> </TD> <TD rowspan="1" colspan="1"> <P>29 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>29 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5</P> </TD> <TD rowspan="1" colspan="1"> <P>8</P> </TD> <TD rowspan="1" colspan="1"> <P>23 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>23 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7</P> </TD> <TD rowspan="1" colspan="1"> <P>7</P> </TD> <TD rowspan="1" colspan="1"> <P>24 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>24 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>6.5</P> </TD> <TD rowspan="1" colspan="1"> <P>24 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>24 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>14</P> </TD> <TD rowspan="1" colspan="1"> <P>7.5</P> </TD> <TD rowspan="1" colspan="1"> <P>17 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>17 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>20</P> </TD> <TD rowspan="1" colspan="1"> <P>8</P> </TD> <TD rowspan="1" colspan="1"> <P>16 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>16 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>40</P> </TD> <TD rowspan="1" colspan="1"> <P>7</P> </TD> <TD rowspan="1" colspan="1"> <P>14 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>14 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>60</P> </TD> <TD rowspan="1" colspan="1"> <P>5.5</P> </TD> <TD rowspan="1" colspan="1"> <P>16 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>16 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>2</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>4</P> </TD> <TD rowspan="1" colspan="1"> <P>20 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>20 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>2</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>3.5</P> </TD> <TD rowspan="1" colspan="1"> <P>19 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>19 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>2</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>3.5</P> </TD> <TD rowspan="1" colspan="1"> <P>16 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>16 x 10<SUP>8</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>2</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>3.5</P> </TD> <TD rowspan="1" colspan="1"> <P>14 x 10<SUP>6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>14 x 10<SUP>8</SUP></P> </TD> </TR> </TBODY> </TABLE> </P></span><span class=""><P><SUP>(a)</SUP> Value of quality factor (Q) at the point where the dose equivalent is maximum in a 30-cm diameter cylinder tissue-equivalent phantom. </P></span><span class=""><P><SUP>(b)</SUP> Monoenergetic neutrons incident normally on a 30-cm diameter cylinder tissue-equivalent phantom. </P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(12)">(12)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Units of Radioactivity.</B></span><span class=""> For purposes of this Chapter, activity is expressed in the SI unit of Becquerel (Bq) or in the special unit of Curie (Ci), or their multiples, or disintegrations or transformations per unit of time. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(12)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> One Becquerel (Bq) = 1 disintegration or transformation per second.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(12)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> One Curie (Ci) = 3.7 x 10</span><span class=""><SUP>10</SUP></span><span class=""> disintegrations or transformations per second = 3.7 x 10</span><span class=""><SUP>10</SUP></span><span class=""> Becquerel (Bq) = 2.22 x 10</span><span class=""><SUP>12</SUP></span><span class=""> disintegrations or transformations per minute.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(13)">(13)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Communications.</B></span><span class=""> All communications and reports concerning this Chapter, and applications filed thereunder should be addressed to the Georgia Department of Natural Resources/EPD, Radioactive Materials Program, at 4244 International Parkway, Suite 120, Atlanta, Georgia 30354. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.01(13)a">a</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Georgia Emergency Radiological Assistance Numbers. </span><span class=""><P>GEORGIA EMERGENCY RADIOLOGICAL ASSISTANCE TELEPHONE NUMBERS</P></span><span class=""><P>To Report a Radiological Emergency or Request Emergency Radiological Assistance, Call the Following Number <B>During Business Hours:</B></P></span><span class=""><P>Georgia Environmental Protection Division</P></span><span class=""><P>Radioactive Materials Program and Environmental Radiation Program</P></span><span class=""><P><B>(404) 362-2675</B></P></span><span class=""><P><B>or</B></P></span><span class=""><P><B>(404) 363-7000</B></P></span><span class=""><P>For <B>24-Hour</B> Radiological Assistance, Call:</P></span><span class=""><P>Georgia Emergency Management Agency</P></span><span class=""><P>Emergency Operations Center</P></span><span class=""><P><B>(404) 656-4863</B></P></span><span class=""><P>Outside the Atlanta Toll-Free Calling Area (In Georgia Only), Call:</P></span><span class=""><P>Georgia Emergency Management Agency</P></span><span class=""><P>Emergency Operations Center</P></span><span class=""><P><B>1-800-241-4113</B></P></span></td> </tr> </table> </td> </tr> </table> <h2><a href="/GAC/391-3-17-.02" name="391-3-17-.02" title="391-3-17-.02">Rule 391-3-17-.02 Licensing of Radioactive Material</a></h2> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(1)">(1)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Purpose and Scope.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(1)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This Rule, </span><span class=""> <a title="391-3-17-.02" href="391-3-17-.02">391-3-17-.02</a></span><span class="">, provides for the licensing of radioactive material. No person shall receive, possess, use, transfer, own, or acquire radioactive material except as authorized in a specific or general license issued pursuant to this Rule or as otherwise provided in this Chapter. However, nothing in this Rule shall apply to any person to the extent such person is subject to regulation by the U.S. Nuclear Regulatory Commission.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(1)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In addition to the requirements of this Rule, all licensees are subject to the requirements of Rules .01, .03, .06, .07, .10, and .11 of this Chapter. Licensees engaged in industrial radiographic operations are subject to the requirements of Rule .04 of this Chapter. Licensees using radioactive material in the healing arts are also subject to the requirements of Rule .05 of this Chapter. Licensees engaged in the extrusion, mining, storage, beneficiating, processing, use, transfer, or disposal of NORM in such a manner as to alter the chemical properties or physical state of the NORM or its potential exposure pathways to humans are also subject to the requirements of Rule .08 of this Chapter. Licensees using irradiators whose dose rate exceeds 500 rads (5 Grays) per hour at one meter from the radioactive sealed sources are also subject to the requirements of Rule .09 of this Chapter. </span><span class=""><P>Note: All numbered and lettered references within this Rule refer to parts of this Rule, unless stated otherwise.</P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)">(2)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Exemptions/Source Material.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person is exempt from this Rule to the extent that such person receives, possesses, uses, owns, or transfers source material in any chemical mixture, compound, solution, or alloy in which the source material is by weight less than 1/20 of one percent (0.05 percent) of the mixture, compound, solution, or alloy.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person is exempt from this Rule to the extent that such person receives, possesses, uses, or transfers unrefined and unprocessed ore containing source material; provided that, except as authorized in a specific license, such person shall not refine or process such ore.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person is exempt from this Rule to the extent that such person receives, possesses, uses, or transfers: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any quantities of thorium contained in: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Incandescent gas mantles,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Vacuum tubes,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Welding rods,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Electric lamps for illuminating purposes provided that each lamp does not contain more than 50 milligrams of thorium,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)1.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Germicidal lamps, sunlamps, and lamps for outdoor or industrial lighting provided that each lamp does not contain more than two grams of thorium,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)1.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Rare earth metals and compounds, mixtures, and products containing not more than 0.25 percent by weight thorium, uranium, or any combination of these, or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)1.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Personnel neutron dosimeters, provided that each dosimeter does not contain more than 50 milligrams of thorium;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Source material contained in the following products: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Glazed ceramic tableware manufactured before August 27, 2013, provided that the glaze contains not more than 20 percent by weight source material,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Glassware containing not more than ten percent by weight source material, but not including commercially manufactured glass brick, pane glass, ceramic tile, or other glass or ceramic used in construction,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Glassware containing not more than 2 percent by weight source material, or for glassware manufactured before August 27, 2013, 10 percent by weight source material; but not including commercially manufactured glass brick, pane glass, ceramic tile, or other glass or ceramic used in construction, or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Piezoelectric ceramic containing not more than two percent by weight source material;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Photographic film, negatives, and prints containing uranium or thorium;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any finished product or part fabricated of, or containing, tungsten-thorium or magnesium-thorium alloys, provided that the thorium content of the alloy does not exceed four percent by weight and that this exemption shall not be deemed to authorize the chemical, physical, or metallurgical treatment or processing of any such product or part;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Uranium contained in counterweights installed in aircraft, rockets, projectiles, and missiles, or stored or handled in connection with installation or removal of such counterweights, provided that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each such counterweight has been impressed with the following legend clearly legible through any plating or other covering: "DEPLETED URANIUM",</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each counterweight is durably and legibly labeled or marked with the identification of the manufacturer and the statement: "UNAUTHORIZED ALTERATIONS PROHIBITED", and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)5.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This exemption shall not be deemed to authorize the chemical, physical, or metallurgical treatment or processing of any such counterweights other than repair or restoration of any plating or other covering; </span><span class=""><P>Note: The requirements specified in (2)(c)5.(i) and (ii) need not be met by counterweights manufactured prior to December 31, 1969, provided that such counterweights are impressed with the legend: "CAUTION - RADIOACTIVE MATERIAL - URANIUM".</P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Natural or depleted uranium metal used as shielding constituting part of any shipping container which is conspicuously and legibly impressed with the legend: "CAUTION - RADIOACTIVE SHIELDING - URANIUM" and the uranium metal is encased in mild steel or equally fire-resistant metal of minimum wall thickness of 1/8 inch (3.2 mm);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Thorium or uranium contained in or on finished optical lenses and mirrors, provided that each lens or mirror does not contain more than 10 percent by weight thorium or uranium or, for lenses manufactured before August 27, 2013, 30 percent by weight of thorium; and that this exemption contained in this subparagraph (c) does not authorize either: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)7.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The shaping, grinding, or polishing of such lens or mirror or manufacturing processes other than the assembly of such lens or mirror into optical systems and devices without any alteration of the lens or mirror; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)7.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The receipt, possession, use, or transfer of uranium or thorium contained in contact lenses, in spectacles, or in eyepieces in binoculars or other optical instruments;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)8.">8.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Uranium contained in detector heads for use in fire detection units, provided that each detector head contains not more than 0.005 microcurie of uranium; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)9.">9.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Thorium contained in any finished aircraft engine part containing nickel-thoria alloy, provided that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)9.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The thorium is dispersed in the nickel-thoria alloy in the form of finely divided thoria (thorium dioxide), and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)9.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The thorium content in the nickel-thoria alloy does not exceed four percent by weight.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)10.">10.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No person may initially transfer for sale or distribution a product containing source material to persons exempt under this subparagraph (c), or equivalent regulations of an Agreement State, unless authorized by a license issued under </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=40.52&amp;title=10#" target="_newtab">10 CFR 40.52</a></span><span class=""> to initially transfer such products for sale or distribution.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)10.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Persons initially distributing source material in products covered by the exemptions in this subparagraph (c) before August 27, 2013, without specific authorization may continue such distribution for 1 year beyond this date. Initial distribution may also be continued until the Commission takes final action on a pending application for license or license amendment to specifically authorize distribution submitted no later than 1 year beyond this date.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(c)10.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Persons authorized to manufacture, process, or produce these materials or products containing source material by an Agreement State, and persons who import finished products or parts, for sale or distribution must be authorized by a license issued under </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=40.52&amp;title=10#" target="_newtab">10 CFR 40.52</a></span><span class=""> for distribution only and are exempt from the requirements of 10 CFR 19 and 20, and 10 CFR 40.32(b) and (c).</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(2)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The exemptions in paragraph (2)(c) do not authorize the manufacture of any of the products described.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)">(3)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Exemptions/Radioactive Material Other Than Source Material.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Exempt Concentrations. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as provided in (3)(a)3. and 4., any person is exempt from this Chapter to the extent that such person receives, possesses, uses, transfers, owns, or acquires products containing radioactive material in concentrations not in excess of those listed in (21)(a), Schedule A.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This section shall not be deemed to authorize the import of radioactive material or products containing radioactive material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A manufacturer, processor, or producer of a product or material is exempt from the requirements of this Rule to the extent that this person transfers products containing radioactive material in concentrations not in excess of those listed in (21)(a) Schedule A and introduced into the product or material by a licensee holding a specific license issued by the Department expressly authorizing such introduction. This exemption does not apply to the transfer of radioactive material contained in any food, beverage, cosmetic, drug, or other commodity or product designed for ingestion or inhalation by, or application to, a human being.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(a)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No person may introduce radioactive material into a product or material knowing or having reason to believe that it will be transferred to persons exempt under (3)(a). or equivalent Regulations of the U.S. Nuclear Regulatory Commission, any Agreement State, or a Licensing State, except in accordance with a specific license issued pursuant to </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=32.11&amp;title=10#" target="_newtab">10 CFR 32.11</a></span><span class="">.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Exempt Quantities. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as provided in (3)(b)3. through 5., any person is exempt from this Chapter to the extent that such person receives, possesses, uses, transfers, owns, or acquires radioactive material in individual quantities each of which does not exceed the applicable quantity set forth in (21)(b), Schedule B. </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person, who possesses radioactive material received or acquired before September 25, 1971, under the general license then provided in </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=31.4&amp;title=10#" target="_newtab">10 CFR 31.4</a></span><span class="">, or similar general license of an Agreement State, is exempt from the requirements of this Chapter to the extent that this person possesses, uses, transfers, or owns byproduct material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Paragraph (3)(b) does not authorize the production, packaging, repackaging, or transfer of radioactive material for purposes of commercial distribution, or the incorporation of radioactive material into products intended for commercial distribution.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No person may, for purposes of commercial distribution, transfer radioactive material in the individual quantities set forth in (21)(b), Schedule B, knowing or having reason to believe that such quantities of radioactive material will be transferred to persons exempt under (3)(b) or equivalent regulations of the U.S. Nuclear Regulatory Commission, any Agreement State, or a Licensing State, except in accordance with a specific license issued by the U.S. Nuclear Regulatory Commission pursuant to Section 32.18 of 10 CFR, Part 32, or by the Department pursuant to (11)(b) which license states that the radioactive material may be transferred by the licensee to persons exempt under (3)(b) or the equivalent regulations of the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(b)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No person may, for purposes of producing an increased radiation level, combine quantities of byproduct material covered by this exemption so that the aggregate quantity exceeds the limits set forth in (21)(b), Schedule B, except for radioactive material combined within a device placed in use before May 3, 1999, or as otherwise permitted by this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Exempt Items. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Certain Items Containing Radioactive Material. Except for persons who apply radioactive material to, or who incorporate radioactive material into, the following products, or persons who initially transfer for sale or distribution the following products containing radioactive material, any person is exempt from the requirements for a license set forth in this Chapter to the extent that he receives, possesses, uses, transfers, owns, or acquires the following products: </span><span class=""><P>Note: Authority to transfer possession or control by the manufacturer, processor, or producer of any equipment, device, commodity, or other product containing radioactive material whose subsequent possession, use, transfer, and disposal by all other persons are exempted from regulatory requirements may be obtained only from the U.S. Nuclear Regulatory Commission, Washington, D.C., 20555.</P></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Timepieces or hands or dials containing not more than the following specified quantities of radioactive material and not exceeding the following specified radiation dose rates:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 25 millicuries (925 MBq) of tritium per timepiece.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 5 millicuries (185 MBq) of tritium per hand.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 15 millicuries (555 MBq) of tritium per dial (bezels when used shall be considered as part of the dial).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 100 microcuries (3.7 MBq) of promethium-147 per watch or 200 microcuries (7.4 MBq) of promethium-147 per any other timepiece.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 20 microcuries (0.74 MBq) of promethium-147 per watch hand or 40 microcuries (1.48 MBq) of promethium-147 per other timepiece hand.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(VI)">(VI)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 60 microcuries (2.22 MBq) of promethium-147 per watch dial or 120 microcuries (4.44 MBq) of promethium-147 per other timepiece dial (bezels when used shall be considered as part of the dial).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(VII)">(VII)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The levels of radiation from hands and dials containing promethium-147 will not exceed, when measured through 50 milligrams per square centimeter of absorber: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(VII)I.">I.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For wrist watches, 0.1 millirad (1 </span><span class="">µ</span><span class="">Gy) per hour at ten centimeters from any surface.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(VII)II.">II.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For pocket watches, 0.1 millirad (1 </span><span class="">µ</span><span class="">Gy) per hour at one centimeter from any surface.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(VII)III.">III.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For any other timepiece, 0.2 millirad (2 </span><span class="">µ</span><span class="">Gy) per hour at ten centimeters from any surface.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(i)(VIII)">(VIII)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> One microcurie (37 kBq) of radium-226 per timepiece in intact timepieces manufactured prior to November 30, 2007. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Static elimination devices which contain, as a sealed source or sources, byproduct material consisting of a total of not more than 18.5 MBq (500 </span><span class="">µ</span><span class="">Ci) of polonium-210 per device. </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ion generating tubes designed for ionization of air that contain, as a sealed source or sources, byproduct material consisting of a total of not more than 18.5 MBq (500 </span><span class="">µ</span><span class="">Ci) of polonium-210 per device or of a total of not more than 1.85 GBq (50 mCi) of hydrogen-3 (tritium) per device.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Such devices authorized before October 23, 2012, for use under the general license then provided in Section 31.3 of 10 CFR, Part 31 and equivalent regulations of Agreement States and manufactured, tested, and labeled by the manufacturer in accordance with the specifications contained in a specific license issued by the Department. </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Precision balances containing not more than one millicurie (37 MBq) of tritium per balance or not more than 0.5 millicurie (18.5 MBq) of tritium per balance part manufactured before December 17, 2007.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> [Reserved]</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Marine compasses containing not more than 750 millicuries (27.8 GBq) of tritium gas and other marine navigational instruments containing not more than 250 millicuries (9.25 GBq) of tritium gas manufactured before December 17, 2007.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> [Reserved]</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(ix)">(ix)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ionization chamber smoke detectors containing not more than 1 microcurie ([MU]Ci) of americium-241 per detector in the form of a foil and designed to protect life and property from fires.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(x)">(x)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Electron tubes, provided that the levels of radiation from each electron tube containing radioactive material will not exceed one millirad (10 [MU]Gy) per hour at one centimeter from any surface when measured through seven milligrams per square centimeter of absorber. Provided also, that each tube does not contain more than one of the following specified quantities of radioactive material: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(x)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 150 millicuries (5.55 GBq) of tritium per microwave receiver protector tube or ten millicuries (370 MBq) of tritium per any other electron tube.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(x)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 1 microcurie (37 kBq) of cobalt-60.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(x)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 5 microcuries (185 kBq) of nickel-63.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(x)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 30 microcuries (1.11 MBq) of krypton-85.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(x)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 5 microcuries (185 kBq) of cesium-137.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(x)(VI)">(VI)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> 30 microcuries (1.11 MBq) of promethium-147. </span><span class=""><P>NOTE: For the purpose of .02(3)(c)1.(x), "Electron tubes" includes spark gap tubes, power tubes, gas tubes including glow lamps, receiving tubes, microwave tubes, indicator tubes, pick-up tubes, radiation detection tubes, and any other completely sealed tube that is designed to conduct or control electrical currents.</P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(xi)">(xi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ionizing radiation measuring instruments containing, for purposes of internal calibration or standardization, one or more sources of radioactive material, provided that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(xi)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each source contains no more than one exempt quantity set forth in (21)(b), Schedule B;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(xi)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each instrument contains no more than ten exempt quantities. For purposes of this requirement, an instrument's source(s) may contain either one or different types of radionuclides and an individual exempt quantity may be composed of fractional parts of one or more of the exempt quantities specified in (21)(b), Schedule B, provided that the sum of such fractions shall not exceed unity; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(xi)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For purposes of .02(3)(c)1.(xi), 0.05 microcurie (1.85 kBq) of americium-241 is considered an exempt quantity under (21)(b), Schedule B.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(xii)">(xii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> [Reserved] </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)1.(xiii)">(xiii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who desires to apply byproduct material to, or to incorporate byproduct material into, the products exempted in 3(c)1., or who desires to initially transfer for sale or distribution such products containing radioactive material, should apply for a specific license with the U.S. Nuclear Regulatory Commission pursuant to Section 32.14 of 10 CFR, Part 32, which license states that the product may be distributed by the licensee to persons exempt under (3)(c)1., or the equivalent regulations of the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Self-Luminous Products Containing Radioactive Material. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Tritium, krypton-85, or promethium-147. Except for persons who manufacture, process, produce, or initially transfer for sale or distribution self-luminous products containing tritium, krypton-85, or promethium-147, any person is exempt from the requirements for a license set forth in this Chapter to the extent that such person receives, possesses, uses, transfers, owns, or acquires tritium, krypton-85 or promethium-147 in self-luminous products manufactured, processed, produced, or initially transferred in accordance with a specific license issued by the U.S. Nuclear Regulatory Commission pursuant to Section 32.22 of 10 CFR, Part 32, which license authorizes the initial transfer of the product to persons who are exempt from regulatory requirements. This exemption does not apply to tritium, krypton-85, or promethium-147 used in products for frivolous purposes or in toys or adornments.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Radium-226. Any person is exempt from this Chapter to the extent that such person receives, possesses, uses, transfers, or owns articles containing less than 0.1 microcurie (3.7 kBq) of radium-226 that were acquired prior to July 12, 1982.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who desires to manufacture, process, or produce, or initially transfer for sale or distribution self-luminous products containing tritium, krypton-85, or promethium-147 for use under paragraph .02(3)(c)2.(i) should apply for a license with the U.S. Nuclear Regulatory Commission pursuant to Section 32.22 of 10 CFR Part 32 and apply to the U.S. Nuclear Regulatory Commission for a certificate of registration in accordance with Section 32.210 of 10 CFR Part 32.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Gas and Aerosol Detectors Containing Radioactive Material.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except for persons who manufacture, process, produce, or initially transfer for sale or distribution gas and aerosol detectors containing radioactive material, any person is exempt from the requirements for a license set forth in this Chapter to the extent that such person receives, possesses, uses, transfers, owns, or acquires radioactive material in gas and aerosol detectors designed to protect health, safety, or property provided that detectors containing radioactive material shall have been manufactured, processed, produced, or initially transferred in accordance with a specific license issued by the U.S. Nuclear Regulatory Commission pursuant to Section 32.26 of 10 CFR, Part 32. This exemption also covers gas and aerosol detectors manufactured or distributed before November 30, 2007, in accordance with a specific license issued by a State under comparable provisions to Section 32.26 of 10 CFR, Part 32 authorizing distribution to persons exempt from regulatory requirements.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Gas and aerosol detectors containing naturally-occurring and accelerator-produced radioactive material (NARM) previously manufactured and distributed to general licensees in accordance with a specific license issued by an Agreement State shall be considered exempt under (3)(c)3.(i), provided that the device is labeled in accordance with the specific license authorizing distribution of the generally licensed device, and provided further that they meet the requirements of </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=32.26&amp;title=10#" target="_newtab">10 CFR 32.26</a></span><span class="">.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Gas and aerosol detectors containing NARM previously manufactured and distributed in accordance with a specific license issued by a Licensing State shall be considered exempt under (3)(c)3.(i), provided that the device is labeled in accordance with the specific license authorizing distribution, and provided further that they meet the requirements of </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=32.26&amp;title=10#" target="_newtab">10 CFR 32.26</a></span><span class="">.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)3.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who desires to manufacture, process, or produce gas and aerosol detectors containing radioactive material, or to initially transfer such products for use under .02(3)(c)3.(i) should apply for a license with the U.S. Nuclear Regulatory Commission pursuant to Section 32.26 of 10 CFR Part 32 and apply to the U.S. Nuclear Regulatory Commission for a certificate of registration in accordance with Section 32.210 of 10 CFR, Part 32.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Radioactive drug: Capsules containing carbon-14 urea for "in vivo" diagnostic use for humans. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as provided in .02(3)(c)4.(ii) and .02(3)(c)4.(iii), any person is exempt from the requirements for a license set forth in O.C.G.A. Section </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Code_of_Georgia/browse?ci=25&amp;id=gasos&amp;codesec=31-13-5&amp;title=31#31-13-5(a)(9)" target="_newtab">31-13-5(a)(9)</a></span><span class=""> (Georgia Radiation Control Act) and from the regulations in this Chapter provided that such person receives, possesses, uses, transfers, owns, or acquires capsules containing one </span><span class="">µ</span><span class="">Ci (37 kBq) carbon-14 urea (allowing for nominal variation that may occur during the manufacturing process) each, for "in vivo" diagnostic use for humans.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who desires to use the capsules for research involving human subjects shall apply for and receive a specific license pursuant to Rule .02 and Rule .05 of this chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)4.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who desires to manufacture, prepare, process, produce, package, repackage, or transfer for commercial distribution such capsules shall apply for and receive a specific license pursuant to Rule .02 of this chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)4.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Nothing in .02(3)(c)4. relieves persons from complying with applicable FDA, other Federal, and State requirements governing receipt, administration, and use of drugs.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except for persons who manufacture, process, produce, or initially transfer for sale or distribution industrial devices containing byproduct material designed and manufactured for the purpose of detecting, measuring, gauging or controlling thickness, density, level, interface location, radiation, leakage, or qualitative or quantitative chemical composition, or for producing an ionized atmosphere, any person is exempt from the requirements for a license set forth in this Chapter to the extent that such person receives, possesses, uses, transfers, owns, or acquires byproduct material, in these certain detecting, measuring, gauging, or controlling devices and certain devices for producing an ionized atmosphere, and manufactured, processed, produced, or initially transferred in accordance with a specific license issued under Section 32.30 of 10 CFR Part 32, which license authorizes the initial transfer of the device for use under this section. This exemption does not cover sources not incorporated into a device, such as calibration and reference sources. </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(3)(c)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who desires to manufacture, process, produce, or initially transfer for sale or distribution industrial devices containing byproduct material for use under .02(3)(c)5. should apply for a license to the U.S. Nuclear Regulatory Commission pursuant to Section 32.30 of 10 CFR Part 32 and to the U.S. Nuclear Regulatory Commission for a certificate of registration in accordance with </span><span class="">§</span><span class="">32.210 of 10 CFR, Part 32.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(4)">(4)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Types of Licenses.</B></span><span class=""> Licenses for radioactive materials are of two types: general and specific. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(4)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> General licenses provided in this Rule are effective without the filing of applications with the Department or the issuance of licensing documents to the particular persons, although the filing of a certificate with the Department may be required by the particular general license. The general licensee is subject to all other applicable portions of this Chapter and any limitations of the general license.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(4)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Specific licenses require the submission of an application to the Department and the issuance of a licensing document by the Department to a named person. The licensee is subject to all applicable portions of this Chapter as well as any limitations specified in the licensing document.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)">(5)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>General Licenses - Source Material.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued authorizing persons to hold bare title to source material without regard to quantity. This general license does not authorize any person to receive, possess, use, or transfer source material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued authorizing commercial and industrial firms; research, educational, and medical institutions; and Federal, State and local government agencies to receive, possess, use, and transfer uranium and thorium, in their natural isotopic concentrations and in the form of depleted uranium, for research, development, educational, commercial, or operational purposes in the following forms and quantities:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No more than 1.5 kg (3.3 lb) of uranium and thorium in dispersible forms (e.g., gaseous, liquid, powder, etc.) at any one time. Any material processed by the general licensee that alters the chemical or physical form of the material containing source material must be accounted for as a dispersible form. A person authorized to possess, use, and transfer source material under this subparagraph may not receive more than a total of 7 kg (15.4 lb) of uranium and thorium in any one calendar year. Persons possessing source material in excess of these limits as of August 27, 2013, may continue to possess up to 7 kg (15.4 lb) of uranium and thorium at any one time for one year beyond this date, or until the Commission takes final action on a pending application submitted on or August 27, 2014, for a specific license for such material; and receive up to 70 kg (154 lb) of uranium or thorium in any one calendar year until December 31, 2014, or until the Commission takes final action on a pending application submitted on or before August 27, 2014, for a specific license for such material; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No more than a total of 7 kg (15.4 lb) of uranium and thorium at any one time. A person authorized to possess, use, and transfer source material under this subparagraph may not receive more than a total of 70 kg (154 lb) of uranium and thorium in any one calendar year. A person may not alter the chemical or physical form of the source material possessed under this subparagraph unless it is accounted for under the limits of subparagraph (b)(1) of this section; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No more than 7 kg (15.4 lb) of uranium, removed during the treatment of drinking water, at any one time. A person may not remove more than 70 kg (154 lb) of uranium from drinking water during a calendar year under this subparagraph; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No more than 7 kg (15.4 lb) of uranium and thorium at laboratories for the purpose of determining the concentration of uranium and thorium contained within the material being analyzed at any one time. A person authorized to possess, use, and transfer source material under this subparagraph may not receive more than a total of 70 kg (154 lb) of source material in any one calendar year.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who receives, possesses, uses, or transfers source material in accordance with the general license in subparagraph (b) of this section. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Is prohibited from administering source material, or the radiation there from, either externally or internally, to human beings except as may be authorized by the NRC in a specific license.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not abandon such source material. Source material may be disposed of as follows: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(c)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A cumulative total of 0.5 kg (1.1 lb) of source material in a solid, non-dispersible form may be transferred each calendar year, by a person authorized to receive, possess, use, and transfer source material under this general license to persons receiving the material for permanent disposal. The recipient of source material transferred under the provisions of this subparagraph (c) is exempt from the requirements to obtain a license under paragraph (5) to the extent the source material is permanently disposed. This provision does not apply to any person who is in possession of source material under a specific license issued under this Chapter; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(c)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In accordance with </span><span class=""> <a title="391-3-17-.03" href="391-3-17-.03">391-3-17-.03</a></span><span class=""> (13) of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(c)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Is subject to the provisions of </span><span class=""> <a title="391-3-17-.03" href="391-3-17-.03">391-3-17-.03</a></span><span class=""> (13) of this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(c)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not export such source material except in accordance with 10 CFR Part 110.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Depleted Uranium in Industrial Products and Devices.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued to receive, acquire, possess, use, or transfer, in accordance with the provisions of (5)(d)2., 3., 4., and 5., depleted uranium contained in industrial products or devices for the purpose of providing a concentrated mass in a small volume of the product or device.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general license in (5)(d)1. applies only to industrial products or devices which have been manufactured either in accordance with a specific license issued to the manufacturer of the products or devices in accordance with a specific license issued to the manufacturer by the U.S. Nuclear Regulatory Commission or an Agreement State which authorizes manufacture of the products or devices for distribution to persons generally licensed by the U.S. Nuclear Regulatory Commission or an Agreement State.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Persons who receive, acquire, possess, or use depleted uranium pursuant to the general license established by (5)(d)1. shall: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> File Department form "Registration Certificate - Use of Depleted Uranium Under General License" with the Department. The form shall be submitted within 30 days after the first receipt or acquisition of such depleted uranium. The registrant shall furnish on the form the following information and such other information as may be required by that form: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)3.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Name and address of the registrant;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)3.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A statement that the registrant has developed and will maintain procedures designed to establish physical control over the depleted uranium described in (5)(d)1. and designed to prevent transfer of such depleted uranium in any form, including metal scrap, to persons not authorized to receive the depleted uranium; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)3.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Name and/or title, address, and telephone number of the individual duly authorized to act for and on behalf of the registrant in supervising the procedures identified in (5)(d)3.(i)(II); and</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Report in writing to the Department any changes in information furnished by him in Department form "Registration Certificate - Use of Depleted Uranium Under General License". The report shall be submitted within 30 days after the effective date of such change.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A person who receives, acquires, possesses, or uses depleted uranium pursuant to the general license established by (5)(d)1:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not introduce such depleted uranium, in any form, into a chemical, physical, or metallurgical treatment or process, except a treatment or process for repair or restoration of any plating or other covering of the depleted uranium;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not abandon such depleted uranium;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)4.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall transfer or dispose of such depleted uranium only by transfer in accordance with the provisions of (19). In the case where the transferee receives the depleted uranium pursuant to the general license established by (5)(d)1., the transferor shall furnish the transferee a copy of this Regulation and a copy of Department form "Registration Certificate - Use of Depleted Uranium Under General License". In the case where the transferee receives the depleted uranium pursuant to a general license contained in the U.S. Nuclear Regulatory Commission's or Agreement State's regulation equivalent to (5)(d)1., the transferor shall furnish the transferee a copy of this Regulation and a copy of Department form "Registration Certificate - Use of Depleted Uranium Under General License "accompanied by a note explaining that use of the product or device is regulated by the U.S. Nuclear Regulatory Commission or Agreement State under requirements substantially the same as those in this Regulation;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)4.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall report in writing to the Department the name and address of the person receiving the depleted uranium pursuant to such transfer within 30 days of any transfer.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(d)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person receiving, acquiring, possessing, using, or transferring depleted uranium pursuant to the general license established by (5)(d)1. is exempt from the requirements of Rule .03 and Rule .07 of this Chapter with respect to the depleted uranium covered by that general license.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who receives, possesses, uses, or transfers source material in accordance with subparagraph (b) of this section shall conduct activities so as to minimize contamination of the facility and the environment. When activities involving such source material are permanently ceased at any site, if evidence of significant contamination is identified, the general licensee shall notify the Department about such contamination and may consult with the Department as to the appropriateness of sampling and restoration activities to ensure that any contamination or residual source material remaining at the site where source material was used under this general license is not to result in exposures that exceed the limits in </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=20.1402&amp;title=10#" target="_newtab">10 CFR 20.1402</a></span><span class=""> of this chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who receives, possesses, uses, or transfers source material in accordance with the general license granted in subparagraph (c) and (e) of this section is exempt from the provisions of 10 CFR parts 19, 20, and 21 to the extent that such receipt, possession, use, and transfer are within the terms of this general license, except that such person shall comply with the provisions of this Chapter to the extent necessary to meet the provisions of subparagraphs (c) and (e) of this section. However, this exemption does not apply to any person who also holds a specific license issued under this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No person may initially transfer or distribute source material to persons generally licensed under subparagraph (b) of this section, or equivalent regulations of an Agreement State, unless authorized by a specific license issued in accordance with this Chapter or equivalent provisions of an Agreement State. This prohibition does not apply to analytical laboratories returning processed samples to the client who initially provided the sample.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for a specific license to initially transfer source material for use under this Chapter will be approved if:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(h)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in this Chapter; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(h)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits adequate information on, and the Department approves the methods to be used for quality control, labeling, and providing safety instructions to recipients.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed under this Chapter shall label the immediate container of each quantity of source material with the type of source material and quantity of material and the words, "radioactive material."</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(j)">(j)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed under this Chapter shall ensure that the quantities and concentrations of source material are as labeled and indicated in any transfer records.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)">(k)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed under this Chapter shall report transfers as follows: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> File a report with the Department. The report shall include the following information: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The name, address, and license number of the person who transferred the source material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For each general licensee under this Chapter or provisions to whom greater than 50 grams (0.11 lb) of source material has been transferred in a single calendar quarter, the name and address of the general licensee to whom source material is distributed; a responsible agent, by name and/or position and phone number, of the general licensee to whom the material was sent; and the type, physical form, and quantity of source material transferred; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The total quantity of each type and physical form of source material transferred in the reporting period to all such generally licensed recipients.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> File a report with each responsible Agreement State agency that identifies all persons, operating under provisions equivalent to this Chapter, to whom greater than 50 grams (0.11 lb) of source material has been transferred within a single calendar quarter. The report shall include the following information specific to those transfers made to the Agreement State being reported to:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The name, address, and license number of the person who transferred the source material; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The name and address of the general licensee to whom source material was distributed; a responsible agent, by name and/or position and phone number, of the general licensee to whom the material was sent; and the type, physical form, and quantity of source material transferred.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The total quantity of each type and physical form of source material transferred in the reporting period to all such generally licensed recipients within the Agreement State.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(k)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Submit each report by January 31 of each year covering all transfers for the previous calendar year. If no transfers were made to persons generally licensed under 10 CFR Part 40.22 or equivalent Agreement State provisions during the current period, a report shall be submitted indicating so. If no transfers have been made to general licensees in a particular Agreement State during the reporting period, this information shall be reported to the responsible Agreement State agency upon request of the Department.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(5)(l)">(l)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed under this Chapter shall maintain all information that supports the reports required by this subparagraph concerning each transfer to a general licensee for a period of 1 year after the event is included in a report to the Department.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)">(6)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>General Licenses - Radioactive Materials Other Than Source Material.</B></span><span class=""> Each general license issued under (6) has its own specific conditions and requirements. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ownership of Radioactive Material. A general license is hereby issued to own radioactive material without regard to quantity. Notwithstanding any other provisions of this Rule, this general license does not authorize the manufacture, production, transfer, receipt, possession, or use of radioactive material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> [Reserved]</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Certain Detecting, Measuring, Gauging, or Controlling Devices and Certain Devices for Producing Light or an Ionizing Atmosphere.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued to commercial and industrial firms and to research, educational and medical institutions, individuals in the conduct of their business, and State or local government agencies to own, receive, acquire, possess, use, or transfer, in accordance with the provisions of (6)(c)2., 3., and 4., radioactive material, excluding special nuclear material, contained in devices designed and manufactured for the purpose of detecting, measuring, gauging, or controlling thickness, density, level, interface location, radiation, leakage, or qualitative or quantitative chemical composition, or for producing light or an ionized atmosphere.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general license in (6)(c)1. applies only to radioactive material contained in devices which have been manufactured or initially transferred and labeled in accordance with the specifications contained: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> in a specific license issued by the Department pursuant to (11)(d); or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> in accordance with the specifications contained In a specific license issued by the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State, which authorizes distribution of devices to persons generally licensed by the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State. </span><span class=""><P>The devices must have been received from one of the specific licensees described in (i) or (ii) above or through a transfer made under (6)(c)3.(viii).</P></span><span class=""><P>Note: Regulations under the Federal Food, Drug, and Cosmetic Act authorizing the use of radioactive control devices in food production require certain additional labeling thereon which is found in Section 179.21 of the Code of Federal Regulations, Title 21.</P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who owns, receives, acquires, possesses, uses, or transfers radioactive material in a device pursuant to the general license in (6)(c)1.:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall assure that all labels affixed to the device at the time of receipt, and bearing a statement that removal of the label is prohibited, are maintained thereon and shall comply with all instructions and precautions provided by such labels;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall assure that the device is tested for leakage of radioactive material and proper operation of the on/off mechanism and indicator, if any, at no longer than six-month intervals or at such other intervals as are specified in the label; however, </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Devices containing only krypton need not be tested for leakage of radioactive material, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Devices containing only tritium or not more than 100 microcuries (3.7 MBq) of other beta- and/or gamma-emitting material or ten microcuries (0.37 MBq) of alpha-emitting material and devices held in storage in the original shipping container prior to initial installation need not be tested for any purpose;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall assure that the tests required by (6)(c)3.(ii) and other testing, installation, servicing, and removal from installation involving the radioactive material, its shielding or containment, are performed:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(iii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In accordance with the instructions provided by the labels, or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(iii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> By a person holding an applicable specific license from the Department, the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State to perform such activities;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall maintain records showing compliance with the requirements of (6)(c)3.(ii) and (iii). The records shall show the results of tests. The records also shall show the dates of performance of, and the names of persons performing, testing, installation, servicing, and removal from installation concerning the radioactive material, its shielding, or containment. Records of tests for leakage of radioactive material required by (6)(c)3.(ii) shall be maintained for three years after the next required leak test is performed. Records of tests of the on/off mechanism and indicator required by (6)(c)3.(ii) shall be maintained for three years after the next required test of the on/off mechanism and indicator is performed. Records which are required by (6)(c)3.(iii) shall be maintained for three years. In case of transfer or disposal, records required by this paragraph (iv) shall be maintained for three years after the transfer or disposal.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall, upon the occurrence of a failure of or damage to, or any indication of a possible failure of or damage to, the shielding of the radioactive material or the on/off mechanism or indicator, or upon the detection of 0.005 microcurie (185 Bq) or more removable radioactive material, immediately suspend operation of the device. The device may not be operated until it has been repaired by the manufacturer or other person holding an applicable specific license from the Department, the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State to repair such devices. The device and any radioactive material from the device may only be disposed of by transfer to a person authorized by an applicable specific license to receive the radioactive material contained in the device or as otherwise approved by the Department. A report containing a brief description of the event and the remedial action taken; and, in the case of detection of 0.005 microcurie (185 Bq) or more of removable radioactive material, or failure or damage to a source likely to result in contamination of the premises or environs, a plan for ensuring that the premises and environs are acceptable for unrestricted use, must be furnished to the Department within 30 days. Under these circumstances, the criteria set out in Rule .03(7)(b) "Radiological requirements for unrestricted use" may be applicable, as determined by the Department on a case-by-case basis;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not abandon the device containing radioactive material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall transfer or dispose of the device containing radioactive material only by export as provided in (6)(c)3.(xiv), by transfer to another general licensee as specified in (6)(c)3.(viii) or equivalent regulations of the NRC or another Agreement State, by transfer to a specific licensee of the Department, the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State whose specific license authorizes him to receive the device or authorizes him to collect waste, or as otherwise approved under (6)(c)(3)(vii)(III).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Within 30 days after transfer of a device to a specific licensee or export, the licensee shall furnish to the Department a report containing identification of the device by manufacturer's (or initial transferor's) name, model number, serial number, the name and address and license number (license number not applicable if exported) of the person receiving the device and the date of transfer;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If transfer is to any other licensee not identified in (vii)(I), the licensee shall obtain written approval from the Department before transferring the device to any other person; however, a holder of a specific license may transfer a device for possession and use under its own specific license without prior approval, if, the holder: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vii)(III)I.">I.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Verifies that the specific license authorizes the possession and use, or applies for and obtains an amendment to the license authorizing the possession and use;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vii)(III)II.">II.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Removes, alters, covers, or clearly and unambiguously augments the existing label (otherwise required by Rule .02(6)(c)3.(i) so that the device is labeled in compliance with Rule .03(12)(d); however the manufacturer, model number, and serial number must be retained;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vii)(III)III.">III.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Obtains the manufacturer's or initial transferor's information concerning maintenance that would be applicable under the specific license (such as leak testing procedures); and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(vii)(III)IV.">IV.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Reports the transfer under Rule .02(6)(c)3.(vii)</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall transfer the device to another general licensee only:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(viii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Where the device remains in use at a particular location. In such case the transferor shall give the transferee a copy of this Regulation and any safety documents identified in the label on the device. Within 30 days of the transfer, report to the Department the manufacturer's (or initial transferor's) name, model number, serial number of the device transferred, the name and mailing address for place of use of the transferee, and the name, title and telephone number of a person identified by the transferee as the individual responsible for having knowledge of and authority to take actions to ensure compliance with the appropriate regulations and requirements; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(viii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Where the device is held in storage by an intermediate person in the original shipping container at its intended location of use prior to initial use by a general licensee;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(ix)">(ix)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall comply with the provisions of Rule .03(15) of this Chapter for reporting radiation incidents, or the theft or loss of licensed material, but shall be exempt from the other requirements contained in Rules .03 and .07 of this Chapter;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(x)">(x)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall appoint an individual responsible for having knowledge of the appropriate regulations and requirements and the authority for taking required actions to comply with appropriate regulations and requirements. The general licensee, through this individual, shall ensure the day-to-day compliance with appropriate regulations and requirements. This appointment does not relieve the general licensee of any of its responsibility in this regard;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)">(xi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall register, in accordance with paragraphs (6)(c)3.(xi)(II) and (III), devices containing at least 10 mCi (370 Mbq) of cesium-137, 0.1 mCi (3.7 MBq) of strontium-90, 1 mCi (37 MBq) of cobalt-60, 0.1 mCi (3.7 MBq) of radium 226, or 1 mCi (37 MBq) of americium-241 or any other transuranic [i.e., element with atomic number greater than uranium (92)], based on the activity indicated on the label. Each address for a location of use, as described under paragraph 3.(xi)(III)IV. of this section, represents a separate general licensee and requires a separate registration.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If in possession of a device meeting the criteria of paragraph (6)(c)3.(xi)(I), shall register these devices annually with the Department. Registration must be done by verifying, correcting, and/or adding to the information provided in a request for registration received from the Department. The registration information must be submitted to the Department within 30 days of the date of the request for registration or as otherwise indicated in the request. In addition, a general licensee holding devices meeting the criteria of (6)(c)3.(xi)(I) is subject to the bankruptcy notification requirement in (13)(e) of this rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In registering devices, the general licensee shall furnish the following information and any other information specifically requested by the Department; </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(III)I.">I.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Name and mailing address of the general licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(III)II.">II.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Information about each device: the manufacturer (or initial transferor), model number, serial number, the radioisotope and activity (as indicated on the label).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(III)III.">III.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Name, title, and telephone number of the responsible person designated as a representative of the general licensee under (6)(c)3.(x).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(III)IV.">IV.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Address or location at which the device(s) are used and/or stored. </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(III)V.">V.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Certification by the responsible representative of the general licensee that the information concerning the device(s) has been verified through a physical inventory and checking of label information.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(III)VI.">VI.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Certification by the responsible representative of the general licensee that they are aware of the requirements of the general license.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xi)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Persons generally licensed by the NRC, an Agreement State, or Licensing State are not eligible for reciprocity.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xii)">(xii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall report changes to the mailing address for the location of use (including change in name of general licensee) to the Department within 30 days of the effective date of the change;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xiii)">(xiii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> May not hold devices that are not in use for longer than two years. If devices with shutters are not being used, the shutter must be locked in the closed position. The testing required by (6)(c)3.(ii) need not be performed during the period of storage only. However, when devices are put back into service or transferred to another person, and have not been tested within the required test interval, they must be tested for leakage before use or transfer and the shutter tested before use. Devices kept in standby for future use are excluded from the two-year time limit if the general licensee performs quarterly physical inventories of these devices while they are in standby.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xiv)">(xiv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not export the device containing byproduct material except in accordance with the requirements of 10 CFR Part 110.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)3.(xv)">(xv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall respond to written requests from the Program to provide information relating to the general license within 30 calendar days of the date of the request, or other time specified in the request. If the general licensee cannot provide the requested information within the allotted time, it shall, within that same time period, request a longer period to supply the information by providing the Program a written justification for the request.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general license in (6)(c)1. does not authorize the manufacture or import of devices containing radioactive material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(c)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general license provided in (6)(c)1. is subject to the provisions of (13), (18), and (19) of this rule, of paragraphs (4), (5), (6), (7), (8), (9) and (10) of Rule .01, and of Rule .06 of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Luminous Safety Devices for Aircraft. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued to own, receive, acquire, possess, and use tritium or promethium-147 contained in luminous safety devices for use in aircraft, provided: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(d)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each device contains not more than ten Curies (370 GBq) of tritium or 300 millicuries (11.1 GBq) of promethium-147; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(d)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each device has been manufactured, assembled, or imported in accordance with a specific license issued by the U.S. Nuclear Regulatory Commission, or each device has been manufactured or assembled in accordance with the specifications contained in a specific license issued by the Department or any Agreement State to the manufacturer or assembler of such device pursuant to licensing requirements equivalent to those in Section 32.53 of 10 CFR, Part 32, of the regulations of the U.S. Nuclear Regulatory Commission.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Persons who own, receive, acquire, possess, or use luminous safety devices pursuant to the general license in (6)(d) are exempt from the requirements of Rules .03 and .07 of this Chapter, except that they shall comply with the provisions of Rule .03(15) of this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(d)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This general license does not authorize the manufacture, assembly, or repair of luminous safety devices containing tritium or promethium-147.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(d)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This general license does not authorize the ownership, receipt, acquisition, possession, or use of promethium-147 contained in instrument dials.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(d)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This general license is subject to the provisions of paragraphs (13), (18), and (19) of this Rule, of paragraphs (4), (5), (6), (7), (8), (9) and (10) of Rule .01, and of Rule .06 of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ice-Detection Devices. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued to own, receive, acquire, possess, use, and transfer strontium-90 contained in ice-detection devices, provided each device contains not more than 50 microcuries (1.85 MBq) of strontium-90 and each device has been manufactured or imported in accordance with a specific license issued by the U.S. Nuclear Regulatory Commission or each device has been manufactured in accordance with the specifications contained in a specific license issued by the Department or any Agreement State to the manufacturer of such device pursuant to licensing requirements equivalent to those in Section 32.61 of 10 CFR, Part 32, of the regulations of the U.S. Nuclear Regulatory Commission.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Persons who own, receive, acquire, possess, use, or transfer strontium-90 contained in ice-detection devices pursuant to the general license in (6)(e)1.: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(e)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall, upon occurrence of visually observable damage, such as a bend or crack or discoloration from overheating to the device, discontinue use of the device until it has been inspected, tested for leakage, and repaired by a person holding a specific license or equivalent licensing document from the U.S. Nuclear Regulatory Commission or an Agreement State to manufacture or service such devices; or shall dispose of the device pursuant to the provisions of Rule .03(13) of this Chapter;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(e)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall assure that all labels affixed to the device at the time of receipt and which bear a statement that prohibits removal of the labels are maintained thereon; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(e)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Are exempt from the requirements of Rules .03 and .07 of this Chapter except that such persons shall comply with the provisions of Rule .03(13) and (15) of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(e)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This general license does not authorize the manufacture, assembly, disassembly, or repair of strontium-90 in ice-detection devices.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(e)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This general license is subject to the provisions of paragraphs (13), (18), and (19) of this Rule, of paragraphs (4), (5), (6), (7), (8), (9) and (10) of Rule .01, and of Rule .06 of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Calibration and Reference Sources. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued to those persons listed below to own, receive, acquire, possess, use, and transfer, in accordance with the provisions of (6)(f)4. and 5., americium-241 in the form of calibration or reference sources: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who holds a specific license issued by the Department which authorizes him to receive, possess, use, and transfer radioactive material; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person who holds a specific license issued by the U.S. Nuclear Regulatory Commission which authorizes him to receive, possess, use, and transfer special nuclear material.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued to own, receive, possess, use, and transfer plutonium in the form of calibration or reference sources in accordance with the provisions of (6)(f)4. and 5. to any person who holds a specific license issued by the Department which authorizes him to receive, possess, use, and transfer radioactive material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued to own, receive, possess, use, and transfer radium-226 in the form of calibration or reference sources in accordance with the provisions of (6)(f)4. and 5. to any person who holds a specific license issued by the Department which authorizes him to receive, possess, use, and transfer radioactive material.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general licenses in (6)(f)1., 2., and 3. apply only to calibration or reference sources which have been manufactured in accordance with the specifications contained in a specific license issued to the manufacturer or importer of the sources by the U.S. Nuclear Regulatory Commission pursuant to Section 32.57 of 10 CFR, Part 32, or Section 70.39 of 10 CFR, Part 70, or which have been manufactured in accordance with the specifications contained in a specific license issued to the manufacturer by the Department, any Agreement State, or Licensing State pursuant to licensing requirements equivalent to those contained in Section 32.57 of 10 CFR, Part 32, or Section 70.39 of 10 CFR, Part 70, of the regulations of the U.S. Nuclear Regulatory Commission.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general licenses provided in (6)(f)1., 2., and 3. are subject to the provisions of paragraphs (13), (18), and (19) of this Rule, of paragraphs (4), (5), (6), (7), (8), (9) and (10) of Rule .01, and of Rules .03, .06, and .07 of this Chapter. In addition, persons who own, receive, acquire, possess, use, or transfer one or more calibration or reference sources pursuant to these general licenses: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not possess at any one time, at any one location of storage or use, more than five microcuries (185 kBq) of americium-241, five microcuries (185 kBq) of plutonium, or five microcuries (185 kBq) of radium-226 in such sources;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not receive, possess, use, or transfer such source unless the source, or the storage container, bears a label that includes one of the following statements, as appropriate, or a substantially similar statement that contains the information called for in one of the following statements, as appropriate: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)5.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The receipt, possession, use, and transfer of this source, Model _____, Serial No. _____, are subject to a general license and the regulations of the U.S. Nuclear Regulatory Commission or of a State with which the U.S. Nuclear Regulatory Commission has entered into an agreement for the exercise of regulatory authority. Do not remove this label. </span><span class=""><P>CAUTION - RADIOACTIVE MATERIAL -</P></span><span class=""><P>THIS SOURCE CONTAINS (AMERICIUM-241)*</P></span><span class=""><P>(PLUTONIUM)*. DO NOT TOUCH RADIOACTIVE PORTION OF THIS SOURCE. </P></span><span class=""><P>_______________________________________</P></span><span class=""><P>(NAME OF MANUFACTURER OR IMPORTER)</P></span><span class=""><P>*Note: Showing only the name of the appropriate material, i.e., either plutonium or americium.</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)5.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The receipt, possession, use, and transfer of this source, Model _____, Serial No. _____, are subject to a general license and the regulations of a Licensing State. Do not remove this label. </span><span class=""><P>CAUTION - RADIOACTIVE MATERIAL -</P></span><span class=""><P>THIS SOURCE CONTAINS RADIUM-226.</P></span><span class=""><P>DO NOT TOUCH RADIOACTIVE PORTION OF THIS SOURCE.</P></span><span class=""><P>_______________________________________</P></span><span class=""><P>(NAME OF MANUFACTURER OR IMPORTER)</P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)5.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not transfer, abandon, or dispose of such source except by transfer to a person authorized by a license from the Department, the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State to receive the source;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)5.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall store such source, except when the source is being used, in a closed container adequately designed and constructed to contain americium-241, plutonium, or radium-226 which might otherwise escape during storage; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)5.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall not use such source for any purpose other than the calibration of radiation detectors or the standardization of other sources. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(f)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> These general licenses do not authorize the manufacture of calibration or reference sources containing americium-241, plutonium, or radium-226. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> General License for Use of Radioactive Material for Certain In Vitro Clinical or Laboratory Testing. </span><span class=""><P>Note: The new drug provisions of the Federal Food, Drug, and Cosmetic Act also govern the availability and use of any specified diagnostic drugs in interstate commerce.</P></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A general license is hereby issued to any physician, veterinarian in the practice of veterinary medicine, clinical laboratory, or hospital to receive, acquire, possess, transfer, or use, for any of the following radioactive material, in accordance with the provisions of (6)(g) 2., 3., 4., 5., and 6., the following radioactive materials in prepackaged units for use in in-vitro clinical or laboratory tests not involving internal or external administration of radioactive material, or the radiation therefrom, to human beings or animals: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Iodine-125, in units not exceeding ten microcuries (370 kBq) each.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Iodine-131, in units not exceeding ten microcuries (370 kBq) each.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Carbon-14, in units not exceeding ten microcuries (370 kBq) each.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Hydrogen-3 (tritium), in units not exceeding 50 microcuries (1.85 MBq) each.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Iron-59, in units not exceeding 20 microcuries (740 kBq) each.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Cobalt-57, in units not exceeding ten microcuries (370 kBq) each.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Selenium-75, in units not exceeding ten microcuries (370 kBq) each.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)1.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Mock Iodine-125 reference or calibration sources, in units not exceeding 0.05 microcurie (1.85 kBq) of iodine-129 and 0.005 microcurie (185 Bq) of americium-241 each.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No person shall receive, acquire, possess, use, or transfer radioactive material pursuant to the general license established by (6)(g)1. until he has filed Department form, "Certificate - In-Vitro Testing with Radioactive Material Under General License" with the Department and received from the Department a validated copy of this form with certification number assigned or until he has been authorized pursuant to (9)(e)3. to use radioactive material under the general license in (6)(g). The physician, veterinarian in the practice of veterinary medicine, clinical laboratory, or hospital shall furnish on the form the following information and such other information as may be required by that form: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Name and address of the physician, veterinarian in the practice of veterinary medicine, clinical laboratory, or hospital;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The location of use; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A statement that the physician, veterinarian in the practice of veterinary medicine, clinical laboratory, or hospital has appropriate radiation measuring instruments to carry out in vitro clinical or laboratory tests with radioactive material as authorized under the general license in (6)(g)1. and that such tests will be performed only by personnel competent in the use of such instruments and in the handling of the radioactive material.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A person who receives, acquires, possesses, or uses radioactive material pursuant to the general license established by (6)(g)1. shall comply with the following: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general licensee shall not possess at any one time, pursuant to the general license in (6)(g)1., at any one location of storage or use, a total amount of iodine-125, iodine-131, selenium-75, iron-59, and/or cobalt-57 in excess of 200 microcuries (7.4 MBq).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general licensee shall store the radioactive material, until used, in the original shipping container or in a container providing the equivalent amount of radiation protection.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general licensee shall use the radioactive material only as authorized by (6)(g)1.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)3.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general licensee shall not transfer the radioactive material to a person who is not authorized to receive it pursuant to a license issued by the Department, the U.S. Nuclear Regulatory Commission, any Agreement State, or Licensing State, nor transfer the radioactive material in any manner other than in the unopened, labeled shipping container as received from the supplier.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)3.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general licensee shall dispose of the Mock Iodine-125 reference or calibration sources described in (6)(g)1.(viii) as required by Rule .03(13) of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The general licensee shall not receive, acquire, possess, or use radioactive material pursuant to (6)(g)1.: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as prepackaged units which are labeled in accordance with the provisions of an applicable specific license issued pursuant to (11)(g) or in accordance with the provisions of a specific license issued by the U.S. Nuclear Regulatory Commission, any Agreement State, or Licensing State which authorizes the manufacture and distribution of iodine-125, iodine-131, carbon-14, hydrogen-3 (tritium), iron-59, selenium-75, cobalt-57, or Mock Iodine-125 to persons generally licensed under (6)(g) or its equivalent, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Unless one of the following statements, as appropriate, or a statement which contains the information called for in one of the following statements, appears on a label affixed to each prepackaged unit or appears in a leaflet or brochure which accompanies the package:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)4.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This radioactive material shall be received, acquired, possessed, and used only by physicians, veterinarians in the practice of veterinary medicine, clinical laboratories, or hospitals and only for in vitro clinical or laboratory tests not involving internal or external administration of the material, or the radiation therefrom, to human beings or animals. Its receipt, acquisition, possession, use, and transfer are subject to the regulations and a general license of the U.S. Nuclear Regulatory Commission or of a State with which the Commission has entered into an agreement for the exercise of regulatory authority. </span><span class=""><P>__________________</P></span><span class=""><P>(NAME OF MANUFACTURER)</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)4.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This radioactive material shall be received, acquired, possessed, and used only by physicians, veterinarians in the practice of veterinary medicine, clinical laboratories, or hospitals and only for in vitro clinical or laboratory tests not involving internal or external administration of the material, or the radiation therefrom, to human beings or animals. Its receipt, acquisition, possession, use, and transfer are subject to the regulations and a general license of a Licensing State. </span><span class=""><P>__________________</P></span><span class=""><P>(NAME OF MANUFACTURER)</P></span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The physician, veterinarian in the practice of veterinary medicine, clinical laboratory, or hospital possessing or using radioactive material under the general license of (6)(g)1. shall report in writing to the Department any changes in the information furnished by him in the "Certificate - In Vitro Testing with Radioactive Material Under General License". The report shall be furnished within 30 days after the effective date of such change.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(6)(g)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person using radioactive material pursuant to the general license of (6)(g)1. is exempt from the requirements of Rules .03 and .07 of this Chapter with respect to radioactive material covered by that general license, except that such persons using the Mock Iodine-125 described in (6)(g)1.(viii) shall comply with the provisions of (13) and (15) of Rule .03 of this Chapter.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)">(7)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Filing Application for Specific Licenses.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Applications for specific licenses shall be filed on forms supplied by the Georgia Department of Natural Resources, Radioactive Materials Program, 4244 International Parkway, Suite 120, Atlanta, Georgia, 30354, or current mailing address. The application shall set forth all applicable information called for by the form.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may at any time after the filing of the original application, and before the expiration of the license, require further statements in order to enable the Department to determine whether the application should be granted or denied or whether a license should be modified or revoked.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each application shall be signed by the applicant or person duly authorized to act for and on his behalf.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for a license may include a request for a license authorizing one or more activities.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In his application, the applicant may incorporate, by reference, information contained in previous applications, statements, or reports filed with the Department, provided that such references are clear and specific by page, paragraph, and date.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Applications and documents submitted to the Department may be made available for public inspection except those documents described in Rule .01(5)(c) which may be withheld from public inspection or discovery.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may verify information contained in applications and secure additional information deemed necessary to make a reasonable determination as to whether to issue a license and whether special conditions should be attached thereto by visiting the facility or location where radioactive materials would be possessed, or used, and by discussing details of proposed possession or use of the radioactive materials with the applicant or the applicant's designated representatives.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Emergency Plan for Large Quantity Users. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each application to possess radioactive materials in unsealed form, on foils or plated sources, or sealed in glass in excess of the quantities specified in (21)(e), Schedule E, must contain either: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An evaluation showing that the maximum dose to a person offsite due to a release of radioactive materials would not exceed one rem (.01 Sv) effective dose equivalent or five rems (.05 Sv) to the thyroid; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An emergency plan for responding to a release of radioactive material. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> One or more of the following factors may be used to support an evaluation submitted under (7)(h)1.(i): </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The radioactive material is physically separated so that only a portion could be involved in an accident;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> All or part of the radioactive material is not subject to release during an accident because of the way it is stored or packaged;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The release fraction in the respirable size range would be lower than the release fraction shown in (21)(e), Schedule E, due to the chemical or physical form of the material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The solubility of the radioactive material would reduce the dose received;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)2.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Facility design or engineered safety features in the facility would cause the release fraction to be lower than shown in (21)(e), Schedule E;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)2.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Operating restrictions or procedures would prevent a release fraction as large as that shown in (21)(e), Schedule E; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)2.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Other factors appropriate for the specific facility. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An emergency plan for responding to a release of radioactive material submitted under (7)(h)1.(ii) must include the following information: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Facility description - a brief description of the licensee's facility and the area near the site.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Types of accidents - an identification of each type of radioactive materials accident for which protective actions may be needed.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Classification of accidents - a classification system for classifying accidents as alerts or site area emergencies.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Detection of accidents - identification of the means of detecting each type of accident in a timely manner.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Mitigation of consequences - a brief description of the means and equipment for mitigating the consequences of each type of accident, including those provided to protect workers on site, and a description of the program for maintaining the equipment.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Assessment of releases - a brief description of the methods and equipment to assess releases of radioactive materials.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Responsibilities - a brief description of the responsibilities of licensee personnel should an accident occur, including identification of personnel responsible for promptly notifying offsite response organizations and the Department; also responsibilities for developing, maintaining, and updating the plan.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Notification and coordination - a commitment to and a brief description of the means to promptly notify offsite response organizations and request offsite assistance, including medical assistance for the treatment of contaminated injured onsite workers when appropriate. A control point must be established to prevent spreading of contamination during recovery activities. The notification and coordination must be planned so that unavailability of some personnel, parts of the facility, and some equipment will not prevent the notification and coordination. The licensee shall also commit to notify the Department immediately after notification of the appropriate offsite response organizations and not later than one hour after the licensee declares an emergency. </span><span class=""><P>Note: This Chapter does not supersede or release licensees from complying with the requirements under the Emergency Planning and Community Right-to-Know Act of 1986, Title III, Pub. L-99-499 or other State or Federal reporting requirements.</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(ix)">(ix)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Information to be communicated - a brief description of the types of information on facility status, radioactive releases, and recommended protective actions, if necessary, to be given to offsite response organizations and to the Department.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(x)">(x)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Training - a brief description of the frequency, performance objectives, and plans for the training that the licensee will provide workers on how to respond to an emergency, including any special instruction and orientation tours the licensee would offer to fire, police, medical, and other emergency personnel. The training shall familiarize personnel with site-specific emergency procedures. Also, the training shall thoroughly prepare site personnel for their responsibilities in the event of accident scenarios postulated as most probable for the specific site, including the use of team training for such scenarios.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(xi)">(xi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Safe shutdown - a brief description of the means of restoring the facility to a safe condition after an accident.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(xii)">(xii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Exercises - provisions for conducting quarterly communications checks with offsite response organizations and biennial onsite exercises to test response to simulated emergencies. Quarterly communications checks with offsite response organizations must include the check and update of all necessary telephone numbers. The licensee shall invite offsite response organizations to participate in the biennial exercises. Participation of offsite response organizations in biennial exercises, although recommended, is not required. Exercises must use accident scenarios postulated as most probable for the specific site, and the scenarios shall not be known to most exercise participants. The licensee shall critique each exercise using individuals not having direct implementation responsibility for the plan. Critiques of exercises must evaluate the appropriateness of the plan, emergency procedures, facilities, equipment, training of personnel, and the overall effectiveness of the response. These exercises must be documented and deficiencies found by the critiques must be corrected.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)3.(xiii)">(xiii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Hazardous chemicals - a certification that the applicant has met its responsibilities under the Emergency Planning and Community Right-to-Know Act of 1986, Title III, Pub. L. 99-499, if applicable to the applicant's activities at the proposed place of use of the radioactive material. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(h)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall allow the offsite response organizations expected to respond in case of an accident 60 days to comment on the licensee's emergency plan before submitting it to the Department. The licensee shall provide any comments received within the 60 days to the Department with the emergency plan.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as provided in paragraphs 2., 3. and 4. of this section, an application for a specific license to use radioactive material in the form of a sealed source or in a device that contains the sealed source must:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(i)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Identify the source or device by manufacturer and model number as registered with the Nuclear Regulatory Commission, an Agreement State, or for a source or a device containing radium-226 or accelerator produced radioactive material with a State under provisions comparable to Section 32.210 of 10 CFR Part 32.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(i)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For sources or devices manufactured before October 23, 2012, that are not registered with the Commission under Section 32.210 of 10 CFR, Part 32 or with an Agreement State, and for which the applicant is unable to provide all categories of information specified in Section 32.210(c) of 10 CFR, Part 32, the application must include: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(i)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> All available information identified in Section 32.210(c) of 10 CFR, Part 32 concerning the source, and, if applicable, the device; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(i)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Sufficient additional information to demonstrate that there is reasonable assurance that the radiation safety properties of the source or device are adequate to protect health and minimize danger to life and property. Such information must include a description of the source or device, a description of radiation safety features, the intended use and associated operating experience, and the results of a recent leak test. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(i)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For sealed sources and devices allowed to be distributed without registration of safety information in accordance with Section 32.210(g)(1) of 10 CFR, Part 32, the applicant may supply only the manufacturer, model number, and radionuclide and quantity.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(i)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If it is not feasible to identify each sealed source and device individually, the applicant may propose constraints on the number and type of sealed sources and devices to be used and the conditions under which they will be used, in lieu of identifying each sealed source and device.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(j)">(j)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application from a medical facility, educational institution, or Federal facility to produce Positron Emission Tomography (PET) radioactive drugs for noncommercial transfer to licensees in its consortium authorized for medical use under Rule .05 or equivalent Nuclear Regulatory Commission or Agreement State requirements shall include:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(j)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A request for authorization for the production of PET radionuclides or evidence of an existing license issued under Rule .02, Nuclear Regulatory Commission or of this chapter or Agreement State requirements for a PET radionuclide production facility within its consortium from which it receives PET radionuclides.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(j)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Evidence that the applicant is qualified to produce radioactive drugs for medical use by meeting one of the criteria in .02(11)(i)2. of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(j)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Identification of individual(s) authorized to prepare the PET radioactive drugs if the applicant is a pharmacy, and documentation that each individual meets the requirements of an authorized nuclear pharmacist as specified in .02(11)(i)5. of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(7)(j)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Information identified in Rule .02(11)(i)3. of this Rule on the PET drugs to be noncommercially transferred to members of its consortium.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)">(8)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>General Requirements for the Issuance of Specific Licenses.</B></span><span class=""> A license application will be approved if the Department determines the following: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> That the applicant is qualified by reason of training and experience to use the material in question for the purpose requested in accordance with this Chapter in such a manner as to minimize danger to public health and safety or property;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> That the applicant's proposed equipment, facilities, and procedures are adequate to minimize danger to public health and safety or property;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> That the issuance of the license will not be inimical to the health and safety of the public; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> That the applicant satisfies any applicable special requirements in (9), (10), and (11).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Bonding Requirements. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Pursuant to Georgia Laws 1979, pp. 1059, 1060, a specific license will be issued to a Major Processor as defined in Rule .01(2) of this Chapter only if the applicant has posted a surety bond with, and made payable to, the Commissioner, Department of Natural Resources, to ensure the protection of the public health and safety in the event of abandonment, insolvency, or other inability of the licensee to meet the requirements of the Act and this Chapter.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(e)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The bond provided shall be not less than $100,000.00, nor more than $5,000,000.00.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(e)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The exact amount of the bond shall be determined by the Director, Environmental Protection Division, and shall be based on the probable extent of contamination, the amount of possible property damage, the costs of removal and disposal of sources of radiation used by the licensee, and the costs of reclamation of the property in the event of abandonment, insolvency, or other inability of the licensee to perform such services to the satisfaction of the Department.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Persons licensed at the time the bonding requirements of this Chapter became effective, and upon notice by the Department, must, within a period of 90 days following such notice, provide the bond required by (8)(e)1. as a condition for continuation of the license.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Environmental Report, Commencement of Construction. In the case of an application for a license to receive and possess radioactive material for the conduct of any activity which the Department determines will significantly affect the quality of the environment, commencement of construction of the plant or facility in which the activity will be conducted shall not begin until the Department has concluded, after weighing the environmental, economic, technical, and other benefits against environmental costs and considering available alternatives, that the action called for is the issuance of the proposed license, with any appropriate conditions to protect environmental values. Commencement of construction prior to such conclusion shall be grounds for denial of a license to receive and possess radioactive material in such plant or facility. As used in this paragraph, the term "commencement of construction" means any clearing of land, excavation, or other substantial action that would adversely affect the environment of a site. The term does not mean site exploration, necessary borings to determine foundation conditions, or other preconstruction monitoring or testing to establish background information related to the suitability of the site or the protection of environmental values.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Financial assurance and record-keeping for decommissioning.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The following are required to furnish financial assurance and record-keeping for decommissioning:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each applicant for a specific license authorizing the possession and use of unsealed radioactive material of half-life greater than 120 days and in quantities exceeding 10</span><span class=""><SUP>5</SUP></span><span class=""> times the applicable quantities set forth in Schedule F shall submit a decommissioning funding plan as described in subparagraphs (8)(g)5 and (8)(g)6. The decommissioning funding plan must also be submitted when a combination of isotopes is involved if R divided by 10</span><span class=""><SUP>5</SUP></span><span class=""> is greater than 1 (unity Rule), where R is defined here as the sum of the ratios of the quantity of each isotope to the applicable value in Schedule F.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each applicant for a specific license authorizing the possession and use of sealed sources or plated foils of half-life greater than 120 days and in quantities exceeding 10</span><span class=""><SUP>12</SUP></span><span class=""> times the applicable quantities set forth in Schedule F shall submit a decommissioning funding plan as described in subparagraphs (8)(g)5 and (8)(g)6. The decommissioning funding plan must also be submitted when a combination of isotopes is involved if R divided by 10</span><span class=""><SUP>12</SUP></span><span class=""> is greater than 1 (unity Rule), where R is defined here as the sum of the ratios of the quantity of each isotope to the applicable value in Schedule F.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each applicant for a specific license authorizing the possession and use of radioactive material of half-life greater than 120 days and in quantities specified in subparagraphs (8)(g)4. shall either: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Submit a decommissioning funding plan as described in subparagraphs (8)(g)5 and (8)(g)6.; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Submit a certification that financial assurance for decommissioning has been provided in the amount prescribed by (8)(g)4. using one of the methods described in (8)(g)7. For an applicant, this certification may state that the appropriate assurance will be obtained after the application has been approved and the license issued but prior to the receipt of licensed material. As part of the certification, a copy of the financial instrument obtained to satisfy the requirements of (8)(g)7. is to be submitted to the Department. If the applicant defers execution of the financial instrument until after the license has been issued, a signed original of the financial instrument obtained to satisfy the requirements (8)(g)7. must be submitted to the Department before the receipt of licensed material. If the applicant does not defer execution of the financial instrument, the applicant shall submit to the Department, as part of the certification a signed original of the financial instrument obtained to satisfy the requirements of (8)(g)7.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each holder of a specific license issued on or after January 1, 1993, which is of a type described in (8)(g)1. or 2. shall provide financial assurance for decommissioning in accordance with the criteria set forth in this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each holder of a specific license issued before January 1, 1993, which is of a type described in (8)(g)1. shall submit, on or before January 1, 1993, a decommissioning funding plan or a certification of financial assurance for decommissioning in an amount at least equal to $1,125,000 in accordance with the criteria set forth in this Rule. If the licensee submits the certification of financial assurance rather than a decommissioning funding plan at this time, the licensee shall include a decommissioning funding plan in any application for license renewal.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each holder of a specific license issued before January 1, 1993, and of a type described in (8)(g)2. shall submit, on or before January 1, 1993, a certification of financial assurance for decommissioning or a decommissioning funding plan in accordance with the criteria set forth in this .02(8)(g).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)3.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Waste collectors and waste processors shall provide financial assurance in an amount based on a decommissioning funding plan as described in subparagraphs .02(8)(g)5 and (8)(g)6. The decommissioning funding plan must also include the cost of disposal of the maximum amount (curies) of radioactive material permitted by the license, and the cost of disposal of the maximum quantity, by volume, of radioactive material that could be present at the licensee's facility at any time, in addition to the cost to remediate the licensee's site to meet the license termination requirements in .02(18).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Table of required amounts of financial assurance for decommissioning by quantity of material. </span><span class=""><P>Greater than 10<SUP>4</SUP> but less than or equal to 10<SUP>5</SUP> times the applicable quantities of Schedule F in unsealed form. (For a combination of isotopes, if R, as defined in (8)(g), divided by 10<SUP>4</SUP> is greater than 1 but R divided by 10<SUP>5</SUP> is less than or equal to 1): $1,125,000</P></span><span class=""><P>Greater than 10<SUP>3</SUP> but less than or equal to 10<SUP>4</SUP> times the applicable quantities of Schedule F in unsealed form. (For a combination of isotopes, if R, as defined in (8)(g), divided by 10<SUP>3</SUP> is greater than 1 but R divided by 10<SUP>4</SUP> is less than or equal to 1): $225,000</P></span><span class=""><P>Greater than 10<SUP>10</SUP> times the applicable quantities of Schedule F in sealed sources or plated foils. (For a combination of isotopes, if R, as defined in (8)(g), divided by 10<SUP>10</SUP> is greater than 1): $113,000</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each decommissioning funding plan must be submitted for review and approval and must contain </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A detailed cost estimate for decommissioning, in an amount reflecting:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The cost of an independent contractor to perform all decommissioning activities;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The cost of meeting the .03(7)(b) criteria for unrestricted use, provided that, if the applicant or licensee can demonstrate its ability to meet the provisions of .03(7)(c), the cost estimate may be based on meeting the .03(7)(c) criteria;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The volume of onsite subsurface material containing residual radioactivity that will require remediation to meet the criteria for license termination; and </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(i)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An adequate contingency factor.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Identification of and justification for using the key assumptions contained in the DCE;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A description of the method of assuring funds for decommissioning from subparagraph 7 of this section, including means for adjusting cost estimates and associated funding levels periodically over the life of the facility;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A certification by the licensee that financial assurance for decommissioning has been provided in the amount of the cost estimate for decommissioning; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)5.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A signed original of the financial instrument obtained to satisfy the requirements of subparagraph 7 of this section (unless a previously submitted and accepted financial instrument continues to cover the cost estimate for decommissioning).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> At the time of license renewal and at intervals not to exceed 3 years, the decommissioning funding plan must be resubmitted with adjustments as necessary to account for changes in costs and the extent of contamination. If the amount of financial assurance will be adjusted downward, this cannot be done until the updated decommissioning funding plan is approved. The decommissioning funding plan must update the information submitted with the original or prior approved plan, and must specifically consider the effect of the following events on decommissioning costs: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Spills of radioactive material producing additional residual radioactivity in onsite subsurface material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Waste inventory increasing above the amount previously estimated;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Waste disposal costs increasing above the amount previously estimated;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Facility modifications;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Changes in authorized possession limits;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Actual remediation costs that exceed the previous cost estimate;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Onsite disposal; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)6.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use of a settling pond.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Financial assurance for decommissioning must be provided by one or more of the following methods: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)7.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prepayment. Prepayment is the deposit prior to the start of operation into an account segregated from licensee assets and outside the licensee's administrative control of cash or liquid assets such that the amount of funds would be sufficient to pay decommissioning costs. Prepayment may be in the form of a trust, escrow account, government fund, certificate of deposit, or deposit of government securities.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)7.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A surety method, insurance, or other guarantee method. These methods guarantee that decommissioning costs will be paid. A surety method may be in the form of a surety bond, letter of credit, or line of credit. A parent company guarantee of funds for decommissioning costs based on a financial test may be used if the guarantee and test are as contained in (21)(d) Schedule D. A parent company guarantee may not be used in combination with other financial methods to satisfy the requirements of this section. For commercial corporations that issue bonds, a guarantee of funds by the applicant or licensee for decommissioning costs based on a financial test may be used if the guarantee and test are as contained in (21)(g) Schedule G. For commercial companies that do not issue bonds, a guarantee of funds by the applicant or licensee for decommissioning: costs may be used if the guarantee and test are as contained in (21)(d) Schedule D. For nonprofit entities, such as colleges, universities, and nonprofit hospitals, a guarantee of funds by the applicant or licensee may be used if the guarantee and test are as contained in (21)(h) Schedule H. A guarantee by the applicant or licensee may not be used in combination with any other financial methods used to satisfy the requirements of this section or in any situation where the applicant or licensee has a parent company holding majority control of the voting stock of the company. Any surety method or insurance used to provide financial assurance for decommissioning must contain the following conditions: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)7.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The surety method or insurance must be open-ended or, if written for a specified term, such as five years, must be renewed automatically, unless 90 days or more prior to the renewal date the issuer notifies the Department, the beneficiary, and the licensee of its intention not to renew. The surety method or insurance must also provide that the full face amount be paid to the beneficiary automatically prior to the expiration without proof of forfeiture if the licensee fails to provide a replacement acceptable to the Department within 30 days after receipt of notification of cancellation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)7.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The surety method or insurance must be payable to a trust established for decommissioning costs. The trustee and trust must be acceptable to the Department. An acceptable trustee includes an appropriate State or Federal government agency or an entity which has the authority to act as a trustee and whose trust operations are regulated and examined by a Federal or State agency.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)7.(ii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The surety method or insurance must remain in effect until the Department has terminated the license.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)7.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An external sinking fund in which deposits are made at least annually, coupled with a surety method or insurance, the value of which may decrease by the amount being accumulated in the sinking fund. An external sinking fund is a fund established and maintained by setting aside funds periodically in an account segregated from licensee assets and outside the licensee's administrative control in which the total amount of funds would be sufficient to pay decommissioning costs at the time termination of operation is expected. An external sinking fund may be in the form of a trust, escrow account, government fund, certificate of deposit, or deposit of government securities. The surety or insurance provisions must be as stated in (8)(g)2.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)7.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In the case of Federal, State, or local government licensees, a statement of intent containing a cost estimate for decommissioning or an amount based on the Table in (8)(g)4., and indicating that funds for decommissioning will be obtained when necessary.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.">8.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed under this Chapter shall keep records of information important to the safe and effective decommissioning of the facility in an identified location until the site is released for unrestricted use by the Department. Before licensed activities are transferred or assigned in accordance with .02(13)(b), licensees shall transfer all records described in (7)(i) through (iv) to the new licensee. In this case, the new licensee will be responsible for maintaining these records until the license is terminated. If records of relevant information to the decommissioning of a facility are kept for other purposes, references to these records and their locations may be used. Information the Department considers important to decommissioning consists of: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Records of spills or other unusual occurrences involving the spread of contamination in and around the facility, equipment, or site. These records may be limited to instances when contamination remains after any cleanup procedures or when there is reasonable likelihood that contaminants may have spread to inaccessible areas as in the case of possible seepage into porous materials such as concrete. These records must include any known information on identification of involved nuclides, quantities, forms, and concentrations.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> As-built drawings and modifications of structures and equipment in restricted areas where radioactive materials are used and/or stored, and of locations of possible inaccessible contamination such as buried pipes which may be subject to contamination. If required drawings are referenced, each relevant document need not be indexed individually. If drawings are not available, the licensee shall substitute appropriate records of available information concerning these areas and locations.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except for areas containing only sealed sources (provided the sources have not leaked or no contamination remains after any leak) or radioactive materials having only half-lives of less than 65 days, or depleted uranium used only for shielding or as penetrators in unused munitions, a list contained in a single document and updated every two years, of the following: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.(iii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> All areas designated and formerly designated as restricted areas as defined under Rule </span><span class=""> <a title="391-3-17-.01(2)" href="391-3-17-.01#391-3-17-.01(2)">391-3-17-.01(2)</a></span><span class="">;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.(iii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> All areas outside of restricted areas that require documentation under (8)(g)8.(i);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.(iii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> All areas outside of restricted areas where current and previous wastes have been buried as documented under Rule .03(14)(i) of this Chapter; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.(iii)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> All areas outside of restricted areas that contain materials such that, if the license expired, the licensee would be required to either decontaminate the area to unrestricted release levels or apply for approval for disposal under Rule .03(13)(b) of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)8.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Records of the cost estimate performed for the decommissioning funding plan or of the amount certified for decommissioning, and records of the funding method used for assuring funds if either a funding plan or certification is used.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(g)9.">9.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Teletherapy licensees are exempted from decommissioning financial assurance requirements for possession of licensed material in sealed sources in quantities greater than 10</span><span class=""><SUP>10</SUP></span><span class=""> times the applicable quantities of Schedule F of this rule, for the purpose of source changes only. This exemption is granted for no more than 30 days for any one source change.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Expiration and termination of licenses and decommissioning of sites and separate buildings or outdoor areas. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each specific license continues in effect, beyond the expiration date if necessary, with respect to possession of radioactive material until the Department notifies the licensee in writing that the license is terminated. During this time, the licensee shall: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Limit actions involving radioactive material to those related to decommissioning; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Continue to control entry to restricted areas until they are suitable for release in accordance with Department requirements. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Within 60 days of the occurrence of any of the following, each licensee shall provide notification to the Department in writing of such occurrence, and either begin decommissioning its site, or any separate building or outdoor area that contains residual radioactivity so that the building or outdoor area is suitable for release in accordance with Department requirements, or submit within 12 months of notification a decommissioning plan, if required by (8)(h)5.(i), and begin decommissioning upon approval of that plan if: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The license has expired pursuant to (14) or (18)(c); or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee has decided to permanently cease principal activities, as defined in this part, at the entire site or in any separate building or outdoor area that contains residual radioactivity such that the building or outdoor area is unsuitable for release in accordance with Department requirements; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No principal activities under the license have been conducted for a period of 24 months; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No principal activities have been conducted for a period of 24 months in any separate building or outdoor area that contains residual radioactivity such that the building or outdoor area is unsuitable for release in accordance with Department requirements. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Coincident with the notification required by (8)(h)2., the licensee shall maintain in effect all decommissioning financial assurances established by the licensee pursuant to (8)(g) in conjunction with a license issuance or renewal or as required by this section. The amount of the financial assurance must be increased or may be decreased, as appropriate, to cover the detailed cost estimate for decommissioning established pursuant to (8)(h)5.(iv)(V). </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any licensee who has not provided financial assurance to cover the detailed cost estimate submitted with the decommissioning plan shall do so when this rule becomes effective.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Following approval of the decommissioning plan, a licensee may reduce the amount of the financial assurance as decommissioning proceeds and radiological contamination is reduced at the site with the approval of the Department. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may grant a request to extend the time periods in (8)(h)2. if the Department determines that this relief is not detrimental to the public health and safety and is otherwise in the public interest. The request must be submitted no later than 30 days before notification pursuant to (8)(h)2. The schedule for decommissioning set forth in (8)(h)2. may not commence until the Department has made a determination on the request.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A decommissioning plan must be submitted if required by license condition or if the procedures and activities necessary to carry out decommissioning of the site or separate building or outdoor area have not been previously approved by the Department and these procedures could increase potential health and safety impacts to workers or to the public, such as in any of the following cases:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Procedures would involve techniques not applied routinely during cleanup or maintenance operations;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Workers would be entering areas not normally occupied where surface contamination and radiation levels are significantly higher than routinely encountered during operation;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Procedures could result in significantly greater airborne concentrations of radioactive materials than are present during operation or;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(i)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Procedures could result in significantly greater releases of radioactive material to the environment than those associated with operation.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may approve an alternate schedule for submittal of a decommissioning plan required pursuant to (8)(h)2. if the Department determines that the alternative schedule is necessary to the effective conduct of decommissioning operations and presents no undue risk from radiation to the public health and safety and is otherwise in the public interest.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Procedures such as those listed in (8)(h)5.(i) with potential health and safety impacts may not be carried out prior to approval of the decommissioning plan.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The proposed decommissioning plan for the site or separate building or outdoor area must include: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(iv)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A description of the conditions of the site or separate building or outdoor area sufficient to evaluate the acceptability of the plan;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(iv)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A description of planned decommissioning activities;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(iv)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A description of methods used to ensure protection of workers and the environment against radiation hazards during decommissioning;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(iv)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A description of the planned final radiation survey; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(iv)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An updated detailed cost estimate for decommissioning, comparison of that estimate with present funds set aside for decommissioning, and a plan for assuring the availability of adequate funds for completion of decommissioning.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(iv)(VI)">(VI)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For decommissioning plans calling for completion of decommissioning later than 24 months after plan approval, the plan shall include a justification for the delay based on the criteria in (8)(h)7.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)5.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The proposed decommissioning plan will be approved by the Department if the information therein demonstrates that the decommissioning will be completed as soon as practicable and that the health and safety of workers and the public will be adequately protected. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)6.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as provided in (8)(h)7., licensees shall complete decommissioning of the site or separate building or outdoor area as soon as practical but no later than 24 months following the initiation of decommissioning.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)6.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as provided in (8)(h)7. when decommissioning involves the entire site, the licensee shall request license termination as soon as practical but no later than 24 months following the initiation of decommissioning. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may approve a request for an alternative schedule for completion of decommissioning of the site or separate building or outdoor area, and license termination if appropriate, if the Department determines that the alternative is warranted by consideration for the following:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)7.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Whether it is technically feasible to complete decommissioning within the allotted 24-month period;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)7.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Whether sufficient waste disposal capacity is available to allow completion of decommissioning within the allotted 24-month period;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)7.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Whether a significant volume reduction in wastes requiring disposal will be achieved by allowing short-lived radionuclides to decay;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)7.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Whether a significant reduction in radiation exposure to workers can be achieved by allowing short-lived radionuclides to decay; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)7.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Other site-specific factors which the Department may consider appropriate on a case-by-case basis, such as the regulatory requirements of other government agencies, lawsuits, ground-water treatment activities, monitored natural ground-water restoration, actions that could result in more environmental harm than deferred cleanup, and other factors beyond the control of the licensee.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(8)(h)8.">8.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> As the final step in decommissioning, the licensee shall follow the requirements of Rule .02(18)(d). </span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)">(9)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Special Requirements for Issuance of Certain Specific Licenses for Radioactive Material.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use of Sealed Sources in Industrial Radiography. In addition to the requirements set forth in (8), a specific license for the use of sealed sources in industrial radiography will be issued if the licensee meets all of the requirements of Rule .04 of this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Human Use of Radioactive Materials in Institutions. In addition to the requirements set forth in (8), a specific license for the human use of radioactive material in an institution will be issued only if the licensee also meets all of the requirements of Rule .05 of this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Specific Licenses to Individual Physicians for Human Use of Radioactive Material. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application by an individual physician or group of physicians for a specific license for human use of radioactive material will be approved if:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in (8), and all of the requirements of Rule .05 of this Chapter;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The application is for use in the applicant's practice in an office outside a medical institution;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant has access to a hospital possessing adequate facilities to hospitalize and monitor the applicant's radioactive patients whenever it is advisable; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant has extensive experience in the proposed use, the handling and administration of radionuclides, and where applicable, the clinical management of radioactive patients.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department will not approve an application by an individual physician or group of physicians for a specific license to receive, possess, or use radioactive material on the premises of a medical institution unless:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The use of radioactive material is limited to:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)2.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The administration of radiopharmaceuticals for diagnostic or therapeutic purposes;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)2.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The performance of diagnostic studies on patients to whom a radiopharmaceutical has been administered;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)2.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The performance of in vitro diagnostic studies; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)2.(i)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The calibration and quality control checks of radioactive assay instrumentation, radiation safety instrumentation, and diagnostic instrumentation;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The physician brings the radioactive material with him and removes the radioactive material when he departs (The institution cannot receive, possess, or store radioactive material other than the amount of material remaining in the patient.); and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(c)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The medical institution does not hold a radioactive material license under (9)(b).</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Human Use of Sealed Sources Containing Radioactive Material. In addition to the requirements set forth in (8), a specific license for the human use of sealed sources containing radioactive material will be issued only if the applicant, or, if the application is made by an institution, the individual user is a physician and either: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Has specialized training in the therapeutic use of the sealed source considered (e.g., teletherapy unit, beta applicator), or has experience equivalent to such training; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Has specialized training in the diagnostic use of the sealed source considered (e.g., bone mineral analyzer) or has experience equivalent to such training.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Specific Licenses for Certain Medical Uses of Radioactive Material.</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Subject to the provisions of (9)(e)2. and 3., an application for a specific license pursuant to (9)(b), (c), or (d), for any medical use or uses of radioactive material specified in Rule .05 of this Chapter, will be approved if: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the requirements of (9)(b), (c), or (d);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant, or the physician designated in the application as the individual user, has adequate clinical experience in the types of uses specified in the application;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant, or the physicians and all other personnel who will be involved in the preparation and use of the radioactive material, has adequate training and experience in the handling of radioactive material appropriate to his participation in the uses specified in the application;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant's radiation detection and measuring instrumentation is adequate for conducting the procedures involved in the uses specified in the application;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant's radiation safety operating procedures are adequate for handling and disposal of the radioactive material involved in the uses specified in the application; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For uses regulated by Rules .05(41) and (44) of this Chapter, any licensee using radioactive material for clinical procedures other than those specified in the product labeling (package insert) shall comply with the product labeling regarding: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(vi)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Chemical and physical form,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(vi)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Route of administration, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)1.(vi)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Dosage range. </span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any licensee who is authorized to use radioactive material pursuant to (9)(e) and to Rule .05 of this Chapter is subject to the following conditions:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For paragraphs (41), (44), and (48) of Rule .05 of this Chapter, no licensee shall receive, possess, or use radioactive material except as a radiopharmaceutical manufactured in the form to be administered to the patient, and labeled, packaged, and distributed in accordance with a specific license issued by the Department pursuant to (11)(i), a specific license issued by the U.S. Nuclear Regulatory Commission pursuant to Section 32.72 of 10 CFR, Part 32, or a specific license issued by an Agreement State or a Licensing State pursuant to equivalent regulations.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For Rule </span><span class=""> <a title="391-3-17-.05(44)" href="391-3-17-.05#391-3-17-.05(44)">391-3-17-.05(44)</a></span><span class="">, no licensee shall receive, possess, or use generators or reagent kits containing radioactive material or shall use reagent kits that do not contain radioactive material to prepare radiopharmaceuticals containing radioactive material, except: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)2.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Reagent kits not containing radioactive material that are approved by the Department, the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State for use by persons licensed pursuant to (9)(d) and to Rule .05 of this Chapter or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)2.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Generators or reagent kits containing radioactive material that are manufactured, labeled, packaged, and distributed in accordance with a specific license issued by the Department pursuant to (11)(i), a specific license issued by the U.S. Nuclear Regulatory Commission pursuant to Section 32.73 of 10 CFR, Part 32, or a specific license issued by an Agreement State or a Licensing State pursuant to equivalent regulations; and</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For Brachytherapy, regulated by Rule .05 of this Chapter, no licensee shall receive, possess, or use radioactive material except as contained in a source or device that has been manufactured, labeled, packaged, and distributed in accordance with a specific license issued by the Department pursuant to (11)(j), a specific license issued by the U.S. Nuclear Regulatory Commission pursuant to Section 32.74 of 10 CFR, Part 32, or a specific license issued to the manufacturer by an Agreement State or a Licensing State pursuant to equivalent regulations.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(e)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any licensee who is licensed pursuant to (9) for one or more of the medical uses regulated by Rule .05 of this Chapter also is authorized to use radioactive material under the general license in (6)(g) for in vitro uses without filing the Certificate as required by (6)(g)2, provided that the licensee is subject to the other provisions of (6)(g).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use of Naturally-Occurring Radioactive Material (NORM). In addition to the requirements set forth in (8), a specific license for the use of NORM will be issued if the licensee meets all of the requirements of Rule .08 of this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(9)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use of Sealed Sources in Irradiators. In addition to the requirements set forth in (8), a specific license for the use of sealed sources in large irradiators will be issued if the licensee meets all of the requirements of Rule .09 of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)">(10)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Special Requirements for Specific Licenses of Broad Scope.</B></span><span class=""> These requirements are for the issuance of non-medical specific licenses of broad scope for radioactive material ("broad licenses") and contain certain regulations governing holders of such licenses. (The issuance of medical specific licenses of broad scope is addressed in (9).) </span><span class=""><P><I>Nota Bene</I>: See Note, in (3)(c)1.</P></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The different types of broad scope licenses are set forth below:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A "Type A specific license of broad scope" is a specific license authorizing receipt, acquisition, ownership, possession, use, and transfer of any chemical or physical form of the radioactive material specified in the license, but not exceeding quantities specified in the license, for any authorized purpose. The quantities specified are usually in the multicurie range.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A "Type B specific license of broad scope" is a specific license authorizing receipt, acquisition, ownership, possession, use, and transfer of any chemical or physical form of radioactive material specified in (21)(c), Schedule C, for any authorized purpose. The possession limit for a Type B broad license, if only one radionuclide is possessed thereunder, is the quantity specified for that radionuclide in (21)(c), Schedule C, Column I. If two or more radionuclides are possessed thereunder, the possession limit for each is determined as follows: For each radionuclide, determine the ratio of the quantity possessed to the applicable quantity specified in (21)(c), Schedule C, Column I, for that radionuclide. The sum of the ratios for all radionuclides possessed under the license shall not exceed unity.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A "Type C specific license of broad scope" is a specific license authorizing receipt, acquisition, ownership, possession, use, and transfer of any chemical or physical form of radioactive material specified in (21)(c), Schedule C, for any authorized purpose. The possession limit for a Type C broad license, if only one radionuclide is possessed thereunder, is the quantity specified for that radionuclide in (21)(c), Schedule C, Column II. If two or more radionuclides are possessed thereunder, the possession limit is determined for each as follows: For each radionuclide, determine the ratio of the quantity possessed to the applicable quantity specified in (21)(c), Schedule C, Column II, for that radionuclide. The sum of the ratios for all radionuclides possessed under the license shall not exceed unity.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for a Type A specific license of broad scope will be approved if: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in (8);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant has engaged in a reasonable number of activities involving the use of radioactive material; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant has established administrative controls and provisions relating to organization and management, procedures, record-keeping, material control and accounting, and management review that are necessary to assure safe operations, including: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The establishment of a Radiation Safety Committee composed of such persons as a Radiation Safety Officer, a representative of management, and persons trained and experienced in the safe use of radioactive material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The appointment of a Radiation Safety Officer who is qualified by training and experience in radiation protection, and who is available for advice and assistance on radiation safety matters; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The establishment of appropriate administrative procedures to assure: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)3.(iii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Control of procurement and use of radioactive material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)3.(iii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Completion of safety evaluations of proposed uses of radioactive material which take into consideration such matters as the adequacy of facilities and equipment, the training and experience of the user, and the operating or handling procedures; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(b)3.(iii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Review, approval, and recording by the Radiation Safety Committee of safety evaluations of proposed uses prepared in accordance with (10)(b)3.(iii)(II) prior to the use of the radioactive material.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for a Type B specific license of broad scope will be approved if: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in (8); and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant has established administrative controls and provisions relating to organization and management, procedures, record-keeping, material control and accounting, and management review that are necessary to assure safe operations, including: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(c)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The appointment of a Radiation Safety Officer who is qualified by training and experience in radiation protection, and who is available for advice and assistance on radiation safety matters, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(c)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The establishment of appropriate administrative procedures to assure: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(c)2.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Control of procurement and use of radioactive material,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(c)2.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Completion of safety evaluations of proposed uses of radioactive material which take into consideration such matters as the adequacy of facilities and equipment, the training and experience of the user, and the operating or handling procedures, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(c)2.(ii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Review, approval, and recording by the Radiation Safety Officer of safety evaluations of proposed uses prepared in accordance with (10)(c)2.(ii)(II) prior to the use of the radioactive material.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for a Type C specific license of broad scope will be approved if: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in (8);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits a statement that radioactive material will be used only by, or under the direct supervision of, individuals who have received: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(d)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A college degree at the bachelor level, or equivalent training and experience, in the physical or biological sciences or in engineering, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(d)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> At least 40 hours of training and experience in the safe handling of radioactive material, and in the characteristics of ionizing radiation, units of radiation dose and quantities, radiation detection instrumentation, and biological hazards of exposure to radiation appropriate to the type and forms of radioactive material to be used; and</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(d)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant has established administrative controls and provisions relating to procurement of radioactive material, procedures, record-keeping, material control and accounting, and management review necessary to assure safe operations.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Specific non-medical licenses of broad scope are subject to the following conditions: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Unless specifically authorized, persons licensed pursuant to (10) shall not:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Conduct tracer studies in the environment involving direct release of radioactive material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Receive, acquire, own, possess, use, or transfer devices containing 100,000 Curies (3.7 PBq) or more of radioactive material in sealed sources used for irradiation of materials;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Conduct activities for which a specific license issued by the Department under (9) or (11) is required; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Add or cause the addition of radioactive material to any food, beverage, cosmetic, drug, or other product designed for ingestion or inhalation by, or application to, a human being.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each Type A specific license of broad scope issued under (10) shall be subject to the condition that radioactive material possessed under the license may only be used by, or under the direct supervision of, individuals approved by the licensee's Radiation Safety Committee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each Type B specific license of broad scope issued under (10) shall be subject to the condition that radioactive material possessed under the license may only be used by, or under the direct supervision of, individuals approved by the licensee's Radiation Safety Officer.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(10)(e)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each Type C specific license of broad scope issued under (10) shall be subject to the condition that radioactive material possessed under the license may only be used by, or under the direct supervision of, individuals who satisfy the requirements of (10)(d).</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)">(11)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Special Requirements for a Specific License to Manufacture, Assemble, Repair, or Distribute Commodities, Products, or Devices which Contain Radioactive Material.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> [Reserved]</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Licensing the Distribution of Naturally-Occurring and Accelerator-Produced Radioactive Material (NARM) in Exempt Quantities. </span><span class=""><P><I>Nota Bene</I>: See Note, in (3)(c)1.</P></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for a specific license to distribute NARM to persons exempted from this Chapter pursuant to (3)(b) will be approved if:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The radioactive material is not contained in any food, beverage, cosmetic, drug, or other commodity designed for ingestion or inhalation by, or application to, a human being;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The radioactive material is in the form of processed chemical elements, compounds, mixtures, tissue samples, bioassay samples, counting standards, plated or encapsulated sources, or similar substances identified as radioactive and to be used for its radioactive properties, but is not incorporated into any manufactured or assembled commodity, product, or device intended for commercial distribution; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits copies of prototype labels and brochures and the Department approves such labels and brochures.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The license issued under (11)(b)1. is subject to the following conditions: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No more than ten exempt quantities shall be sold or transferred in any single transaction. However, an exempt quantity may be composed of fractional parts of one or more of the exempt quantities provided the sum of the fractions shall not exceed unity.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each exempt quantity shall be separately and individually packaged. No more than ten such packaged exempt quantities shall be contained in any outer package for transfer to persons exempt pursuant to (3)(b). The outer package shall be such that the dose rate at the external surface of the package does not exceed 0.5 millirem (5 </span><span class="">µ</span><span class="">Sv) per hour.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The immediate container of each quantity or separately- packaged fractional quantity of radioactive material shall bear a durable and legible label which: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(iii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Identifies the radionuclide and the quantity of radioactivity, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(iii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Bears the words "Radioactive Material".</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In addition to the labeling information required by (11)(b)2.(iii), the label affixed to the immediate container, or an accompanying brochure, shall:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(iv)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> State that the contents are exempt from Licensing State requirements,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(iv)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Bear the words "Radioactive Material - Not for Human Use - Introduction into Foods, Beverages, Cosmetics, Drugs, or Medicinals, or into Products Manufactured for Commercial Distribution is Prohibited - Exempt Quantities Should Not Be Combined", and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)2.(iv)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Set forth appropriate additional radiation safety precautions and instructions relating to the handling, use, storage, and disposal of the radioactive material.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed under (11)(b) shall maintain records identifying, by name and address, each person to whom radioactive material is transferred for use under (3)(b) or the equivalent regulations of a Licensing State, and stating the kinds and quantities of radioactive material transferred. An annual summary report stating the total quantity of each radionuclide transferred under the specific license shall be filed with the Department. Each report shall cover the year ending June 30, and shall be filed within 30 days thereafter. If no transfers of radioactive material have been made pursuant to (11)(b) during the reporting period, the report shall so indicate.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> [Reserved]</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Licensing the Manufacture and Initial Transfer of Devices to Persons Generally Licensed Under (6)(c). </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for a specific license to initially transfer devices containing radioactive material to persons generally licensed under (6)(c) or equivalent regulations of the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State will be approved if: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements of (8);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits sufficient information relating to the design, manufacture, prototype testing, quality control, labels, proposed uses, installation, servicing, leak testing, operating and safety instructions, and potential hazards of the device to provide reasonable assurance that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The device can be safely operated by persons not having training in radiological protection,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Under ordinary conditions of handling, storage, and use of the device, the radioactive material contained in the device will not be released or inadvertently removed from the device, and it is unlikely that any person will receive in any period of one year a dose in excess of ten percent of the annual limits specified in Rule .03(5)(a)1. of this Chapter, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(ii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Under accident conditions (such as fire and explosion) associated with handling, storage, and use of the device, it is unlikely that any person would receive an external radiation dose or dose commitment in excess of the following organ doses: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(ii)(III)I.">I.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Whole body; head and trunk; active blood-forming organs; gonads; or lens of eye 15 rem (150 mSv); </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(ii)(III)II.">II.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Hands and forearms; feet and ankles; localized areas of skin averaged over areas no larger than one square centimeter 200 rem (2 Sv); </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(ii)(III)III.">III.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Other Organs 50 rem (500 mSv); and </span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each device bears a durable, legible, and clearly visible label or labels approved by the Department, which contain in a clearly identified and separate statement: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(iii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Instructions and precautions necessary to assure safe installation, operation, and servicing of the device (documents such as operating and service manuals may be identified in the label and used to provide this information);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(iii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The requirement, or lack of requirement, for leak testing, or for testing any on/off mechanism and indicator, including the maximum time interval for such testing, and the identification of radioactive material by isotope, quantity of radioactivity, and date of determination of the quantity; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(iii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The information called for in one of the following statements, as appropriate, in the same or substantially similar form: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(iii)(III)I.">I.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The receipt, possession, use, and transfer of this device, Model ____, Serial No.____, are subject to a general license or the equivalent and to the regulations of the U.S. Nuclear Regulatory Commission or of a State with which the U.S. Nuclear Regulatory Commission has entered into an agreement for the exercise of regulatory authority. This label shall be maintained on the device in a legible condition. Removal of this label is prohibited. </span><span class=""><P>CAUTION - RADIOACTIVE MATERIAL</P></span><span class=""><P>___________________________________</P></span><span class=""><P>(NAME OF MANUFACTURER OR INITIAL TRANSFEROR)</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(iii)(III)II.">II.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The receipt, possession, use, and transfer of this device, Model ____, Serial No.____, are subject to a general license or the equivalent, and to the regulations of a Licensing State. This label shall be maintained on the device in a legible condition. Removal of this label is prohibited. </span><span class=""><P>CAUTION - RADIOACTIVE MATERIAL</P></span><span class=""><P>_________________________________</P></span><span class=""><P>(NAME OF MANUFACTURER OR INITIAL TRANSFEROR)</P></span><span class=""><P>Note: The model, serial number, and name of the manufacturer or distributor may be omitted from the appropriate label provided the information is elsewhere specified in labeling affixed to the device. Devices distributed pursuant to Regulations equivalent to (11)(d) prior to January 1, 1981, may bear labels authorized by the Regulations in effect on January 1, 1980. Devices distributed on or after January 1, 1981, including devices redistributed upon radioactive sources exchange, shall bear labels authorized in (11)(d).</P></span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each device having a separable source housing that provides the primary shielding for the source also bears, on the source housing, a durable label containing the device model number and serial number, the isotope and quantity, the words, "Caution-Radioactive Material," the radiation symbol described in Rule .03(12), and the name of the manufacturer or initial distributor.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each device meeting the criteria of (6)(c)3.(xii), bears a permanent (e.g., embossed, etched, stamped, or engraved) label affixed to the source housing if separable, or the device if the source housing is not separable, that includes the words, "Caution-Radioactive Material," and, if practical, the radiation symbol described in Rule .03(12).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)1.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The device has been registered in the Sealed Source and Device Registry. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In the event the applicant desires that the device be tested at intervals longer than six months, either for proper operation of the on/off mechanism and indicator, if any, or for leakage of radioactive material, or for both, the applicant shall include in his application sufficient information to demonstrate that such longer interval is justified by performance characteristics of the device or similar devices and by design features which have a significant bearing on the probability or consequences of leakage of radioactive material from the device or failure of the on/off mechanism and indicator. In determining the acceptable interval for the test for leakage of radioactive material, the Department will consider information that includes, but is not limited to: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Primary containment (source capsule);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Protection of primary containment;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Method of sealing containment;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Containment construction materials;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Form of contained radioactive material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Maximum temperature withstood during prototype tests;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Maximum pressure withstood during prototype tests;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Maximum quantity of contained radioactive material;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(ix)">(ix)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Radiotoxicity of contained radioactive material; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)2.(x)">(x)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Operating experience with identical devices or similarly designed and constructed devices.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In the event the applicant desires that the general licensee under (6)(c), or under equivalent regulations of the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State, be authorized to install the device, collect the sample to be analyzed by a specific licensee for leakage of radioactive material, service the device, test the on/off mechanism and indicator, or remove the device from installation, the applicant shall include in his application written instructions to be followed by the general licensee, estimated calendar quarter doses associated with such activity or activities, and the basis for such estimates. The submitted information shall demonstrate that the performance of such activity or activities by an individual untrained in radiological protection, in addition to other handling, storage, and use of devices under the general license, is unlikely to cause that individual to receive a dose in excess of ten percent of the annual limits specified in Rule .03(5)(a)1. of this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed under (11)(d) shall provide the information specified in (11)(d)4.(i) to each generally licensed recipient to whom a device is to be transferred. This information must be provided before the device may be transferred. In the case of a transfer through an intermediate person, the information must also be provided to the intended user prior to initial transfer to the intermediate person. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The required information includes: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A copy of the general license contained in (6)(c); if (6)(c)3.(ii) through (iv) or (6)(c)3.(xii) do not apply to the particular device, these rules may be omitted.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A copy of Rule .01(4), (5), (6), (7), (8), (9) and (10), Rule .02(13), (18), and (19), Rule .03(15)(a) and (b) and Rule .06;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A list of the services that can only be performed by a specific licensee;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(i)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Information on acceptable disposal options including estimated costs of disposal; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(i)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An indication that improper disposal can result in high civil penalties.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If a device containing radioactive material is to be transferred for use under a general license contained in the U.S. Nuclear Regulatory Commission's, Agreement State's, or Licensing State's regulation equivalent to (6)(c), the licensee shall provide the information specified in (11)(d)4.(ii) to each person to whom a device is to be transferred. This information must be provided before the device may be transferred. In the case of a transfer through an intermediate person, the information must also be provided to the intended user prior to initial transfer to the intermediate person. The required information includes: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A copy of this equivalent regulation or, alternatively, furnish a copy of the general license contained in (6)(c) to each person to whom he directly or through an intermediate person transfers radioactive material in a device for use pursuant to the general license of the U.S. Nuclear Regulatory Commission, the Agreement State, or the Licensing State. In the case of a transfer through an intermediate person, the information must also be provided to the intended user prior to initial transfer to the intermediate person. If a copy of the general license in (6)(c) is furnished to such a person, it shall be accompanied by a note explaining that the use of the device is regulated by the U.S. Nuclear Regulatory Commission, Agreement State, or Licensing State under requirements substantially the same as those in (6)(c); if certain paragraphs of the regulations do not apply to the particular device, those paragraphs may be omitted;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A list of the services that can only be performed by a specific licensee;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(ii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Information on acceptable disposal options including estimated costs of disposal;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(ii)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An indication that improper disposal can result in high civil penalties; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(ii)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The name or title, address, and telephone number of the contact at the appropriate NRC Regional Office or Agreement State from which additional information may be obtained.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)4.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An alternative approach to informing customers may be proposed by the licensee for approval by the Department.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each device that is transferred after January 1, 2003, must meet the labeling requirements of (11)(d)1.(iii) through (v).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If a notification of bankruptcy has been made under (13)(e) or the license is to be terminated, each person licensed under (11)(d) shall provide, upon request, to the Department and as appropriate to any Agreement State or the NRC, records of final disposition required under (11)(d)4.(viii).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall report to the Department all transfers of such devices to persons for use under the general license in (6)(c) and report all receipts of such devices from persons licensed under (6)(c).</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Such report shall identify each general licensee by the following: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The name and mailing address for the location of use; if there is no mailing address for the location of use, an alternate address for the general licensee shall be submitted along with information on the actual location of use;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The name, title, and telephone number of the person identified by the general licensee as having knowledge of and authority to take required actions to ensure compliance with the appropriate regulations and requirements;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The date of the transfer;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(i)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The type, model number, and serial number of the device transferred; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(i)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The quantity and type of radioactive material contained in the device.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If one or more intermediate persons will temporarily possess the device at the intended place of use prior to its possession by the user, the report shall include the same information for both the intended user and each intermediate person, and clearly designate the intermediate person(s).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For devices received from a (6)(c) general licensee, the report must include the identity of the general licensee by name and address, the type, model number, and serial number of the device received, the date of receipt, and, in the case of devices not initially transferred by the reporting licensee, the name of the manufacturer or initial transferor.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee makes changes to a device possessed by a (6)(c) general licensee, such that the label must be changed to update required information, the report must identify the general licensee, the device, and the changes to information on the device label.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The report must cover each calendar quarter, must be filed within 30 days of the end of the calendar quarter, and must clearly indicate the period covered by the report.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The report must clearly identify the specific licensee submitting the report and include the license number of the specific licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)7.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If no transfers have been made to or from persons generally licensed under (6)(c) during the reporting period, the report shall so indicate.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.">8.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall furnish reports to other agencies as follows:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Report to the U.S. Nuclear Regulatory Commission all transfers of such devices to persons for use under the U.S. Nuclear Regulatory Commission general license in Section 31.5 of 10 CFR, Part 31 and all receipts of devices from U.S. Nuclear Regulatory Commission Section 31.5 general licensees;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Report to the responsible state agency all transfers of devices manufactured and distributed pursuant to (11)(d) for use under a general license in that state's regulations equivalent to (6)(c) and all receipts of devices from general licensees in the state agency's jurisdiction;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The reports identified in 8.(i) and 8.(ii) shall identify each general licensee by the following:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(iii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The name and mailing address for the location of use; if there is no mailing address for the location of use, an alternate address for the general licensee shall be submitted along with information on the actual location of use.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(iii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The name, title and telephone number the person identified by the general licensee as having knowledge of and authority to take required actions to ensure compliance with the appropriate regulations and requirements;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(iii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The date of the transfer;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(iii)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The type, model, and serial number of the device transferred; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(iii)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The quantity and type of radioactive material contained in the device.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If one or more intermediate persons will temporarily possess the device at the intended place of use prior to its possession by the user, the report shall include the same information for both the intended user and each intermediate person, and clearly designate the intermediate person(s).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For devices received from a (6)(c) general licensee, the report must include the identity of the general licensee by name and address, the type, model number, and serial number of the device received, the date of receipt, and, in the case of devices not initially transferred by the reporting licensee, the name of the manufacturer or initial transferor.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee makes changes to a device possessed by a general licensee, such that the label must be changed to update required information, the report must identify the general licensee, the device, and the changes to information on the device label.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The report must cover each calendar quarter, must be filed within 30 days of the end of the calendar quarter, and must clearly indicate the period covered by the report.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The report must clearly identify the specific licensee submitting the report and must include the license number of the specific licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(ix)">(ix)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If no transfers have been made to U.S. Nuclear Regulatory Commission licensees during the reporting period, report this information to the U.S. Nuclear Regulatory Commission; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)8.(x)">(x)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If no transfers have been made to general licensees within a particular state during the reporting period, report this information to the responsible state agency upon request of that agency.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(d)9.">9.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed under (11)(d) to distribute devices to generally licensed persons shall maintain all information concerning transfers and receipts of devices that supports the reports required by (11)(d)4. These records shall be maintained for a period of three years following the date of the recorded event. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Special Requirements for the Manufacture, Assembly, or Repair of Luminous Safety Devices for Use in Aircraft. An application for a specific license to manufacture, assemble, repair, or initially transfer luminous safety devices containing tritium or promethium-147 for use in aircraft, and for distribution to persons generally licensed under (6)(d), will be approved subject to the following conditions: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in (8), and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the requirements of Sections 32.53, 32.54, 32.55, and 32.56 of 10 CFR, Part 32, or their equivalent.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Special Requirements for License to Manufacture or Initially Transfer Calibration Sources Containing Americium-241, Plutonium, or Radium-226 for Distribution to Persons Generally Licensed Under (6)(f). An application for a specific license to manufacture or initially transfercalibration and reference sources containing americium-241, plutonium, or radium-226 to persons generally licensed under (6)(f) will be approved subject to the following conditions: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(f)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirement of (8), and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(f)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the requirements of Sections 32.57, 32.58, and 32.59 of 10 CFR, Part 32, and Section 70.39 of 10 CFR, Part 70, or their equivalent.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Manufacture and Distribution of Radioactive Material for Certain In Vitro Clinical or Laboratory Testing Under General License. An application for a specific license to manufacture or distribute radioactive material for use under the general license of (6)(g) will be approved subject to the following conditions:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in (8);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The radioactive material is to be prepared for distribution in prepackaged units of:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Iodine-125 in units not exceeding ten microcuries (370 kBq) each,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Iodine-131 in units not exceeding ten microcuries (370 kBq) each,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Carbon-14 in units not exceeding ten microcuries (370 kBq) each,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Hydrogen-3 (tritium) in units not exceeding 50 microcuries (1.85 MBq) each,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Iron-59 in units not exceeding 20 microcuries (740 kBq) each,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Cobalt-57 in units not exceeding ten microcuries (370 kBq) each,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Selenium-75 in units not exceeding ten microcuries (370 kBq) each,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)2.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Mock Iodine-125 in units not exceeding 0.05 microcurie (1.85 kBq) of iodine-129 and 0.005 microcurie (185 Bq) of americium-241 each;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each prepackaged unit bears a durable and clearly visible label:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Identifying the radioactive contents as to chemical form and radionuclide, and indicating that the amount of radioactivity does not exceed ten microcuries (370 kBq) of iodine-125, iodine-131, carbon-14, cobalt-57, or selenium-75; 50 microcuries (1.85 Mbq) of hydrogen-3 (tritium); 20 microcuries (740 kBq) of iron-59; or Mock Iodine-125 in units not exceeding 0.05 microcurie (1.85 kBq) of iodine-129 and 0.005 microcurie (185 Bq) of americium-241 each; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Displaying the radiation caution symbol described in Rule </span><span class=""> <a title="391-3-17-.03" href="391-3-17-.03">391-3-17-.03</a></span><span class="">, of this Chapter, and the words, "CAUTION, RADIOACTIVE MATERIAL", and "Not for Internal or External Use in Humans or Animals";</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> One of the following statements, as appropriate, or a substantially similar statement which contains the information called for in one of the following statements, appears on a label affixed to each prepackaged unit or appears in a leaflet or brochure which accompanies the package: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This radioactive material may be received, acquired, possessed, and used only by physicians, veterinarians in the practice of veterinary medicine, clinical laboratories, or hospitals and only for in vitro clinical or laboratory tests not involving internal or external administration of the material, or the radiation therefrom, to human beings or animals. Its receipt, acquisition, possession, use, and transfer are subject to the regulations of and a general license of the U.S. Nuclear Regulatory Commission or of a State with which the U.S. Nuclear Regulatory Commission has entered into an agreement for the exercise of regulatory authority. </span><span class=""><P>___________________________</P></span><span class=""><P>(NAME OF MANUFACTURER)</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> This radioactive material may be received, acquired, possessed, and used only by physicians, veterinarians in the practice of veterinary medicine, clinical laboratories, or hospitals and only for in vitro clinical or laboratory tests not involving internal or external administration of the material, or the radiation therefrom, to human beings or animals. Its receipt, acquisition, possession, use, and transfer are subject to the regulations of and a general license of a Licensing State. </span><span class=""><P>___________________________</P></span><span class=""><P>(NAME OF MANUFACTURER);</P></span><span class=""><P>and</P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(g)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The label affixed to the unit, or the leaflet or brochure, which accompanies the package, contains adequate information as to the precautions to be observed in handling and storing such radioactive material. In the case of the Mock Iodine-125 reference or calibration source, the information accompanying the source must also contain directions to the licensee regarding the waste disposal requirements set out in Rule .03(13) of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Licensing the Manufacture and Distribution of Ice-Detection Devices. An application for a specific license to manufacture and initially transfer ice-detection devices to persons generally licensed under (6)(e) will be approved subject to the following conditions: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(h)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements of (8), and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(h)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The criteria of Sections 32.61 and 32.62 of 10 CFR, Part 32, are met.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Manufacture, Preparation, or Transfer, for Commercial Distribution of Pharmaceuticals Containing Radioactive Material for Medical Use. An application for a specific license to manufacture, prepare, or transfer for commercial distribution pharmaceuticals containing radioactive material for use by persons licensed pursuant to (9) for the uses listed in (41), (44), and (48) of Rule .05 of this Chapter will be approved subject to the following conditions:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in (8);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits evidence that the applicant is at least one of the following: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Registered or licensed with the U.S. Food and Drug Administration (FDA) as the owner or operator of a drug establishment that engages in the manufacture, preparation, propagation, compounding, or processing of a drug under </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=207.20&amp;title=21#207.20(a)" target="_newtab">21 CFR 207.20(a)</a></span><span class="">;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Registered or licensed with a State Agency as a drug manufacturer;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Licensed as a pharmacy by the Georgia State Board of Pharmacy;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Operating as a nuclear pharmacy within a Federal medical institution; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)2.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A Positron Emission Tomography (PET) drug production facility registered with a State agency.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits information on the radionuclide, chemical and physical form, packaging including maximum activity per vial, syringe, generator, or other container of the radiopharmaceutical, and shielding provided by the packaging to show it is appropriate for safe handling and storage of radiopharmaceuticals by licensees; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the following requirements:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A label is affixed to each transport radiation shield, whether it is constructed of lead, glass, plastic, or other material, of a radiopharmaceutical to be transferred for commercial distribution. The label must include the radiation symbol and words "Caution, Radioactive Material" or "Danger Radioactive Material"; the name of the radiopharmaceutical or its abbreviation, and quantity of radioactivity at a specified date and time. For radiopharmaceuticals with a half-life greater than 100 days, the time may be omitted.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A label is affixed to each syringe, vial, or other container used to hold a radiopharmaceutical to be transferred for commercial distribution. The label must include the words "Caution, Radioactive Material" or "Danger Radioactive Material" and an identifier that ensures that the syringe, vial, or other container can be correlated with the information on the transport radiation shield label, leaflet, or brochure.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A licensee described by (11)(i)2.(iii) or (iv):</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> May prepare radiopharmaceuticals for medical use, as defined in Rule .05(2)(s) provided that the radiopharmaceutical is prepared by either an authorized nuclear pharmacist, as specified in (ii) and (iv) or an individual under the supervision of an authorized nuclear pharmacist as specified in Rule .05(18)(b).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> May allow a pharmacist to work as an authorized nuclear pharmacist if this individual: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Qualifies as an authorized nuclear pharmacist as defined in .05(2)(e),</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Meets the requirements specified in Rule .05(24)(b) and .05(27) and the licensee has received an approved license amendment identifying this individual as an authorized nuclear pharmacist, or has notified the Department in accordance with Rule .05(11), or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.(ii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Is designated as an authorized nuclear pharmacist in accordance with (iv).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The actions authorized in (i) and (ii) are permitted not withstanding more restrictive language in license conditions.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> May designate a nuclear pharmacist in accordance with Rule .05(26) as an authorized nuclear pharmacist if the individual is identified as of December 31, 1996, as an "authorized user" on a license issued by the Department, the NRC, or an Agreement State, under this rule or equivalent requirements, or if the individual was a nuclear pharmacist preparing only radiopharmaceuticals containing accelerator produced radioactive material and the individual practiced at a Government Agency or Federally recognized Indian Tribe before November 30, 2007 or at all other pharmacies before 'August 8, 2009, or an earlier date as noticed by the NRC.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)5.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Shall provide to the Department a copy of each individual's certification by the Board of Pharmaceutical Specialties, or the Department, NRC, Agreement State license, or permit issued by a licensee of broad scope, or documentation that only accelerator-produced radioactive materials were used in the practice of nuclear pharmacy at a Government agency or Federally recognized Indian Tribe before November 30, 2007 or at all other locations of use before August 8, 2009, or an earlier date as noticed by the NRC, and a copy of the individual's license to practice pharmacy in the State of Georgia issued by the Secretary of State's office, no later than 30 days after the date that the licensee allows pursuant to (ii) and (iii), the individual to work as an authorized nuclear pharmacist.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A licensee shall possess and use instrumentation to measure the radioactivity of radiopharmaceuticals. The licensee shall measure, by direct measurements or by combination of measurements and calculations, the amount of radioactivity in dosages of alpha-, beta-, or photon-emitting radiopharmaceuticals prior to transfer for commercial distribution. In addition, the licensee shall: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)6.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Perform test before initial use, periodically, and following repair, on each instrument for accuracy, linearity, and geometry dependence, as appropriate for the use of the instrument; and make adjustments when necessary; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)6.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Check each instrument for constancy and proper operation at the beginning of each day of use.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(i)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Nothing in this section relieves the licensee from complying with applicable FDA, other Federal, or other State requirements governing radiopharmaceuticals.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)">(j)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Manufacture and Distribution of Sources or Devices Containing Radioactive Material for Medical Use. An application for a specific license to manufacture and distribute sources and devices containing radioactive material to persons licensed pursuant to Rule .05 of this chapter for use as a calibration, transmission, or reference source or for medical uses regulated by Rule .05(55), (65), or (67) of this Chapter will be approved subject to the following conditions: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements of (8);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits sufficient information regarding each type of source or device pertinent to an evaluation of its radiation safety, including: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The radioactive material contained, its chemical and physical form, and amount,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Details of design and construction of the source or device,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Procedures for, and results of, prototype tests to demonstrate that the source or device will maintain its integrity under stresses likely to be encountered in normal use and accidents,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For devices containing radioactive material, the radiation profile of a prototype device,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Details of quality control procedures to assure that production sources and devices meet the standards of the design and prototype tests,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Procedures and standards for calibrating sources and devices,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Legend and methods for labeling sources and devices as to their radioactive content, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)2.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Instructions for handling and storing the source or device from the radiation safety standpoint. (These instructions are to be included on a durable label attached to the source or device or attached to a permanent storage container for the source or device. Instructions which are too lengthy for such label may be summarized on the label and printed in detail on a brochure that is referenced on the label.)</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The label affixed to the source or device, or to the permanent storage container for the source or device, contains information on the radionuclide, quantity, and date of assay, and a statement that the source or device is licensed by the Department for distribution to persons licensed pursuant to (9) and to Rule .05(55), (65), or (67) of this Chapter or under equivalent licenses of the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The source or device has been registered in the Sealed Source and Device Registry;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In the event the applicant desires that the source or device be required to be tested for leakage of radioactive material at intervals longer than six months, he shall include in his application sufficient information to demonstrate that such longer interval is justified by performance characteristics of the source or device or similar sources or devices and by design features that have a significant bearing on the probability or consequences of leakage of radioactive material from the source;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(j)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In determining the acceptable interval for test of leakage of radioactive material, the Department will consider information that includes, but is not limited to, that which is listed in (11)(d)2.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)">(k)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Requirements for License to Manufacture and Distribute Industrial Products Containing Depleted Uranium for Mass-Volume Applications. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for a specific license to manufacture industrial products and devices containing depleted uranium for use pursuant to (5)(d) or equivalent regulations of the U.S. Nuclear Regulatory Commission or an Agreement State will be approved subject to the following conditions:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant satisfies the general requirements specified in (8);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits sufficient information relating to the design, manufacture, prototype testing, quality control procedures, labeling or marking, proposed uses, and potential hazards of the industrial product or device to provide reasonable assurance that possession, use, or transfer of the depleted uranium in the product or device is not likely to cause any individual to receive in any period of 1 year a radiation dose in excess of ten percent of the annual limits specified in Rule .03(5)(a)1. of this Chapter; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant submits sufficient information regarding the industrial product or device and the presence of depleted uranium for a mass-volume application in the product or device to provide reasonable assurance that unique benefits will accrue to the public because of the usefulness of the product or device.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In the case of an industrial product or device whose unique benefits are questionable, the Department will approve an application for a specific license under (11)(k) only if the product or device is found to combine a high degree of utility and low probability of uncontrolled disposal and dispersal of significant quantities of depleted uranium into the environment.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may deny any application for a specific license under (11)(k) if the end use(s) of the industrial product or device cannot be reasonably foreseen.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed pursuant to (11)(k)1. shall:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Maintain the level of quality control required by the license in the manufacture of the industrial product or device and in the installation of the depleted uranium into the product or device;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Label or mark each unit to:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Identify the manufacturer of the product or device and the number of the license under which the product or device was manufactured, the fact that the product or device contains depleted uranium, and the quantity of depleted uranium in each product or device; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> State that the receipt, possession, use, and transfer of the product or device are subject to a general license or the equivalent and to the regulations of the U.S. Nuclear Regulatory Commission or an Agreement State;</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Assure that the depleted uranium before being installed in each product or device has been impressed with the following legend clearly legible through any plating or other covering: "Depleted Uranium";</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Furnish a copy of the general license contained in:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(iv)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> (5) (d) and a copy of Department form "Registration Certificate - Use of Depleted Uranium Under General License" to each person to whom he transfers depleted uranium in a product or device for use pursuant to the general license contained in (5)(d), or </span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(iv)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The U.S. Nuclear Regulatory Commission's or Agreement State's regulation equivalent to (5)(d) and a copy of the U.S. Nuclear Regulatory Commission's or Agreement State's certificate, or, alternatively, furnish a copy of the general license contained in (5)(d) and a copy of Department form "Registration Certificate - Use of Depleted Uranium Under General License" to each person to whom he transfers depleted uranium in a product or device for use pursuant to the general license of the U.S. Nuclear Regulatory Commission or an Agreement State, with a note explaining that use of the product or device is regulated by the U.S. Nuclear Regulatory Commission or an Agreement State under requirements substantially the same as those in (5)(d);</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Report to the Department all transfers of industrial products or devices to persons for use under the general license in (5)(d). Such report shall identify each general licensee by name and address, an individual by name and/or position who may constitute a point of contact between the Department and the general licensee, the type and model number of device transferred, and the quantity of depleted uranium contained in the product or device. The report shall be submitted within 30 days after the end of each calendar quarter in which such a product or device is transferred to the generally licensed person. If no transfers have been made to persons generally licensed under (5)(d) during the reporting period, the report shall so indicate;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Report to other agencies as follows: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(vi)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> To the U.S. Nuclear Regulatory Commission all transfers of industrial products or devices to persons for use under the U.S. Regulatory Commission general license in Section 40.25 of 10 CFR, Part 40;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(vi)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> To the responsible state agency all transfers of devices manufactured and distributed pursuant to </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/Code_of_Federal_Regulations/browse?ci=25&amp;id=gasos&amp;codesec=32.210&amp;title=10#" target="_newtab">10CFR 32.210</a></span><span class=""> for use under a general license in that state's regulations equivalent to (5)(d);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(vi)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Have such reports identify each general licensee by name and address, an individual by name and/or position who may constitute a point of contact between the agency and the general licensee, the type and model number of the device transferred, and the quantity of depleted uranium contained in the product or device. The report shall be submitted within 30 days after the end of each calendar quarter in which such product or device is transferred to the generally licensed person;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(vi)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If no transfers have been made to U.S. Nuclear Regulatory Commission licensees during the reporting period, report this information to the U.S. Nuclear Regulatory Commission; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(vi)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If no transfers have been made to general licensees within a particular Agreement State during the reporting period, report this information to the responsible Agreement State agency upon the request of that agency; and</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(k)4.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Keep records showing the name, address, and point of contact for each general licensee to whom he transfers depleted uranium in industrial products or devices for use pursuant to the general license provided in (5)(d) or equivalent regulations of the U.S. Nuclear Regulatory Commission or an Agreement State. The records shall be maintained for a period of two years and shall show the date of each transfer, the quantity of depleted uranium in each product or device transferred, and compliance with the report requirements of (11).</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(11)(l)">(l)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> [Reserved] </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(12)">(12)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Issuance of Specific Licenses.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(12)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Upon a determination that an application meets the requirements of the Act and the Regulations of the Department, the Department may issue a specific license authorizing the proposed activity in such form and containing such conditions and limitations as it deems appropriate or necessary to effectuate the purposes of the Act.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(12)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may incorporate in any license at the time of issuance, or thereafter, such additional requirements and conditions, as authorized by Rule, Regulation, or Order, with respect to the licensee's receipt, possession, use, and transfer of radioactive material subject to this Chapter as necessary in order to: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(12)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Minimize danger to public health and safety or property;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(12)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Require such reports and the keeping of such records, and to provide for such inspections of activities under the license as necessary to effectuate the purposes of the Act; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(12)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prevent loss or theft of material subject to this Rule.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)">(13)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Specific Terms and Conditions of Licenses.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each license issued pursuant to this Rule shall be subject to all the provisions of the Act, and to all Rules, and Regulations of the Department and Orders of the Director.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No license issued or granted under this Rule and no right to possess or utilize radioactive material granted by any license issued pursuant to this Rule shall be transferred, assigned, or in any manner disposed of, either voluntarily or involuntarily, directly or indirectly, through transfer of control of any license to any person unless the Department, after securing full information, finds that the transfer is in accordance with the provisions of the Act, and gives its consent in writing. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An application for transfer of license must include:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(b)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The identity, technical and financial qualification of the proposed transferee; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(b)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Financial assurance for decommissioning information required by .02(8)(g). </span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each person licensed by the Department pursuant to this Rule shall confine use and possession of the material licensed to the locations and purposes authorized in the license.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall notify the Department in writing immediately and request termination of his license when the licensee decides to terminate all activities involving radioactive materials authorized under the license. This notification and request for termination must include the information specified in (18)(d).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each general licensee required to register by (6)(c)3.(xi) and each specific licensee shall notify the Department in writing immediately following the filing of a voluntary or involuntary petition for bankruptcy under any Chapter of Title 11 (Bankruptcy) of the United States Code by or against: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An entity (as that term is defined in </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/United_States_Code/browse?ci=25&amp;id=gasos&amp;codesec=101&amp;title=11#101(15)" target="_newtab">11 U.S.C. 101(15)</a></span><span class=""> ) controlling the licensee or listing the license or licensee as property of the estate; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(e)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An affiliate (as that term is defined in </span><span class=""> <a href="https://links.casemakerlegal.com/states/us/books/United_States_Code/browse?ci=25&amp;id=gasos&amp;codesec=101&amp;title=11#101(2)" target="_newtab">11 U.S.C. 101(2)</a></span><span class=""> of the licensee.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The notification specified in (13)(e) shall indicate the bankruptcy court in which the petition for bankruptcy was filed and the date of the filing of the petition.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Security requirements for portable gauges. Each portable gauge licensee shall use a minimum of two independent physical controls that form tangible barriers to secure portable gauges from unauthorized removal, whenever portable gauges are not under the control and constant surveillance of the licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee preparing technetium-99m radiopharmaceuticals from molybdenum-99/technetium-99m generators or rubidium-82 from strontium-82/rubidium-82 generators shall test the generator eluates for molybdenum-99 breakthrough or strontium-82 and strontium-85 contamination, respectively, in accordance with Rule .05(45)(a)(b) and (c). The licensee shall record the results of each test and retain each record for 3 years after the record is made.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Authorization under .02(7)(j) to produce Positron Emission Tomography (PET) radioactive drugs for noncommercial transfer to medical use licensees in its consortium does not relieve the licensee from complying with applicable FDA, other Federal, and State requirements governing radioactive drugs. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(i)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee authorized under .02(7)(j) to produce PET radioactive drugs for noncommercial transfer to medical use licensees in its consortium shall: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(i)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Satisfy the labeling requirements in .02(11)(i)4. of this Rule for each PET radioactive drug transport radiation shield and each syringe, vial, or other container used to hold a PET radioactive drug intended for noncommercial distribution to members of its consortium.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(i)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Possess and use instrumentation to measure the radioactivity of the PET radioactive drugs intended for noncommercial distribution to members of its consortium and meet the procedural, radioactivity measurement, instrument test, instrument check, and instrument adjustment requirements in .02(11)(i)6. of this Rule.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(i)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A licensee that is a pharmacy authorized under .02(7)(j) to produce PET radioactive drugs for noncommercial transfer to medical use licensees in its consortium shall require that any individual that prepares PET radioactive drugs shall be: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(i)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> an authorized nuclear pharmacist that meets the requirements in .02(11)(i)5. of this Rule, or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(i)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> an individual under the supervision of an authorized nuclear pharmacist as specified in Rule .05(18).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(13)(i)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A pharmacy, authorized under .02(7)(j) to produce PET radioactive drugs for noncommercial transfer to medical use licensees in its consortium that allows an individual to work as an authorized nuclear pharmacist, shall meet the requirements of .02(11)(i)5.(v) of this Rule.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(14)">(14)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Expiration of Licenses.</B></span><span class=""> Except as provided in (15)(b), each specific license shall expire at the end of the day, in the month and year stated therein.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)">(15)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Renewal of Licenses.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> No less than 30 days before the expiration date specified in a specific license, the licensee shall either: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Submit an application for license renewal filed in accordance with (7), or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Notify the Department in writing in accordance with (13)(d) and (15)(c) if the licensee decides not to renew the license.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In any case in which a licensee, not less than 30 days prior to the expiration of his existing license, has filed an application in proper form for renewal or for a new license authorizing the same activities, such existing license shall not expire until the application has been finally determined by the Department.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If a licensee does not submit an application for license renewal on or before the expiration date specified in the license, then the licensee shall, on or before that expiration date: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Terminate the use of radioactive material,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Remove radioactive contamination to the extent practicable,</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(c)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Properly dispose of the radioactive material, and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(15)(c)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Submit the information specified in (18)(d).</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(16)">(16)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Amendment of Licenses at Request of Licensee.</B></span><span class=""> Applications for amendment of a license shall be filed in accordance with (7) and shall specify the respects in which the licensee desires the license to be amended and the grounds for such amendment.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(17)">(17)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Department Action on Applications to Renew or Amend.</B></span><span class=""> In considering an application by a licensee to renew or amend the license, the Department will apply the criteria set forth in (8), (9), (10), or (11), as applicable.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)">(18)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Modification, Revocation, and Termination of Licenses.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The terms and conditions of all licenses shall be subject to amendment, revision, or modification, or the license may be suspended or revoked by reason of amendments to the Act, or by reason of Rules, Regulations, and Orders issued by the Director.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any license may be revoked, suspended, or modified, in whole or in part, for any material false statement in the application or any statement of fact required under provisions of the Act or of this Rule, or because of conditions revealed by such application or statement of fact or any report, record, or inspection or other means which would warrant the Department to refuse to grant a license on an original application, or for violation of, or failure to observe, any of the terms and conditions of the Act, of the license, or of any Rule, Regulation, or Order of the Department.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each specific license revoked by the Department expires at the end of the day on the date of the Department's final determination to revoke the license, or on the expiration date stated in the determination, or as otherwise provided by Department Order.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may terminate a specific license upon request submitted by the licensee to the Department in writing provided the following: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee certifies the disposition of all licensed material, including accumulated wastes, by submitting a completed "Request to Terminate Radioactive Materials License" form or equivalent information; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee conducts a radiation survey of the premises where the licensed activities were carried out and submits a report of the results of the survey unless the licensee demonstrates that the premises are suitable for release in accordance with the requirements for decommissioning in Rule .03(7). As appropriate, the licensee shall: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(d)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Report levels of gamma radiation in units of microroentgen (millisieverts) per hour at one meter from surfaces, and report levels of radioactivity, including alpha and beta, in units of disintegrations per minute or microcuries (megabecquerels) per 100 square centimeters - removable and fixed - for surfaces, microcuries (megabecquerels) per milliliter for water, and picocuries (becquerels) per gram for solids such as soils or concrete; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(d)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Specify the survey instrument(s) used and certify that each instrument is properly calibrated and tested.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(d)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If detectable levels of residual radioactive contamination are found, the license continues to be in effect, even beyond the expiration date if necessary, with respect to possession of residual radioactive material as contamination until the Department notifies the licensee in writing that the license is terminated. Each licensee who possesses residual radioactive material under this paragraph shall initiate decommissioning activities as required by (8)(h).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(d)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If no residual radioactive contamination is detected, the licensee shall submit a certification that no detectable radioactive contamination was found. If the information submitted is found to be adequate, the Department will notify the licensee in writing that the license is terminated.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Specific licenses, including expired licenses, will be terminated by written notice to the licensee when the Department determines that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Radioactive material has been properly disposed;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Reasonable effort has been made to eliminate residual radioactive contamination, if present; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A radiation survey has been performed which demonstrates that the premises are suitable for release in accordance with Department requirements for decommissioning in Rule .03(7); or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Other information submitted by the licensee is sufficient to demonstrate that the premises are suitable for release in accordance with Department requirements for decommissioning in Rule .03(7).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prior to license termination, each licensee authorized to possess radioactive material with a half-life greater than 120 days, in an unsealed form, shall forward the following records to the Department:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Records of disposal of licensed material made under Rule .03(13)(b) (including burials authorized before January 28, 1982),.03(13)(c), .03(13)(d), .03(13)(e); and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Records required by Rule .03(14)(c)2.(iv).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If licensed activities are transferred or assigned in accordance with Rule .02(13)(b), each licensee authorized to possess radioactive material, with a half-life greater than 120 days, in an unsealed form, shall transfer the following records to the new licensee and the new licensee will be responsible for maintaining these records until the license is terminated: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Records of disposal of licensed material made under Rule .03(13)(b) (including burials authorized before January 28, 1982), .03(13)(c), .03(13)(d), .03(13)(e); and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Records required by Rule .03(14)(c)2.(iv).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(18)(e)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prior to license termination, each licensee shall forward the records required by Rule .02(8)(g)8. to the Department.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)">(19)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Transfer of Material.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Authorization for Transfer. No licensee shall transfer radioactive material except as authorized pursuant to (19)(b).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Condition of Transfer. Any licensee may transfer radioactive material, subject to acceptance by the transferee, to:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department, after receiving prior approval from the Department;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The United States Department of Energy or any successor thereto;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person exempt from this Rule to the extent permitted under such exemption;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person licensed to receive such material under terms of a general license or its equivalent, or specific license or equivalent licensing document issued by the Department, the U.S. Nuclear Regulatory Commission, any Agreement State, or any Licensing State, to any person otherwise authorized to receive such material by the Federal Government or any agency thereof, the Department, any Agreement State, or any Licensing State; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(b)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any person authorized by the Department in writing.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Before transferring radioactive material to a specific licensee of the Department, the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State, or to a general licensee who is required to register with the Department, the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State prior to receipt of the radioactive material, the licensee transferring the material shall verify that the transferee's license authorizes the receipt of the type, form, and quantity of radioactive material to be transferred.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The following methods for the verification required by (19)(c) are acceptable: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The transferor may possess, and read, a current copy of the transferee's specific license or registration certificate.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The transferor may have in his possession a written certification by the transferee that the transferee is authorized by license or registration certificate to receive the type, form, and quantity of radioactive material to be transferred, specifying the license or registration certificate number, issuing agency, and expiration date.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(d)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For emergency shipments, the transferor may accept oral certification by the transferee that the transferee is authorized by license or registration certificate to receive the type, form, and quantity of radioactive material to be transferred, specifying the license or registration certificate number, issuing agency, and expiration date; provided that the oral certification is confirmed in writing within ten days.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(d)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The transferor may obtain other sources of information compiled by a reporting service from official records of the Department, the U.S. Nuclear Regulatory Commission, the licensing agency of an Agreement State, or a Licensing State regarding the identity of licensees and the scope and expiration date of licenses and registration.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(d)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> When none of the methods of verification described in paragraphs (19)(d)1., 2., 3., and 4. is readily available or when a transferor desires to verify that information received by one of such methods is correct or up-to-date, the transferor may obtain and record confirmation from the Department, the U.S. Nuclear Regulatory Commission, the licensing agency of an Agreement State, or a Licensing State that the transferee is licensed to receive the radioactive material.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(19)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Preparation for shipment and transport of radioactive material shall be in accordance with the provisions of Rule .06 of this Chapter.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)">(20)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Reciprocity.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Persons licensed by other Agencies. Subject to the provisions of this Chapter, any person who holds a specific license from the U.S. Nuclear Regulatory Commission, a Licensing State, or any Agreement State, other than this State, and issued by the agency having jurisdiction where the licensee maintains an office for directing the licensed activity and at which radiation safety records are normally maintained, is hereby granted a general license to conduct the activities authorized in such licensing document within this State, except in areas of exclusive federal jurisdiction, for a period not in excess of 180 days in any calendar year provided that:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensing document does not limit the activity authorized by such document to specified installations or locations;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The out-of-state licensee notifies the Department in writing at least three days prior to engaging in such activity. Such notification shall indicate the location, period, and type of proposed possession and use within the State, and shall be accompanied by a copy of the pertinent licensing document. If, for a specific case, the 3-day period would impose an undue hardship on the out-of-state licensee, he may, upon application to the Department, obtain permission to proceed sooner;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The out-of-state licensee complies with all applicable Rules of the Department, and with all the terms and conditions of his licensing document except any such terms and conditions that may be inconsistent with applicable Rules of the Department;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(a)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Provided further that the Department may require the out-of-state licensee to supply such other information as the Department may reasonably request; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(a)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The out-of-state licensee shall not transfer or dispose of radioactive material possessed or used under the general license provided in (20)(a) except by transfer to a person who is: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(a)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Specifically licensed by the Department, the U.S. Nuclear Regulatory Commission, or by another Licensing State to receive such material; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(a)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Exempt from the requirements for a license for such material under (3)(a).</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Notwithstanding the provisions of (20)(a), any person who holds a specific license issued by the U.S. Nuclear Regulatory Commission, a Licensing State, or an Agreement State authorizing the holder to manufacture, transfer, install, or service a device described in (6)(c)1. within areas subject to the jurisdiction of the licensing body is hereby granted a general license to install, transfer, demonstrate, or service such device in this State provided that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Such person shall file a report with the Department within 30 days after the end of each calendar quarter in which any device is transferred to or installed in this State. Each such report shall identify each general licensee to whom such a device is transferred by name and address, the type of device transferred, and the quantity and type of radioactive material contained in the device;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The device has been manufactured, labeled, installed, and serviced in accordance with applicable provisions of the specific license issued to such person by the U.S. Nuclear Regulatory Commission, a Licensing State, or an Agreement State;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Such person shall assure that any labels required to be affixed to the device under regulations of the authority which licensed the manufacturing of the device bear a statement that "Removal of This Label is Prohibited"; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The holder of the specific license shall furnish to each general licensee to whom he transfers such a device or on whose premises he installs such a device a copy of the general license contained in (6)(c).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(20)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may withdraw, limit, or qualify its acceptance of any specific license or equivalent licensing document issued by another agency, or any product distributed pursuant to such licensing document, upon determining that such action is necessary in order to prevent undue hazard to public health and safety, to property, or to the environment.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)">(21)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Schedules.</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Schedule A. </span><span class=""><P><B>SCHEDULE A</B></P></span><span class=""><P><B>EXEMPT CONCENTRATIONS</B></P></span><span class=""><P> <TABLE> <TBODY> <TR> <TD rowspan="1" colspan="1"> <P><B>Exempt Concentrations</B></P> <P>Element</P> <P>(Atomic Number)</P> </TD> <TD rowspan="1" colspan="1"> <P><B>Schedule A</B></P> <P>Isotope</P> </TD> <TD rowspan="1" colspan="1"> <P>Column I</P> <P>Gas </P> <P>Concentration</P> <P>(µCi/mL) <SUP>(1)</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>Column II</P> <P>Liquid and Solid</P> <P>Concentration</P> <P>(µCi/mL) <SUP>(2)</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony (51)</P> </TD> <TD rowspan="1" colspan="1"> <P>Sb 122</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Sb 124</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Sb 125</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Argon (18)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ar 37</P> </TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ar 41</P> </TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-7</SUP></P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic (33)</P> </TD> <TD rowspan="1" colspan="1"> <P>As 73</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>As 74</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>As 76</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>As 77</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>8 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium (56)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ba 131</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ba 140</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Beryllium (4)</P> </TD> <TD rowspan="1" colspan="1"> <P>Be 7</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bismuth (83)</P> </TD> <TD rowspan="1" colspan="1"> <P>Bi 206</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bromine (35)</P> </TD> <TD rowspan="1" colspan="1"> <P>Br 82</P> </TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-7</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium (48)</P> </TD> <TD rowspan="1" colspan="1"> <P>Cd 109</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Cd 115m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Cd 115</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Calcium (20)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ca 45</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-5</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ca 47</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Carbon (6)</P> </TD> <TD rowspan="1" colspan="1"> <P>C 14</P> </TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>8 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium (58)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ce 141</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ce 143</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ce 144</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium (55)</P> </TD> <TD rowspan="1" colspan="1"> <P>Cs 131</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Cs 134m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Cs 134</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-5</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chlorine (17)</P> </TD> <TD rowspan="1" colspan="1"> <P>Cl 38</P> </TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-7</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chromium (24)</P> </TD> <TD rowspan="1" colspan="1"> <P>Cr 51</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt (27)</P> </TD> <TD rowspan="1" colspan="1"> <P>Co 57</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Co 60</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Copper (29)</P> </TD> <TD rowspan="1" colspan="1"> <P>Cu 64</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Dysprosium (66)</P> </TD> <TD rowspan="1" colspan="1"> <P>Dy 165</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Dy 166</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Erbium (68)</P> </TD> <TD rowspan="1" colspan="1"> <P>Er 169</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Er 171</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium (63) (T<SUP>0.5</SUP> = 9.2 h)</P> </TD> <TD rowspan="1" colspan="1"> <P>Eu 152</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Eu 155</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Fluorine (9)</P> </TD> <TD rowspan="1" colspan="1"> <P>F 18</P> </TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>8 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gadolinium (64)</P> </TD> <TD rowspan="1" colspan="1"> <P>Gd 153</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Gd 159</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>8 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gallium (31)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ga 72</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Germanium (32)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ge 71</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gold (79)</P> </TD> <TD rowspan="1" colspan="1"> <P>Au 196</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Au 198</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Au 199</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hafnium (72)</P> </TD> <TD rowspan="1" colspan="1"> <P>Hf 181</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hydrogen (1)</P> </TD> <TD rowspan="1" colspan="1"> <P>H 3</P> </TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium (49)</P> </TD> <TD rowspan="1" colspan="1"> <P>In 113m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>In 114m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine (53)</P> </TD> <TD rowspan="1" colspan="1"> <P>I 126</P> </TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-9</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-5</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>I 131</P> </TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-9</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-5</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>I 132</P> </TD> <TD rowspan="1" colspan="1"> <P>8 x 10<SUP>-8</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>I 133</P> </TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-8</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-5</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>I 134</P> </TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-7</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iridium (77)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ir 190</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ir 192</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ir 194</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron (26)</P> </TD> <TD rowspan="1" colspan="1"> <P>Fe 55</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>8 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Fe 59</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Krypton (36)</P> </TD> <TD rowspan="1" colspan="1"> <P>Kr 85m</P> </TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Kr 85</P> </TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lanthanum (57)</P> </TD> <TD rowspan="1" colspan="1"> <P>La 140</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lead (82)</P> </TD> <TD rowspan="1" colspan="1"> <P>Pb 203</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lutetium (71)</P> </TD> <TD rowspan="1" colspan="1"> <P>Lu 177</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese (25)</P> </TD> <TD rowspan="1" colspan="1"> <P>Mn 52</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Mn 54</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Mn 56</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury (80)</P> </TD> <TD rowspan="1" colspan="1"> <P>Hg 197m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Hg 197</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Hg 203</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Molybdenum (42)</P> </TD> <TD rowspan="1" colspan="1"> <P>Mo 99</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neodymium (60)</P> </TD> <TD rowspan="1" colspan="1"> <P>Nd 147</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Nd 149</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel (28)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ni 65</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium (columbium) (41)</P> </TD> <TD rowspan="1" colspan="1"> <P>Nb 95</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Nb 97</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium (76)</P> </TD> <TD rowspan="1" colspan="1"> <P>Os 185</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Os 191m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Os 191</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Os 193</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Palladium (46)</P> </TD> <TD rowspan="1" colspan="1"> <P>Pd 103</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Pd 109</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Phosphorus (15)</P> </TD> <TD rowspan="1" colspan="1"> <P>P 32</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum (78)</P> </TD> <TD rowspan="1" colspan="1"> <P>Pt 191</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Pt 193m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Pt 197m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Pt 197</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Polonium (84)</P> </TD> <TD rowspan="1" colspan="1"> <P>Po 210</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-6</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Potassium (19)</P> </TD> <TD rowspan="1" colspan="1"> <P>K 42</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Praseodymium (59)</P> </TD> <TD rowspan="1" colspan="1"> <P>Pr 142</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Pr 143</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium (61)</P> </TD> <TD rowspan="1" colspan="1"> <P>Pm 147</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Pm 149</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Radium (88)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ra 226</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-7</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ra 228</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-7</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhenium (75)</P> </TD> <TD rowspan="1" colspan="1"> <P>Re 183</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Re 186</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Re 188</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhodium (45)</P> </TD> <TD rowspan="1" colspan="1"> <P>Rh 103m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-1</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rubidium (37)</P> </TD> <TD rowspan="1" colspan="1"> <P>Rb 86</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium (44)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ru 97</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ru 103</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>8 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ru 105</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ru 106</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Samarium (62)</P> </TD> <TD rowspan="1" colspan="1"> <P>Sm 153</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>8 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium (21)</P> </TD> <TD rowspan="1" colspan="1"> <P>Sc 46</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Sc 47</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Sc 48</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Selenium (34)</P> </TD> <TD rowspan="1" colspan="1"> <P>Se 75</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silicon (14)</P> </TD> <TD rowspan="1" colspan="1"> <P>Si 31</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver (47)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ag 105</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ag 110m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Ag 111</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium (11)</P> </TD> <TD rowspan="1" colspan="1"> <P>Na 24</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium (38)</P> </TD> <TD rowspan="1" colspan="1"> <P>Sr 85</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Sr 89</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Sr 91</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Sr 92</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sulfur (16)</P> </TD> <TD rowspan="1" colspan="1"> <P>S 35</P> </TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-8</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tantalum (73)</P> </TD> <TD rowspan="1" colspan="1"> <P>Ta 182</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium (43)</P> </TD> <TD rowspan="1" colspan="1"> <P>Tc 96m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-1</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Tc 96</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium (52)</P> </TD> <TD rowspan="1" colspan="1"> <P>Te 125m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Te 127m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Te 127</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Te 129m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Te 131m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Te 132</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Terbium (65)</P> </TD> <TD rowspan="1" colspan="1"> <P>Tb 160</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium (81)</P> </TD> <TD rowspan="1" colspan="1"> <P>Tl 200</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Tl 201</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Tl 202</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Tl 204</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thulium (69)</P> </TD> <TD rowspan="1" colspan="1"> <P>Tm 170</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>5 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin (50)</P> </TD> <TD rowspan="1" colspan="1"> <P>Sn 113</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>9 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Sn 125</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten (wolfram) (74)</P> </TD> <TD rowspan="1" colspan="1"> <P>W 181</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>W 187</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Vanadium (23)</P> </TD> <TD rowspan="1" colspan="1"> <P>V 48</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon (54)</P> </TD> <TD rowspan="1" colspan="1"> <P>Xe 131m</P> </TD> <TD rowspan="1" colspan="1"> <P>4 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Xe 133</P> </TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Xe 135</P> </TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-6</SUP></P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ytterbium (70)</P> </TD> <TD rowspan="1" colspan="1"> <P>Yb 175</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium (39)</P> </TD> <TD rowspan="1" colspan="1"> <P>Y 90</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Y 91m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Y 91</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Y 92</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Y 93</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>3 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc (30)</P> </TD> <TD rowspan="1" colspan="1"> <P>Zn 65</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-3</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Zn 69m</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>7 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Zn 69</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-2</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium (40)</P> </TD> <TD rowspan="1" colspan="1"> <P>Zr 95</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>6 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>Zr 97</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>2 x 10<SUP>-4</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Beta- and/or gamma-emitting radioactive material not listed above with half-life less than three years</P> </TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-10</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>1 x 10<SUP>-6</SUP></P> </TD> </TR> </TBODY> </TABLE> </P></span><span class=""><P>Note: Many radioisotopes disintegrate into isotopes that are also radioactive. In expressing the concentrations in Schedule A, the activity stated is that of the parent isotope and takes into account the daughters. For purposes of (3)(a) where there is involved a combination of isotopes, the limit for the combination should be derived as follows:</P></span><span class=""><P>Determine for each isotope in the product the ratio between the concentration present in the product and the exempt concentration established in Schedule A for the specific isotope when not in combination. The sum of such ratios may not exceed "1" (i.e., unity).</P></span><span class=""><P> <P><img class="ImageLink" src="/pdf/ga/admin/2017/391-3-17-2.png" alt=" image: ga/admin/2017/391-3-17-2.png"></P> </P></span><span class=""><P>Footnotes: <SUP>(1)</SUP> Values are given only for those materials normally used as gases.</P></span><span class=""><P><SUP>(2)</SUP>µCi/gm for solids. </P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Schedule B. </span><span class=""><P><B> SCHEDULE B</B></P></span><span class=""><P><B> EXEMPT QUANTITIES</B></P></span><span class=""><P> <TABLE> <TBODY> <TR> <TD rowspan="1" colspan="1"> <P><B>Schedule B - Exempt Quantities</B></P> <P>Radioactive Material</P> </TD> <TD rowspan="1" colspan="1"> <P>Exempt Quantity</P> <P>(Microcuries)</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-122 (Sb 122)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-124 (Sb 124)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-125 (Sb 125)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-73 (As 73)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-74 (As 74)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-76 (As 76)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-77 (As 77)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-131 (Ba 131)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-133 (Ba 133)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-140 (Ba 140)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bismuth-210 (Bi 210)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bromine-82 (Br 82)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-109 (Cd 109)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-115m (Cd 115m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-115 (Cd 115)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Calcium-45 (Ca 45)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Calcium-47 (Ca 47)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Carbon-14 (C 14)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-141 (Ce 141)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-143 (Ce 143)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-144 (Ce 144)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-129 (Cs 129)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-131 (Cs 131)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-134m (Cs 134m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-134 (Cs 134)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-135 (Cs 135)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-136 (Cs 136)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-137 (Cs 137)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chlorine-36 (Cl 36)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chlorine-38 (Cl 38)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chromium-51 (Cr 51)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-57 (Co 57)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-58m (Co 58m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-58 (Co 58)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-60 (Co 60)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Copper-64 (Cu 64)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Dysprosium-165 (Dy 165)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Dysprosium-166 (Dy 166)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Erbium-169 (Er 169)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Erbium-171 (Er 171)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-152 (Eu 152) 9.2h</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-152 (Eu 152) 13 yr</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-154 (Eu 154)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-155 (Eu 155)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Fluorine-18 (F 18)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gadolinium-153 (Gd 153)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gadolinium-159 (Gd 159)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gallium-67 (Ga 67)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gallium-72 (Ga 72)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Germanium-68 (Ge 68)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Germanium-71 (Ge 71)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gold-195 (Au 195)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gold-198 (Au 198)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gold-199 (Au 199)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hafnium-181 (Hf 181)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Holmium-166 (Ho 166)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hydrogen-3 (H 3)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-111 (In 111)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-113m (In 113m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-114m (In 114m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-115m (In 115m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-115 (In 115)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-123 (I 123)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-125 (I 125)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-126 (I 126)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-129 (I 129)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-131 (I 131)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-132 (I 132)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-133 (I 133)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-134 (I 134)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-135 (I 135)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iridium-192 (Ir 192)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iridium-194 (Ir 194)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-52 (Fe 52)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-55 (Fe 55)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-59 (Fe 59)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Krypton-85 (Kr 85)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Krypton-87 (Kr 87)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lanthanum-140 (La 140)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lutetium-177 (Lu 177)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-52 (Mn 52)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-54 (Mn 54)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-56 (Mn 56)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-197m (Hg 197m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-197 (Hg 197)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-203 (Hg 203)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Molybdenum-99 (Mo 99)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neodymium-147 (Nd 147)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neodymium-149 (Nd 149)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-59 (Ni 59)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-63 (Ni 63)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-65 (Ni 65)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-93m (Nb 93m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-95 (Nb 95)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-97 (Nb 97)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-185 (Os 185)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-191m (Os 191m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-191 (Os 191)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-193 (Os 193)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Palladium-103 (Pd 103)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Palladium-109 (Pd 109)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Phosphorus-32 (P 32)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-191 (Pt 191)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-193m (Pt 193m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-193 (Pt 193)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-197m (Pt 197m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-197 (Pt 197)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Polonium-210 (Po 210)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Potassium-42 (K 42)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Potassium-43 (K 43)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Praseodymium-142 (Pr 142)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Praseodymium-143 (Pr 143)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium-147 (Pm 147)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium-149 (Pm 149)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhenium-186 (Re 186)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhenium-188 (Re 188)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhodium-103m (Rh 103m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhodium-105 (Rh 105)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rubidium-81 (Rb 81)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rubidium-86 (Rb 86)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rubidium-87 (Rb 87)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-97 (Ru 97)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-103 (Ru 103)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-105 (Ru 105)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-106 (Ru 106)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Samarium-151 (Sm 151)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Samarium-153 (Sm 153)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-46 (Sc 46)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-47 (Sc 47)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-48 (Sc 48)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Selenium-75 (Se 75)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silicon-31 (Si 31)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-105 (Ag 105)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-110m (Ag 110m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-111 (Ag 111)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium-22 (Na 22)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium-24 (Na 24)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-85 (Sr 85)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-89 (Sr 89)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-90 (Sr 90)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-91 (Sr 91)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-92 (Sr 92)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sulphur-35 (S 35)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tantalum-182 (Ta 182)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-96 (Tc 96)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-97m (Tc 97m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-97 (Tc 97)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-99m (Tc 99m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-99 (Tc 99)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-125m (Te 125m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-127m (Te 127m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-127 (Te 127)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-129m (Te 129m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-129 (Te 129)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-131m (Te 131m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-132 (Te 132)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Terbium-160 (Tb 160)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-200 (Tl 200)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-201 (Tl 201)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-202 (Tl 202)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-204 (Tl 204)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thulium-170 (Tm 170)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thulium-171 (Tm 171)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin 113-(Sn 113)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin 125-(Sn 125)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-181 (W 181)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-185 (W 185)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-187 (W 187)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Vanadium-48 (V 48)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-131m (Xe 131m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-133 (Xe 133)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-135 (Xe 135)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ytterbium-175 (Yb 175)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-87 (Y 87)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-88 (Y 88)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-90 (Y 90)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-91 (Y 91)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-92 (Y 92)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-93 (Y 93)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-65 (Zn 65)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-69m (Zn 69m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-69 (Zn 69)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-93 (Zr 93)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-95 (Zr 95)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-97 (Zr 97)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Any radioactive material not listed above other than alpha- emitting radioactive material</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> </TBODY> </TABLE> </P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Schedule C. </span><span class=""><P><B>SCHEDULE C</B></P></span><span class=""><P><B>LIMITS FOR BROAD LICENSES</B></P></span><span class=""><P> <TABLE> <TBODY> <TR> <TD rowspan="1" colspan="1"> <P><B>Schedule C - Limits For Broad Licenses</B></P> <P>Radioactive Materials</P> </TD> <TD rowspan="1" colspan="1"> <P>Column I (Curies)</P> </TD> <TD rowspan="1" colspan="1"> <P>Column II (Curies)</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-122 (Sb 122)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-124 (Sb 124)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-125 (Sb 125)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-73 (As 73)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-74 (As 74)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-76 (As 76)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-77 (As 77)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-131 (Ba 131)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-140 (Ba 140)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Beryllium-7 (Be 7)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bismuth-210 (Bi 210)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bromine-82 (Br 82)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-109 (Cd 109)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-115m (Cd 115m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-115 (Cd 115)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Calcium-45 (Ca 45)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Calcium-47 (Ca 47)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Carbon-14 (C 14)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-141 (Ce 141)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-143 (Ce 143)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-144 (Ce 144)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-131 (Cs 131)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-134m (Cs 134m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-134 (Cs 134)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-135 (Cs 135)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-136 (Cs 136)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-137 (Cs 137)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chlorine-36 (Cl 36)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chlorine-38 (Cl 38)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chromium-51 (Cr 51)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-57 (Co 57)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-58m (Co 58m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-58 (Co 58)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-60 (Co 60)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Copper-64 (Cu 64)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Dysprosium-165 (Dy 165)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Dysprosium-166 (Dy 166)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Erbium-169 (Er 169)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Erbium-171 (Er 171)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-152 (Eu 152) 9.2h</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-152 (Eu 152) 13 yr</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-154 (Eu 154)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-155 (Eu 155)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Fluorine-18 (F 18)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gadolinium-153 (Gd 153)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gadolinium-159 (Gd 159)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gallium-72 (Ga 72)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Germanium-71 (Ge 71)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gold-198 (Au 198)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gold-199 (Au 199)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hafnium-181 (Hf 181)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Holmium-166 (Ho 166)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hydrogen-3 (H 3)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-113m (In 113m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-114m (In 114m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-115m (In 115m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-115 (In 115)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-125 (I 125)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-126 (I 126)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-129 (I 129)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-131 (I 131)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-132 (I 132)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-133 (I 133)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-134 (I 134)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-135 (I 135)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iridium-192 (Ir 192)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iridium-194 (Ir 194)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-55 (Fe 55)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-59 (Fe 59)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Krypton-85 (Kr 85)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Krypton-87 (Kr 87)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lanthanum-140 (La 140)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lutetium-177 (Lu 177)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-52 (Mn 52)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-54 (Mn 54)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-56 (Mn 56)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-197m (Hg 197m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-197 (Hg 197)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-203 (Hg 203)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Molybdenum-99 (Mo 99)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neodymium-147 (Nd 147)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neodymium-149 (Nd 149)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-59 (Ni 59)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-63 (Ni 63)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-65 (Ni 65)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-93m (Nb 93m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-95 (Nb 95)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-97 (Nb 97)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-185 (Os 185)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-191m (Os 191m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-191 (Os 191)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-193 (Os 193)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Palladium-103 (Pd 103)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Palladium-109 (Pd 109)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Phosphorus-32 (P 32)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-191 (Pt 191)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-193m (Pt 193m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-193 (Pt 193)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-197m (Pt 197m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-197 (Pt 197)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Polonium-210 (Po 210)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>0.0001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Potassium-42 (K 42)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Praseodymium-142 (Pr 142)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Praseodymium-143 (Pr 143)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium-147 (Pm 147)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium-149 (Pm 149)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Radium-226 </P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>0.0001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhenium-186 (Re 186)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhenium-188 (Re 188)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhodium-103m (Rh 103m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> <TD rowspan="1" colspan="1"> <P>0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhodium-105 (Rh 105)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rubidium-86 (Rb 86)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rubidium-87 (Rb 87)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-97 (Ru 97)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-103 (Ru 103)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-105 (Ru 105)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-106 (Ru 106)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Samarium-151 (Sm 151)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Samarium-153 (Sm 153)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-46 (Sc 46)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-47 (Sc 47)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-48 (Sc 48)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Selenium-75 (Se 75)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silicon-31 (Si 31)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-105 (Ag 105)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-110m (Ag 110m)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-111 (Ag 111)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium-22 (Na 22)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium-24 (Na 24)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-85m (Sr 85m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> <TD rowspan="1" colspan="1"> <P>10.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-85 (Sr 85)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-89 (Sr 89)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-90 (Sr 90)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>0.0001</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-91 (Sr 91)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-92 (Sr 92)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sulphur-35 (S 35)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tantalum-182 (Ta 182)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-96 (Tc 96)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-97m (Tc 97m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-97 (Tc 97)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-99m (Tc 99m)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-99 (Tc 99)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-125m (Te 125m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-127m (Te 127m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-127 (Te 127)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-129m (Te 129m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-129 (Te 129)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-131m (Te 131m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-132 (Te 132)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Terbium-160 (Tb 160)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-200 (Tl 200)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-201 (Tl 201)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-202 (Tl 202)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-204 (Tl 204)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thulium-170 (Tm 170)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thulium-171 (Tm 171)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin 113-(Sn 113)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin 125-(Sn 125)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-181 (W 181)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-185 (W 185)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-187 (W 187)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Vanadium-48 (V 48)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-131m (Xe 131m)</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> <TD rowspan="1" colspan="1"> <P>0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-133 (Xe 133)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-135 (Xe 135)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ytterbium-175 (Yb 175)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-90 (Y 90)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-91 (Y 91)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-92 (Y 92)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-93 (Y 93)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-65 (Zn 65)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-69m (Zn 69m)</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-69 (Zn 69)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-93 (Zr 93)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-95 (Zr 95)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-97 (Zr 97)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Any radioactive material other than source material, or alpha-emitting radioactive material not listed above.</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> </TR> </TBODY> </TABLE> </P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Schedule D. Criteria Relating to Use of Financial Tests and Parent Company Guarantees for Providing Reasonable Assurance of Funds for Decommissioning. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Introduction. An applicant or licensee may provide reasonable assurance of the availability of funds for decommissioning based on obtaining a parent company guarantee that funds will be available for decommissioning costs and on a demonstration that the parent company passes a financial test. This schedule establishes criteria for passing the financial test and for obtaining the parent company guarantee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Financial Test. To pass the financial test, the parent company must meet the criteria of either (21)(d)2.(i) or (21)(d)2.(ii) as follows:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The parent company must have: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> two of the following three ratios: a ratio of total liabilities to net worth less than 2.0; a ratio of the sum of net income plus depreciation, depletion, and amortization to total liabilities greater than 0.1; and a ratio of current assets to current liabilities greater than 1.5;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Net working capital and tangible net worth each at least six times the current decommissioning cost estimates (or prescribed amount if a certification is used);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Tangible net worth of at least $10 million; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(i)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Assets located in the United States amounting to at least 90 percent of total assets or at least six times the current decommissioning cost estimates (or prescribed amount if a certification is used).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The parent company must have: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A current rating for its most recent bond issuance of AAA, AA, A, or BBB as issued by Standard and Poor's or Aaa, Aa, A, or Baa as issued by Moody's;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Tangible net worth each at least six times the current decommissioning cost estimates for the total of all facilities or parts thereof (or prescribed amount if a certification is used);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(ii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Tangible net worth of at least $10 million; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(ii)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Assets located in the United States amounting to at least 90 percent of total assets or at least six times the current decommissioning cost estimates for the total of all facilities or parts thereof (or prescribed amount if a certification is used).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The parent company's independent certified public accountant must have compared the data used by the parent company in the financial test, which is derived from the independently-audited, year-end financial statements for the latest fiscal year, with the amounts in such financial statement. In connection with that procedure the licensee shall inform the Department within 90 days of any matters coming to the auditor's attention that cause the auditor to believe that the data specified in the financial test should be adjusted and that the company no longer passes the test.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)2.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> After the initial financial test, the parent company must repeat the passage of the test within 120 days after the close of each succeeding fiscal year. If the parent company no longer meets the requirements, as appropriate, of either (21)(d)2.(i) or (21)(d)2.(ii), the licensee must send notice to the Department of intent to establish alternate financial assurance as specified in the Department's Regulations. The notice must be sent by certified mail within 90 days after the end of the fiscal year for which the year-end financial data show that the parent company no longer meets the financial test requirements. The licensee must provide alternate financial assurance within 120 days after the end of such fiscal year.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Parent Company Guarantee. The terms of a parent company guarantee which an applicant or licensee obtains must provide that:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The parent company guarantee shall remain in force unless the guarantor sends notice of cancellation by certified mail to the licensee and the Department. Cancellation may not occur, however, during the 120 days beginning on the date of receipt of the notice of cancellation by both the licensee and the Department, as evidenced by the return receipts;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee fails to provide alternate financial assurance as specified in the Department's Regulations within 90 days after receipt by the licensee and the Department of a notice of cancellation of the parent company guarantee from the guarantor, the guarantor shall provide such alternative financial assurance in the name of the licensee;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The parent company guarantee and financial test provisions must remain in effect until the Department has terminated the license; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(d)3.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If a trust is established for decommissioning costs, the trustee and trust must be acceptable to the Department. An acceptable trustee includes an appropriate State or Federal government agency or an entity which has the authority to act as a trustee and whose trust operations are regulated and examined by a Federal or State agency.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Schedule E. </span><span class=""><P><B>SCHEDULE E</B></P></span><span class=""><P><B>QUANTITIES OF RADIOACTIVE MATERIALS REQUIRING</B></P></span><span class=""><P><B>CONSIDERATION OF THE NEED FOR AN EMERGENCY PLAN</B></P></span><span class=""><P><B>FOR RESPONDING TO A RELEASE</B></P></span><span class=""><P> <TABLE> <TBODY> <TR> <TD rowspan="1" colspan="1"> <P><B>Schedule E - Emergency Plan For Responding to a Release</B></P> <P>Radioactive Material <SUP>(1)</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>Release Fraction</P> </TD> <TD rowspan="1" colspan="1"> <P>Quantity</P> <P>(Curies)</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Actinium-228</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>4,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Americium-241</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Americium-242</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Americium-243</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-124</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>4,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-126</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>6,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-133</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-140</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>30,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bismuth-207</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>5,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bismuth-210</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>600</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-109</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-113</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>80</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Calcium-45</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>20,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Californium-252</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>9 (20 mg)</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Carbon-14 (Non Carbon dioxide)</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>50,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-141</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-144</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>300</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-134</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>2,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-137</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>3,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chlorine-36</P> </TD> <TD rowspan="1" colspan="1"> <P>0.5</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chromium-51</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>300,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-60</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>5,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Copper-64</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>200,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Curium-242</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>60</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Curium-243</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>3</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Curium-244</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>4</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Curium-245</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-152</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>500</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-154</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>400</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-155</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>3,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Germanium-68</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>2,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gadolinium-153</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>5,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gold-198</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>30,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hafnium-172</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>400</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hafnium-181</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>7,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Holmium-166m</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hydrogen-3</P> </TD> <TD rowspan="1" colspan="1"> <P>0.5</P> </TD> <TD rowspan="1" colspan="1"> <P>20,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-125</P> </TD> <TD rowspan="1" colspan="1"> <P>0.5</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-131</P> </TD> <TD rowspan="1" colspan="1"> <P>0.5</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-114m</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iridium-192</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>40,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-55</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>40,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-59</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>7,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Krypton-85</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> <TD rowspan="1" colspan="1"> <P>6,000,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lead-210</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>8</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-56</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>60,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-203</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Molybdenum-99</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>30,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neptunium-237</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-63</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>20,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-94</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>300</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Phosphorus-32</P> </TD> <TD rowspan="1" colspan="1"> <P>0.5</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Phosphorus-33</P> </TD> <TD rowspan="1" colspan="1"> <P>0.5</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Polonium-210</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Potassium-42</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>9,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium-145</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>4,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium-147</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>4,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Radium-226</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-106</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>200</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Samarium-151</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>4,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-46</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>3,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Selenium-75</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-110m</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium-22</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>9,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium-24</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-89</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>3,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-90</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>90</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sulfur-35</P> </TD> <TD rowspan="1" colspan="1"> <P>0.5</P> </TD> <TD rowspan="1" colspan="1"> <P>900</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-99</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-99m</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>400,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-127m</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>5,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-129m</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>5,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Terbium-160</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>4,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thulium-170</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>4,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin-13</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin-123</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>3,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin-126</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Titanium-44</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Vanadium-48</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>7,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-133</P> </TD> <TD rowspan="1" colspan="1"> <P>1.0</P> </TD> <TD rowspan="1" colspan="1"> <P>900,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-91</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>2,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-65</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>5,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-93</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>400</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-95</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>5,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Any other beta-/gamma-emitter</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mixed fission products</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mixed Corrosion Products</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Contaminated equipment, beta/gamma</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Irradiated material, any form other than solid noncombustible</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Irradiated material, solid noncombustible</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mixed radioactive waste, beta/gamma</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Packaged mixed waste, beta/gamma<SUP>2</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>10,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Any other alpha-emitter</P> </TD> <TD rowspan="1" colspan="1"> <P>0.001</P> </TD> <TD rowspan="1" colspan="1"> <P>2</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Contaminated equipment, alpha</P> </TD> <TD rowspan="1" colspan="1"> <P>0.0001</P> </TD> <TD rowspan="1" colspan="1"> <P>20</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Packaged waste, alpha<SUP>(2)</SUP></P> </TD> <TD rowspan="1" colspan="1"> <P>0.0001</P> </TD> <TD rowspan="1" colspan="1"> <P>20</P> </TD> </TR> </TBODY> </TABLE> </P></span></td> </tr> </table><span class=""><P>Footnotes:</P></span><span class=""><P><SUP>(1)</SUP> For combinations of radioactive materials listed above, consideration of the need for an emergency plan is required if the sum of the ratios of the quantity of each radioactive material authorized to the quantity listed for that material in Schedule E exceeds one.</P></span><span class=""><P><SUP>(2)</SUP> Waste packaged in Type B containers does not require an emergency plan. </P></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Schedule F </span><span class=""><P><B>SCHEDULE F</B></P></span><span class=""><P><B>QUANTITIES FOR USE WITH DECOMMISSIONING</B></P></span><span class=""><P> <TABLE> <TBODY> <TR> <TD rowspan="1" colspan="1"> <P><B>Schedule F - Quantities for Use With Decommissioning</B></P> <P>Radioactive Material</P> </TD> <TD rowspan="1" colspan="1"> <P>Quantity <U>Microcurie <sup>[<a name="fn-FR-391-3-17-.02-schF-a_1" href="#ftn.fn-FR-391-3-17-.02-schF-a_1">1</a>]</sup><SUP>/</SUP>)</U></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Americium-241</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-122</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-124</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Antimony-125</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-73</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-74</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-76</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Arsenic-77</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-131</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-133</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Barium-140</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bismuth-210</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bromine-82</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-109</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-115m</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cadmium-115</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Calcium-45</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Calcium-47</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Carbon-14</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-141</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-143</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cerium-144</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-131</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-134m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-134</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-135</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-136</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cesium-137</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chlorine-36</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chlorine-38</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Chromium-51</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-58m</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-58</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Cobalt-60</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Copper-64</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Dysprosium-165</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Dysprosium-166</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Erbium-169</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Erbium-171</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-152 (9.2 h)</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-152 (13 yr)</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-154</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Europium-155</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Florine-18</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gadolinium-153</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gadolinium-159</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gallium-72</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Germanium-71</P> </TD> <TD rowspan="1" colspan="1"> <P>0</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hafnium-181</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Holmium-166</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Hydrogen-3</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-113m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-114m</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-115m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Indium-115</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-125</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-126</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-129</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-131</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-132</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-133</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-134</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iodine-135</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iridium-192</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iridium-194</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-55</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Iron-59</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Krypton-85</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Krypton-87</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lanthanum-140</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lutetium-177</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-52</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-54</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Manganese-56</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-197m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-197</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Mercury-203</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Molybdenum-99</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neodymium-147</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Neodymium-149</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-59</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-63</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Nickel-65</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-93m</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-95</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Niobium-97</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-185</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-191m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-191</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Osmium-193</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Palladium-103</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Palladium-109</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Phosphorus-32</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-191</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-193m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-193</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-197m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Platinum-197</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Plutonium-239</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Polonium-210</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Potassium-42</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Praseodymium-142</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Praseodymium-143</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium-147</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Promethium-149</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Radium-226</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhenium-186</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhenium-188</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhodium-103m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rhodium-105</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rubidium-86</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Rubidium-87</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-97</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-103</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-105</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ruthenium-106</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Samarium-151</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Samarium-153</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-46</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-47</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Scandium-48</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Selenium-75</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silicon-31</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-105</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-110m</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Silver-111</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium-22</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sodium-24</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-85</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-89</P> </TD> <TD rowspan="1" colspan="1"> <P>1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-90</P> </TD> <TD rowspan="1" colspan="1"> <P>0.1</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-91</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Strontium-92</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Sulfur-35</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tantalum-182</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-96</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-97m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-97</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-99m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Technetium-99</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-125m</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-127m</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-127</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-129m</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-129</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-131m</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tellurium-132</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Terbium-160</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-200</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-201</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-202</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thallium-204</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thorium (natural)<U><sup>[<a name="fn-FR-391-3-17-.02-schF-b_2" href="#ftn.fn-FR-391-3-17-.02-schF-b_2">2</a>]</sup><SUP>/</SUP></U></P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thulium-170</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thulium-171</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin-113</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tin-125</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-181</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-185</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Tungsten-187</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Uranium (natural)<U><sup>[<a name="fn-FR-391-3-17-.02-schF-c_3" href="#ftn.fn-FR-391-3-17-.02-schF-c_3">3</a>]</sup><SUP>/</SUP></U></P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Uranium-233</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Uranium-234</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Uranium-235</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Vanadium-48</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-131m</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-133</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Xenon-135</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Ytterbium-175</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-90</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-91</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-92</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Yttrium-93</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-65</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-69m</P> </TD> <TD rowspan="1" colspan="1"> <P>100</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zinc-69</P> </TD> <TD rowspan="1" colspan="1"> <P>1,000</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-93</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-95</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Zirconium-97</P> </TD> <TD rowspan="1" colspan="1"> <P>10</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Any alpha emitting radionuclide not listed above or mixtures of alpha emitters of unknown composition.</P> </TD> <TD rowspan="1" colspan="1"> <P>0.01</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1">&nbsp;</TD> <TD rowspan="1" colspan="1">&nbsp;</TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Any radionuclide other than alpha emitting radionuclides, not listed above or mixtures of beta emitters of unknown composition.</P> </TD> <TD rowspan="1" colspan="1"> <P>0.10</P> </TD> </TR> </TBODY> </TABLE> </P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Schedule G. Criteria Relating to Use of Financial Tests and Self Guarantees for Providing Reasonable Assurance of Funds for Decommissioning. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Introduction </span><span class=""><P>An applicant or licensee may provide reasonable assurance of the availability of funds for decommissioning based on furnishing its own guarantee that funds will be available for decommissioning costs and on a demonstration that the company passes the financial test of (21)(g)2. The terms of the self-guarantee are in (21)(g)3. This schedule establishes criteria for passing the financial test for the self-guarantee and establishes the terms for a self-guarantee.</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Financial Test </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> To pass the financial test, a company must meet all of the following criteria: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Tangible net worth at least ten times the total current decommissioning cost estimate for the total of all facilities or parts thereof (or the current amount required if certification is used) for all decommissioning activities for which the company is responsible as self-guaranteeing licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Assets located in the United States amounting to at least 90 percent of total decommissioning cost estimate for the total of all facilities or parts thereof (or the current amount required if certification is used) for all decommissioning activities for which the company is responsible as self-guaranteeing licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(i)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A current rating for its most recent bond issuance of AAA, AA, or A as issued by Standard and Poors (S&amp;P), or Aaa, Aa, or A as issued by Moodys.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> To pass the financial test, a company must meet all of the following additional requirements: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The company must have at least one class of equity securities registered under the Security Exchange Act of 1934.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The company's independent certified public accountant must have compared the data used by the company in the financial test, which is derived from the independently audited, year-end financial statements for the latest fiscal year, with the amounts in such financial statement. In connection with that procedure, the licensee shall inform the Department within 90 days of any matters coming to the attention of the auditor that cause the auditor to believe that the data specified in the financial test should be adjusted and that the company no longer passes the test.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(ii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> After the initial financial test, the company must repeat passage of the test within 90 days after the close of each succeeding fiscal year.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee no longer meets the requirements of (21)(g)2.(i), the licensee must send immediate notice to the Department of its intent to establish alternate financial assurance as specified in the Department's regulations within 120 days of such notice.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Company Self-Guarantee </span><span class=""><P>The terms of a self-guarantee which an applicant or licensee furnishes must provide that:</P></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The guarantee will remain in force unless the licensee sends notice of cancellation by certified mail to the Department. Cancellation may not occur, however, during the 120 days beginning on the date of receipt of the notice of cancellation by the Department, as evidence by the return receipt.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall provide alternative financial assurance as specified in the Department's regulations within 90 days following receipt by the Department of a notice of cancellation of the guarantee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The guarantee and financial test provisions must remain in effect until the Department has terminated the license or until another financial assurance method acceptable to the Department has been put in effect by the licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)3.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee will promptly forward to the Department and the licensee's independent auditor all reports covering the latest fiscal year filed by the licensee with the Securities and Exchange Commission pursuant to the requirements of Section 13 of the Securities and Exchange Act of 1934.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)3.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If, at any time, the licensee's most recent bond issuance ceases to be rated in any category of "A" or above by either Standard and Poors or Moodys, the licensee will provide notice in writing of such fact to the Department within 20 days after publication of the change by the rating service. If the licensee's most recent bond issuance ceases to be rated in any category of A or above by both Standard and Poors and Moodys, the licensee no longer meets the requirements of (21)(g)2.(i).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(g)3.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant or licensee must provide to the Department a written guarantee (a written commitment by a corporate officer) which states that the licensee will fund and carry out the required decommissioning activities or, upon issuance of an order by the Department, the licensee will set up and fund a trust in the amount of the current cost estimates for decommissioning.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Schedule H. Criteria Relating to Use of Financial Tests and Self-Guarantee For Providing Reasonable Assurance of Funds For Decommissioning by Nonprofit Colleges, Universities, and Hospitals. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Introduction </span><span class=""><P>An applicant or licensee may provide reasonable assurance of the availability of funds for decommissioning based on furnishing its own guarantee that funds will be available for decommissioning costs and on a demonstration that the applicant or licensee passes the financial test of (h)2. The terms of the self-guarantee are in (h)3. This schedule establishes criteria for passing the financial test for the self-guarantee and establishes the terms for a self-guarantee.</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Financial Test </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For colleges and universities, to pass the financial test a college or university must meet either the criteria in (h)2.(i)(I) or the criteria in (h)2.(i)(II). </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For applicants or licensees that issue bonds, a current rating for its most recent uninsured, uncollateralized, and unencumbered bond issuance of AAA, AA, or A as issued by Standard and Poors (S&amp;P) or Aaa, Aa, or A as issued by Moodys.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For applicants or licensees that do not issue bonds, unrestricted endowment consisting of assets located in the United States of at least $50 million, or at least 30 times the total current decommissioning cost estimate (or the current amount required if certification is used), whichever is greater, for all decommissioning activities for which the college or university is responsible as a self-guaranteeing licensee.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For hospitals, to pass the financial test a hospital must meet either the criteria in (h)2.(ii)(I) or the criteria in (h)2.(ii)(II): </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For applicants or licensees that issue bonds, a current rating for its most recent uninsured, uncollateralized, and unencumbered bond issuance of AAA, AA, or A as issued by Standard and Poors (S&amp;P) or Aaa, Aa, or A as issued by Moodys.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For applicants or licensees that do not issue bonds, all the following tests must be met:</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(ii)I.">I.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> (Total Revenues less total expenditures) divided by total revenues must be equal to or greater than 0.04.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(ii)II.">II.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Long term debt divided by net fixed assets must be less than or equal to 0.67.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(ii)III.">III.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> (Current assets and depreciation fund) divided by current liabilities must be greater than or equal to 2.55.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(ii)IV.">IV.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Operating revenues must be at least 100 times the total current decommissioning cost estimate (or the current amount required if certification is used) for all decommissioning activities for which the hospital is responsible as a self-guaranteeing license.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In addition, to pass the financial test, a licensee must meet all the following requirements: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(iii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee's independent certified public accountant must have compared the data used by the licensee in the financial test, which is required to be derived from the independently audited year-end financial statements, based on United States generally accepted accounting practices, for the latest fiscal year, with the amounts in such financial statement. In connection with that procedure, the licensee shall inform the Department within 90 days of any matters coming to the attention of the auditor that cause the auditor to believe that the data specified in the financial test should be adjusted and that the licensee no longer passes the test.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(iii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> After the initial financial test, the licensee must repeat passage of the test within 90 days after the close of each succeeding fiscal year.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)2.(iii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee no longer meets the requirements of (h)1., the licensee must send notice to the Department of its intent to establish alternative financial assurance as specified in Department regulations. The notice must be sent by certified mail, return receipt requested, within 90 days after the end of the fiscal year for which the year-end financial data show that the licensee no longer meets the financial test requirements. The licensee must provide alternate financial assurance within 120 days after the end of such fiscal year.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Self-Guarantee </span><span class=""><P>The terms of a self-guarantee which an applicant or licensee furnishes must provide that:</P></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The guarantee shall remain in force unless the licensee sends notice of cancellation by certified mail, and/or return receipt requested, to the Department. Cancellation may not occur unless an alternative financial assurance mechanism is in place.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall provide alternative financial assurance as specified in the Department's regulations within 90 days following receipt by the Department of a notice of cancellation of the guarantee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The guarantee and financial test provisions must remain in effect until the Department has terminated the license or until another financial assurance method acceptable to the Department has been put in effect by the licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)3.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The applicant or licensee must provide to the Department a written guarantee (a written commitment by a corporate officer or officer of the institution) which states that the licensee will fund and carry out the required decommissioning activities or, upon issuance of an order by the Department, the licensee will set up and fund a trust in the amount of the current cost estimates for decommissioning.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.02(21)(h)3.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If, at any time, the licensee's most recent bond issuance ceases to be rated in any category of "A" or above by either Standard and Poors or Moodys, the licensee shall provide notice in writing of such fact to the Department within 20 days after publication of the change by the rating service.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <h2><a href="/GAC/391-3-17-.03" name="391-3-17-.03" title="391-3-17-.03">Rule 391-3-17-.03 Standards for Protection Against Radiation</a></h2> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(1)">(1)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>General Provisions</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(1)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Purpose. </span><span class=""><P>This Rule, <a title="391-3-17-.03" href="391-3-17-.03">391-3-17-.03</a>, establishes standards for protection against ionizing radiation resulting from activities conducted pursuant to licenses issued by the Department. The requirements in this Rule are designed to control the receipt, possession, use, transfer, and disposal of sources of radiation by any licensee so that the total dose to an individual, including doses resulting from all sources of radiation other than background radiation, does not exceed the standards for protection against radiation prescribed in this Rule. However, nothing in this Rule shall be construed as limiting actions that may be necessary to protect health and safety.</P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(1)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Scope. </span><span class=""><P>This Rule applies to persons licensed by the Department on or after January 1, 1994, to receive, possess, use, transfer, or dispose of sources of radiation. The limits in this Rule do not apply to doses due to background radiation, to exposure of patients to radiation for the purpose of medical diagnosis or therapy, or to voluntary participation in medical research programs.</P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)">(2)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Definitions</B></span><span class=""><P>The definitions set forth for certain terms under <a title="391-3-17-.01" href="391-3-17-.01">391-3-17-.01</a> are applicable to those terms as used in this Rule, unless the term is otherwise defined herein. As used in this Rule:</P></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Air-purifying respirator" means a respirator with an air-purifying filter, cartridge, or canister that removes specific air contaminants by passing ambient air through the air-purifying element.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Assigned protection factor" (APF) means the expected workplace level of respiratory protection that would be provided by a properly functioning respirator or a class of respirators to properly fitted and trained users. Operationally, the inhaled concentration can be estimated by dividing the ambient airborne concentration by the APF.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Atmosphere-supplying respirator" means a respirator that supplies the respirator user with breathing air from a source independent of the ambient atmosphere, and includes supplied-air respirators (SARs) and self-contained breathing apparatus (SCBA) units.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Annual limit on intake" (ALI) means the derived limit for the amount of radioactive material taken into the body of an adult worker by inhalation or ingestion in a year. ALI is the smaller value of intake of a given radionuclide in a year by the reference man that would result in a committed effective dose equivalent of five rem (0.05 Sv) or a committed dose equivalent of 50 rem (0.5 Sv) to any individual organ or tissue. ALI values for intake by ingestion and by inhalation of selected radionuclides are given in Table I, Columns 1 and 2, of Appendix B to 10 CFR 20.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Chelating agent" means amine polycarboxylic acids, hydroxycarboxylic acids, gluconic acid, and polycarboxylic acids.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Chemical description" means a description of the principal chemical characteristics of a low-level radioactive waste.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Class" means a classification scheme for inhaled material according to its rate of clearance from the pulmonnary region of the lung. Materials are classified as D, W, or Y, which apply to a range of clearance half-times: for Class D (Days), of less than ten days; for Class W (Weeks), from ten to 100 days; and for Class Y (Years), of greater than 100 days. For purposes of this Chapter, "lung class" and "inhalation class" are equivalent terms.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Computer-readable medium" means that the Department's computer can transfer the information from the medium into its memory.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Consignee" means the designated receiver of the shipment of low-level radioactive waste.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(j)">(j)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Constraint (dose constraint)" means a value above which specified licensee actions are required.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(k)">(k)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Critical Group" means the group of individuals reasonably expected to receive the greatest exposure to residual radioactivity for any applicable set of circumstances.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(l)">(l)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Declared pregnant woman" means any woman who has voluntarily informed the licensee, in writing, of her pregnancy and the estimated date of conception. The declaration remains in effect until the declared pregnant woman withdraws the declaration in writing or is no longer pregnant.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(m)">(m)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Decommission" means to remove a facility or site safely from service and reduce residual radioactivity to a level that permits release of the property for unrestricted use and termination of the license.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(n)">(n)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Decontamination facility" means a facility operating under a Department, U.S. Nuclear Regulatory Commission, Agreement State or Licensing State license whose principal purpose is decontamination of equipment or materials to accomplish recycle, reuse, or other waste management objectives, and, for purposes of this part, is not considered to be a consignee for LLW shipments.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(o)">(o)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Demand respirator" means an atmosphere-supplying respirator that admits breathing air to the facepiece only when a negative pressure is created inside the facepiece by inhalation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(p)">(p)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Derived air concentration" (DAC) means the concentration of a given radionuclide in air which, if breathed by the reference man for a working year of 2,000 hours under conditions of light work (inhalation rate of 1.2 cubic meters of air per hour), results in an intake of one ALI. DAC values are given in Table I, Column 3 of Appendix B to 10 CFR 20.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(q)">(q)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Derived air concentration-hour" (DAC-hour) means the product of the concentration of radioactive material in air, expressed as a fraction or multiple of the derived air concentration for each radionuclide, and the time of exposure to that radionuclide, in hours. A licensee may take 2,000 DAC-hours to represent one ALI, equivalent to a committed effective dose equivalent of five rem (0.05 Sv).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(r)">(r)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Disposable respirator" means a respirator for which maintenance is not intended and that is designed to be discarded after excessive breathing resistance, sorbent exhaustion, physical damage, or end-of-service-life renders it unsuitable for use. Examples of this type of respirator are a disposable half-mask respirator or a disposable escape-only self-contained breathing apparatus (SCBA).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(s)">(s)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Disposal container" means a container principally used to confine low-level radioactive waste during disposal operations at a land disposal facility (also see "high integrity container"). Note that for some shipments, the disposal container may be the transport package.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(t)">(t)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Distinguishable from background" means that the detectable concentration of a radionuclide is statistically different from the background concentration of that radionuclide in the vicinity of the site or, in the case of structures, in similar materials using adequate measurement technology, survey, and statistical techniques.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(u)">(u)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Dosimetry processor" means a person that processes and evaluates individual monitoring equipment devices in order to determine the radiation dose delivered to the monitoring devices.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "EPA identification number" means the number received by a transporter following application to the Administrator of EPA as required by 40 CFR part 263.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(w)">(w)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Filtering facepiece" (dust mask) means a negative pressure particulate respirator with a filter as an integral part of the facepiece or with the entire facepiece composed of the filtering medium, not equipped with elastomeric sealing surfaces and adjustable straps.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(x)">(x)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Fit factor" means a quantitative estimate of the fit of a particular respirator to a specific individual, and typically estimates the ratio of the concentration of a substance in ambient air to its concentration inside the respirator when worn.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(y)">(y)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Fit test" means the use of a protocol to qualitatively or quantitatively evaluate the fit of a respirator on an individual.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(z)">(z)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Generator" means a licensee operating under a Department, U.S. Nuclear Regulatory Commission or Agreement State license who (1) is a waste generator or (2) is the licensee to whom waste can be attributed within the context of the Low-Level Radioactive Waste Policy Amendments Act of 1985 (e.g., waste generated as a result of decontamination or recycle activities).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(aa)">(aa)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Helmet" means a rigid respiratory inlet covering that also provides head protection against impact and penetration.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(bb)">(bb)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "High integrity container (HIC)" means a container commonly designed to meet the structural stability requirements of Rule </span><span class=""> <a title="391-3-17-.03(13)(g)" href="391-3-17-.03#391-3-17-.03(13)(g)">391-3-17-.03(13)(g)</a></span><span class="">, and to meet Department of Transportation requirements for a Type A package.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(cc)">(cc)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Hood" means a respiratory inlet covering that completely covers the head and neck and may also cover portions of the shoulders and torso.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(dd)">(dd)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Land disposal facility" means the land, buildings and structures, and equipment that are intended to be used for the disposal of radioactive waste. For purposes of this Rule, a "geologic repository" as defined in 10 CFR Part 60 is not considered a "land disposal facility."</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ee)">(ee)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Lens dose equivalent" (LDE) means the external exposure of the lens of the eye and is taken as the dose equivalent at a tissue depth of 0.3 centimeter (300 mg/cm</span><span class=""><SUP>2</SUP></span><span class="">).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ff)">(ff)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Loose-fitting facepiece" means a respiratory inlet covering that is designed to form a partial seal with the face.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(gg)">(gg)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Nationally tracked source" means a sealed source containing a quantity equal to or greater than Category 1 or Category 2 levels of any radioactive material listed in Table 3 of </span><span class=""> <a title="391-3-17-.03" href="391-3-17-.03">391-3-17-.03</a></span><span class=""> (15). In this context a sealed source is defined as radioactive material that is sealed in a capsule or closely bonded, in a solid form and which is not exempt from regulatory control. It does not mean material encapsulated solely for disposal, or nuclear material contained in any fuel assembly, subassembly, fuel rod, or fuel pellet. Category 1 nationally tracked sources are those containing radioactive material at a quantity equal to or greater than the Category 1 threshold. Category 2 nationally tracked sources are those containing radioactive material at a quantity equal to or greater than the Category 2 threshold but less than the Category 1 threshold.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(hh)">(hh)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Negative pressure respirator" (tight fitting) means a respirator in which the air pressure inside the facepiece is negative during inhalation with respect to the ambient air pressure outside the respirator.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Nonstochastic effect" means a health effect, the severity of which varies with the dose and for which a threshold is believed to exist. Radiation-induced cataract formation is an example of a nonstochastic effect. For purposes of this Chapter, "deterministic effect" is an equivalent term.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(jj)">(jj)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Positive pressure respirator" means a respirator in which the pressure inside the respiratory inlet covering exceeds the ambient air pressure outside the respirator.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(kk)">(kk)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Physical description" means the items called for on NRC Form 541 or equivalent form to describe a low-level radioactive waste.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ll)">(ll)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Planned special exposure" means an infrequent exposure to radiation separate from and in addition to the annual occupational dose limits.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(mm)">(mm)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Powered air-purifying respirator" (PAPR) means an air-purifying respirator that uses a blower to force the ambient air through air-purifying elements to the inlet covering.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(nn)">(nn)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Pressure demand respirator" means a positive pressure atmosphere-supplying respirator that admits breathing air to the facepiece when the positive pressure is reduced inside the facepiece by inhalation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(oo)">(oo)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Qualitative fit test" (QLFT) means a pass/fail fit test to assess the adequacy of respirator fit that relies on the individual's response to the test agent.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(pp)">(pp)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Quantitative fit test" (QNFT) means an assessment of the adequacy of respirator fit by numerically measuring the amount of leakage into the respirator.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(qq)">(qq)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Reference man" means a hypothetical aggregation of human physical and physiological characteristics determined by international consensus. These characteristics may be used by researchers and public health workers to standardize results of experiments and to relate biological insult to a common base.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(rr)">(rr)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Residual radioactivity" means radioactivity in structures, materials, soils, groundwater, and other media at a site resulting from activities under the licensee's control. This includes radioactivity from all licensed and unlicensed sources used by the licensee, but excludes background radiation. It also includes radioactive materials remaining at the site as a result of routine or accidental releases of radioactive material at the site and previous burials at the site, even if those burials were made in accordance with the provisions of Rule </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Rules and Regulations/browse?ci=25&amp;id=gasos&amp;codesec=391-3-17-.03&amp;title=391#" target="_newtab">.03</a></span><span class=""> of this Chapter.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ss)">(ss)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Residual waste" means low-level radioactive waste resulting from processing or decontamination activities that cannot be easily separated into distinct batches attributable to specific waste generators. This waste is attributable to the processor or decontamination facility, as applicable.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(tt)">(tt)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Respiratory protective device" means an apparatus, such as a respirator, used to reduce an individual's intake of airborne radioactive materials.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(uu)">(uu)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Self-contained breathing apparatus" (SCBA) means an atmosphere-supplying respirator for which the breathing air source is designed to be carried by the user.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(vv)">(vv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Sanitary sewerage" means a system of public sewers for carrying off waste water and refuse, but excluding sewage treatment facilities, septic tanks, and leach fields owned or operated by the licensee.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ww)">(ww)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Shipper" means the licensed entity (i.e., the waste generator, waste collector, or waste processor) who offers low-level radioactive waste for transportation, typically consigning this type of waste to a licensed waste collector, waste processor, or land disposal facility operator.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(xx)">(xx)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Shipping paper" means NRC Form 540 and, if required, NRC Form 540A or equivalent forms which include the information required by DOT in 49 CFR Part 172.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(yy)">(yy)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Source material" means </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(yy)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Uranium or thorium, or any combination thereof, in any physical or chemical form; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(yy)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ores that contain by weight one-twentieth of one percent (0.05 percent) or more of uranium, thorium, or any combination thereof. Source material does not include special nuclear material.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(zz)">(zz)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Stochastic effect" means a health effect that occurs randomly and for which the probability of the effect occurring, rather than its severity, is assumed to be a linear function of dose without threshold. Hereditary effects and cancer incidence are examples of stochastic effects. For purposes of this Chapter, "probabilistic effect" is an equivalent term.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(aaa)">(aaa)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Supplied-air respirator" (SAR) or airline respirator means an atmosphere-supplying respirator for which the source of breathing air is not designed to be carried by the user.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(bbb)">(bbb)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Tight-fitting facepiece" means a respiratory inlet covering that forms a complete seal with the face.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ccc)">(ccc)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Uniform Low-Level Radioactive Waste Manifest" or "Uniform Manifest" means the combination of NRC Forms 540, 541, and if necessary, 542, and their respective continuation sheets as needed, or equivalent forms.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ddd)">(ddd)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "User seal check" (fit check) means an action conducted by the respirator user to determine if the respirator is properly seated to the face. Examples include negative pressure check, positive pressure check, irritant smoke check, or isoamyl acetate check.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(eee)">(eee)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Very high radiation area" means an area, accessible to individuals, in which radiation levels from radioactive materials external to the body could result in an individual receiving an absorbed dose in excess of 500 rads (5 Gray) in one hour at one meter from a source of radiation or from any surface that the radiation penetrates.</span><span class=""><sup>[<a name="fn-FR-391-3-17-.03-8" href="#ftn.fn-FR-391-3-17-.03-8">1</a>]</sup></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(fff)">(fff)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Waste collector" means an entity, operating under a Department, U.S. Nuclear Regulatory Commission, Agreement State, or Licensing State license, whose principal purpose is to collect and consolidate waste generated by others, and to transfer this waste, without processing or repackaging the collected waste, to another licensed waste collector, licensed waste processor, or licensed land disposal facility.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(ggg)">(ggg)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Waste description" means the physical, chemical and radiological description of a low-level radioactive waste as called for on NRC Form 541 or equivalent form.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(hhh)">(hhh)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Waste generator" means an entity, operating under a Department, U.S. Nuclear Regulatory Commission, Agreement State, or Licensing State license, who (1) possesses any material or component that contains radioactivity or is radioactively contaminated for which the licensee foresees no further use, and (2) transfers this material or component to a licensed land disposal facility or to a licensed waste collector or processor for handling or treatment prior to disposal. A licensee performing processing or decontamination services may be a "waste generator" if the transfer of low-level radioactive waste from its facility is defined as "residual waste."</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Waste processor" means an entity, operating under a Department, U.S. Nuclear Regulatory Commission, Agreement State, or Licensing State license, whose principal purpose is to process, repackage, or otherwise treat low-level radioactive material or waste generated by others prior to eventual transfer of waste to a licensed low-level radioactive waste land disposal facility.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(jjj)">(jjj)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Waste type" means a waste within a disposal container having a unique physical description (i.e., a specific waste descriptor code or description; or a waste sorbed on or solidified in a specifically defined media).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(2)(kkk)">(kkk)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> "Weighting factor" (w</span><span class=""><SUB>T</SUB></span><span class="">) for an organ or tissue (T) means the proportion of the risk of stochastic effects resulting from irradiation of that organ or tissue to the total risk of stochastic effects when the whole body is irradiated uniformly. For calculating the effective dose equivalent, the values of w</span><span class=""><SUB>T</SUB></span><span class=""> are: </span><span class=""><P>ORGAN DOSE WEIGHTING FACTORS</P></span><span class=""><P> <TABLE border="0"> <TR> <TD rowspan="1" colspan="1"> <P><U>Organ or Tissue</U></P> </TD> <TD rowspan="1" colspan="1"> <P><U>w<SUB>T</SUB></U></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Gonads</P> </TD> <TD rowspan="1" colspan="1"> <P>0.25</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Breast</P> </TD> <TD rowspan="1" colspan="1"> <P>0.15</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Red bone marrow</P> </TD> <TD rowspan="1" colspan="1"> <P>0.12</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Lung</P> </TD> <TD rowspan="1" colspan="1"> <P>0.12</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Thyroid</P> </TD> <TD rowspan="1" colspan="1"> <P>0.03</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Bone surfaces</P> </TD> <TD rowspan="1" colspan="1"> <P>0.03</P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Remainder</P> </TD> <TD rowspan="1" colspan="1"> <P>0.30<SUP>a</SUP></P> </TD> </TR> <TR> <TD rowspan="1" colspan="1"> <P>Whole Body</P> </TD> <TD rowspan="1" colspan="1"> <P>1.00<SUP>b</SUP></P> </TD> </TR> </TABLE> </P></span><span class=""><P><SUP>a </SUP> 0.30 result s from 0.06 for each of five "remainder" organs, excluding the skin and the lens of the eye, that receive the highest doses.</P></span><span class=""><P><SUP>b</SUP> For the purpose of weighting the external whole body dose, for adding it to the internal dose, a single weighting factor, w<SUB>T</SUB> = 1.0, has been specified. The use of other weighting factors for external exposure will be approved on a case-by-case basis until such time as specific guidance is issued.</P></span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(3)">(3)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Implementation</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(3)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Any existing license condition that is more restrictive than this Rule remains in force until there is an amendment or renewal of the license.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(3)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If a license condition exempts a licensee from a provision of Rule </span><span class=""> <a title="391-3-17-.03" href="391-3-17-.03">391-3-17-.03</a></span><span class=""> in effect on or before January 1, 1994, it also exempts the licensee from the corresponding provision of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(3)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If a license condition cites provisions of Rule </span><span class=""> <a title="391-3-17-.03" href="391-3-17-.03">391-3-17-.03</a></span><span class=""> in effect prior to January 1, 1994, which do not correspond to any provisions of this Rule, the license condition remains in force until there is an amendment or renewal of the license that modifies or removes this condition.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(4)">(4)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Radiation Protection Programs</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(4)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall develop, document, and implement a Radiation Protection Program sufficient to ensure compliance with the provisions of this Rule. See (14)(b) of this Rule for record-keeping requirements relating to these Programs.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(4)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall use, to the extent practical, procedures and engineering controls based upon sound radiation protection principles to achieve occupational doses and doses to members of the public that are as low as is reasonably achievable (ALARA).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(4)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall, at least annually, review the Radiation Protection Program content and implementation.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(4)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> To implement the ALARA requirements of .03(4)(b), and notwithstanding the requirements in.03(5)(i) of this rule, a constraint on air emissions of radioactive material to the environment, excluding Radon-222 and its daughters, shall be established by licensees such that the individual member of the public likely to receive the highest dose will not be expected to receive a total effective dose equivalent in excess of ten (10) mrem (0.1 mSv) per year from these emissions. If a licensee subject to this requirement exceeds this dose constraint, the licensee shall report the exceedance as provided in.03(15)(c) and promptly take appropriate corrective action to ensure against recurrence.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)">(5)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Occupational Dose Limits and Dose Limits for Individual Members of the Public</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Occupational Dose Limits for Adults. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall control the occupational dose to individual adults, except for planned special exposures pursuant to (5)(f) of this Rule, in accordance with the following dose limits: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An annual limit, which is the more limiting of: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)1.(i)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The total effective dose equivalent being equal to five (5) rem (0.05 Sv); or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)1.(i)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The sum of the deep dose equivalent and the committed dose equivalent to any individual organ or tissue other than the lens of the eye being equal to 50 rem (0.50 Sv). </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The annual limits to the lens of the eye, to the skin of the whole body, and to the skin of the extremities, which are: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)1.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A lens dose equivalent of 15 rem (0.15 Sv); and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)1.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A shallow dose equivalent of 50 rem (0.50 Sv) to the skin of the whole body or to the skin of any extremity.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Doses received in excess of the annual limits, including doses received during accidents, emergencies, and planned special exposures, shall be subtracted from the limits for planned special exposures that the individual may receive during the current year and during the individual's lifetime, listed in (5)(f)5.(i) and (ii) of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> When the external exposure is determined by measurement with an external personal monitoring device, the deep-dose equivalent must be used in place of the effective dose equivalent, unless the effective dose equivalent is determined by a dosimetry method approved by the NRC. The assigned deep dose equivalent shall be for the portion of the body receiving the highest exposure. The assigned shallow dose equivalent shall be the dose averaged over the contiguous ten (10) square centimeters of skin receiving the highest exposure.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The deep dose equivalent, lens dose equivalent, and shallow dose equivalent may be assessed from surveys or other radiation measurements for the purpose of demonstrating compliance with the occupational dose limits, if the individual monitoring device was not in the region of highest potential exposure or the results of individual monitoring are unavailable.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Derived air concentration (DAC) and annual limit on intake (ALI) values are specified in Table I of Appendix B to 10 CFR 20 and may be used to determine the individual's dose and to demonstrate compliance with the occupational dose limits. See (14)(g) of this Rule for maintaining records of these exposures.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Notwithstanding the annual dose limits, the licensee shall limit the soluble uranium intake by an individual to ten milligrams in a week in consideration of chemical toxicity. See footnote 3 of Appendix B 10 CFR 20.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(a)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall reduce the dose that an individual may be allowed to receive in the current year by the amount of occupational dose received while employed by any other person during the current year. See (5)(e) of this Rule.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Compliance with Requirements for Summation of External and Internal Doses. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> General Requirements. If the licensee is required to monitor pursuant to both (8)(b)1. and 2. of this Rule, the licensee shall demonstrate compliance with the dose limits by summing external and internal doses. If the licensee is required to monitor only pursuant to (8)(b)1. of this Rule or only pursuant to (8)(b)2. of this Rule, then summation is not required to demonstrate compliance with the dose limits. The licensee must demonstrate compliance with the requirements for summation of external and internal doses pursuant to (5)(b)2., 3., and 4. of this Rule. The dose equivalents for the lens of the eye, the skin, and the extremities are not included in the summation, but are subject to separate limits.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Intake by Inhalation. If the only intake of radionuclides is by inhalation, the total effective dose equivalent limit is not exceeded if the sum of the deep dose equivalent divided by the total effective dose equivalent limit and one of the following does not exceed unity: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(b)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The sum of the fractions of the inhalation ALI for each radionuclide;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(b)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The total number of derived air concentration-hours (DAC-hours) for all radionuclides divided by 2,000; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(b)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The sum of the calculated committed effective dose equivalents to all significantly irradiated organs or tissues (T) calculated from bioassay data using appropriate biological models and expressed as a fraction of the annual limit. For purposes of this requirement, an organ or tissue is deemed to be significantly irradiated if, for that organ or tissue, the product of the weighting factors, w</span><span class=""><SUB>T</SUB></span><span class="">, and the committed dose equivalent, H</span><span class=""><SUB>T,50</SUB></span><span class="">, per unit intake is greater than ten percent of the maximum weighted value of H</span><span class=""><SUB>50</SUB></span><span class=""> (i.e., w</span><span class=""><SUB>T</SUB></span><span class="">H</span><span class=""><SUB>T,50</SUB></span><span class="">), per unit intake for any organ or tissue.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Intake by Oral Ingestion. If the occupationally-exposed individual receives an intake of radionuclides by oral ingestion greater than ten percent of the applicable oral ALI, the licensee shall account for this intake and include it in demonstrating compliance with the limits.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Intake through Wounds or Absorption through Skin. The licensee shall evaluate and, to the extent practical, account for intakes through wounds or skin absorption. The intake through intact skin has been included in the calculation of DAC for hydrogen-3 and does not need to be evaluated or accounted for pursuant to (5)(b)4. of this Rule.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Determination of External Dose from Airborne Radioactive Material. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Licensees shall, when determining the dose from airborne radioactive material, include the contribution to the deep dose equivalent, lens dose equivalent, and shallow dose equivalent from external exposure to the radioactive cloud. See Appendix B, footnotes 1 and 2, of 10 CFR 20.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Airborne radioactivity measurements and DAC values shall not be used as the primary means to assess the deep dose equivalent when the airborne radioactive material includes radionuclides other than noble gases or if the cloud of airborne radioactive material is not relatively uniform. The determination of the deep dose equivalent to an individual shall be based upon measurements using instruments or individual monitoring devices.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Determination of Internal Exposure. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For purposes of assessing the dose used to determine compliance with occupational dose equivalent limits, the licensee shall, when required under (8)(b) of this Rule, take suitable and timely measurements of: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Concentrations of radioactive materials in air in work areas during operations;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Quantities of radionuclides in the body;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Quantities of radionuclides excreted from the body; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Combinations of these measurements.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Unless respiratory protective equipment is used, as provided in (10)(d) of this Rule, or the assessment of intake is based on bioassays, the licensee shall assume that an individual inhales radioactive material at the airborne concentration in which the individual is present.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> When specific information on the physical and biochemical properties of the radionuclides taken into the body or the behavior of the material in an individual is known, the licensee may: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use that information to calculate the committed effective dose equivalent, and, if used, the licensee shall document that information in the individual's record;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Upon prior approval of the Department, adjust the DAC or ALI values to reflect the actual physical and chemical characteristics of airborne radioactive material, for example, aerosol size distribution or density; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Separately assess the contribution of fractional intakes of Class D, W, or Y compounds of a given radionuclide to the committed effective dose equivalent. See Appendix B of 10 CFR 20.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee chooses to assess intakes of Class Y material using the measurements given in (5)(d)1.(ii) or (iii) of this Rule, the licensee may delay the recording and reporting of the assessments for periods up to seven months, unless otherwise required by (15)(b) or (15)(c) of this Rule. This delay permits the licensee to make additional measurements basic to the assessments.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the identity and concentration of each radionuclide in a mixture are known, the fraction of the DAC applicable to the mixture for use in calculating DAC-hours shall be either: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The sum of the ratios of the concentration to the appropriate DAC value (i.e. D, W, or Y) from Appendix B of 10 CFR 20, for each radionuclide in the mixture; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The ratio of the total concentration for all radionuclides in the mixture to the most restrictive DAC value for any radionuclide in the mixture.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the identity of each radionuclide in a mixture is known, but the concentration of one or more of the radionuclides in the mixture is not known, the DAC for the mixture shall be the most restrictive DAC of any radionuclide in the mixture.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> When a mixture of radionuclides in the air exists, a licensee may disregard certain radionuclides in the mixture if: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)7.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee uses the total activity of the mixture in demonstrating compliance with the dose limits in (5)(a) of this Rule and in complying with the monitoring requirements in (8)(b)2. of this Rule;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)7.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The concentration of any radionuclide disregarded is less than ten percent of its DAC; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)7.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The sum of these percentages for all of the radionuclides disregarded in the mixture does not exceed 30 percent.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)8.">8.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> When determining the committed effective dose equivalent, the following information may be considered: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)8.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In order to calculate the committed effective dose equivalent, the licensee may assume that the inhalation of one ALI, or an exposure of 2,000 DAC-hours, results in a committed effective dose equivalent of five rem (0.05 Sv) for radionuclides that have their ALIs or DACs based on the committed effective dose equivalent;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(d)8.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> When the ALI (and the associated DAC) is determined by the non-stochastic organ dose limit of 50 rem (0.50 Sv), the intake of radionuclides that would result in a committed effective dose equivalent of five rem (0.05 Sv), (i.e., the stochastic ALI) is listed in parentheses in Table I of Appendix B of 10 CFR 20. In this case, the licensee may, as a simplifying assumption, use the stochastic ALIs to determine the committed effective dose equivalent. However, if the licensee uses the stochastic ALIs, the licensee shall also demonstrate that the limit in (5)(a)1.(i)(II) of this Rule is not exceeded.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Determination of Prior Occupational Dose. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> For each individual who is likely to receive, in a year, an occupational dose requiring monitoring pursuant to (8)(b) of this Rule, the licensee shall: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Determine the occupational radiation dose received during the current year; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Attempt to obtain the records of lifetime cumulative occupational radiation dose.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prior to permitting an individual to participate in a planned special exposure, the licensee shall determine: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The internal and external doses from all previous planned special exposures; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> All doses in excess of the limits, including doses received during accidents and emergencies, received during the lifetime of the individual.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In complying with the requirements of (5)(e)1. of this Rule, a licensee may: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Accept, as a record of the occupational dose that the individual received during the current year, a written signed statement from the individual, or from the individual's most recent employer for work involving radiation exposure, that discloses the nature and the amount of any occupational dose that the individual may have received during the current year;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Accept, as the record of lifetime cumulative radiation dose, an up-to-date Department Form "Occupational Radiation Exposure History" or equivalent, signed by the individual and countersigned by an appropriate official of the most recent employer for work involving radiation exposure, or the individual's current employer if the individual is not employed by the licensee; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Obtain the individual's dose equivalent from the most recent employer for work involving radiation exposure, or the individual's current employer if the individual is not employed by the licensee, by telephone, telegram, electronic media, facsimile, or letter. The licensee shall request a written verification of the dose data if the authenticity of the transmitted report cannot be established.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall record the exposure history, as required by (5)(e)1. of this Rule, on Department Form "Occupational Radiation Exposure History" or other clear and legible record, and all of the information required on that form. The form or record shall show each period in which the individual received occupational exposure to radiation or radioactive material and shall be signed by the individual who received the exposure. For each period for which the licensee obtains, the licensee shall use the dose shown in the report in preparing the Department Form "Occupational Radiation Exposure History" or equivalent form. For any period in which the licensee does not obtain a report, the licensee shall place a notation on the "Occupational Radiation Exposure History" or equivalent form indicating the periods of time for which data are not available.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Licensees are not required to partition historical dose between external dose equivalents and internal committed dose equivalents of radionuclides assessed under the Regulations in effect before January 1, 1994. Further, occupational exposure histories obtained and recorded on Department Form "Occupational Radiation Exposure History" or equivalent before January 1, 1994, might not have included effective dose equivalent but may be used in the absence of specific information on the intake of radionuclides by the individual.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee is unable to obtain a complete record of an individual's current and previously accumulated occupational dose, the licensee shall assume: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)6.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In establishing administrative controls under (5)(a)7. of this Rule, for the current year, that the allowable dose limit for the individual is reduced by 1.25 rem (12.5 mSv) for each quarter for which records were unavailable and the individual was engaged in activities that could have resulted in occupational radiation exposure; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)6.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> That the individual is not available for planned special exposures.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(e)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall retain the records on Department Form "Occupational Radiation Exposure History" or equivalent until the Department terminates each pertinent license requiring this record. The licensee shall retain records used in preparing Department Form "Occupational Radiation Exposure History" or equivalent for three years after the record is made.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Planned Special Exposures. A licensee may authorize an adult worker to receive doses in addition to and accounted for separately from the doses received under the limits specified in (5)(a) of this Rule provided that each of the following conditions is satisfied: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee authorizes a planned special exposure only in an exceptional situation when alternatives that might avoid the higher exposure estimated to result from the planned special exposure are unavailable or impractical (i.e., industrial radiography source retrieval for an area that cannot be evacuated).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The management official of the licensee (and employer if the employer is not the licensee) specifically authorizes the planned special exposure, in writing, before the exposure occurs.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Before a planned special exposure, the licensee ensures that each individual involved is: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Informed of the purpose of the planned operation;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Informed of the estimated doses and associated potential risks and specific radiation levels or other conditions that might be involved in performing the task; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)3.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Instructed in the measures to be taken to keep the dose ALARA considering other risks that may be present.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prior to permitting an individual to participate in a planned special exposure, the licensee ascertains prior doses as required by (5)(e)2. of this Rule during the lifetime for each individual involved.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Subject to (5)(a)2. of this Rule, the licensee shall not authorize a planned special exposure that would cause an individual to receive a dose from all planned special exposures and all doses in excess of the limits to exceed: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The numerical values of any of the dose limits in (5)(a)1. of this Rule in any year; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Five times the annual dose limits in (5)(a)1. of this Rule during the individual's lifetime.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee maintains records of the conduct of a planned special exposure in accordance with (14)(f) of this Rule and submits a written report in accordance with (15)(d) of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(f)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee records the best estimate of the dose resulting from the planned special exposure in the individual's record and informs the individual, in writing, of the dose within 30 days after the date of the planned special exposure. The dose from planned special exposures shall not be considered in controlling the future occupational dose of the individual pursuant to (5)(a)1. of this Rule but shall be included in evaluations required by (5)(f)1. and (5)(f)5. of this Rule.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(g)">(g)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Occupational Dose Limits for Minors. The annual occupational dose limits for minors are ten percent of the annual occupational dose limits specified for adult workers in (5)(a) of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(h)">(h)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Dose to an Embryo/Fetus. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(h)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall ensure that the dose equivalent to an embryo/fetus during the entire pregnancy, due to occupational exposure of a declared pregnant woman, does not exceed 0.5 rem (5 mSv). For record-keeping requirements, see (14)(g) of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(h)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall make efforts to avoid substantial variation</span><span class=""><sup>[<a name="fn-FR-391-3-17-.03-9" href="#ftn.fn-FR-391-3-17-.03-9">2</a>]</sup></span><span class=""> above a uniform monthly exposure rate to a declared pregnant woman so as to satisfy the limit in (5)(h)1. of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(h)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The dose equivalent to an embryo/fetus shall be taken as the sum of: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(h)3.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The deep-dose equivalent to the declared pregnant woman; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(h)3.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The dose equivalent to the embryo/fetus from radionuclides in the embryo/fetus and radionuclides in the declared pregnant woman.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(h)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If by the time the woman declares pregnancy to the licensee the dose equivalent to the embryo/fetus is found to have exceeded 0.50 rem (5.0 mSv), or is within 0.05 rem (0.5 mSv) of this dose equivalent, the licensee shall be deemed to be in compliance with (5)(h)1. of this Rule if the additional dose equivalent to the embryo/fetus does not exceed 0.05 rem (0.5 mSv) during the remainder of the pregnancy.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Radiation Dose Limits for Individual Members of the Public. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall conduct operations so that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as provided in (5)(i)1.(iii) the total effective dose equivalent to individual members of the public from the licensed operation does not exceed 0.1 rem (1 mSv) in a year, exclusive of the dose contributions from background radiation, from any medical administration the individual has received, from exposure to individuals administered radioactive material and released in accordance with Rule </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Rules and Regulations/browse?ci=25&amp;id=gasos&amp;codesec=391-3-17-.05&amp;title=391#391-3-17-.05(37)" target="_newtab">.05(37)</a></span><span class="">, from voluntary participation in medical research programs, and from the licensee's disposal of radioactive material into sanitary sewerage in accordance with (13)(c) of this Rule; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The dose in any unrestricted area from external sources, exclusive of the dose contributions from individuals administered radioactive material and released in accordance with Rule </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Rules and Regulations/browse?ci=25&amp;id=gasos&amp;codesec=391-3-17-.05&amp;title=391#391-3-17-.05(37)" target="_newtab">.05(37)</a></span><span class="">, does not exceed 0.002 rem (0.02 mSv) in any one hour.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The total effective dose equivalent to individual members of the public from infrequent exposure to radiation from radiation machines does not exceed 0.5 rem (5 mSv).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A licensee or license applicant may apply for prior Department authorization to operate up to an annual dose limit for an individual member of the public of 0.5 rem (5 mSv). The licensee or license applicant shall include the following information in this application: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Demonstration of the need for and the expected duration of operations in excess of the limit in (5)(i)1. of this Rule;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee's program to assess and control dose within the 0.5 rem (5 mSv) annual limit; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The procedure to be followed to maintain the dose as low as is reasonably achievable (ALARA).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In addition to the requirements of this Rule, a licensee subject to the provisions of the U.S. Environmental Protection Agency's (EPA) generally applicable environmental radiation standards in 40 CFR Part 190 shall comply with those standards.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(i)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may impose additional restrictions on radiation levels in unrestricted areas and on the total quantity of radionuclides that a licensee may release in effluents in order to restrict the collective dose.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(j)">(j)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Compliance with Dose Limits for Individual Members of the Public. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(j)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall make or cause to be made, as appropriate, surveys of radiation levels in unrestricted areas and radioactive materials in effluents released to unrestricted areas to demonstrate compliance with the dose limits for individual members of the public in (5)(i) of this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(j)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A licensee shall show compliance with the annual dose limit in (5)(i) of this Rule by: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(j)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Demonstrating by measurement or calculation that the total effective dose equivalent to the individual likely to receive the highest dose from the licensed operation does not exceed the annual dose limit; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(j)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Demonstrating that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(j)2.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The annual average concentrations of radioactive material released in gaseous and liquid effluents at the boundary of the unrestricted area do not exceed the values specified in Table II of Appendix B of 10 CFR 20.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(j)2.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If an individual were continually present in an unrestricted area, the dose from external sources would not exceed 0.002 rem (0.02 mSv) in one hour and 0.05 rem (0.50 mSv) in one year.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(5)(j)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Upon approval from the Department, the licensee may adjust the effluent concentration values in Appendix B, Table II of 10 CFR 20, for members of the public, to take into account the actual physical and chemical characteristics of the effluents (e.g., aerosol size distribution, solubility, density, radioactive decay equilibrium, and chemical form).</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)">(6)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Testing for Leakage or Contamination of Sealed Sources</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee in possession of any sealed source shall assure that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each sealed source, other than hydrogen-3, with a half-life greater than 30 days and in any form other than gas, shall be tested for leakage or contamination as follows: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Prior to initial use;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Unless otherwise authorized by the Department, at intervals not to exceed six months, except that each source designed for the purpose of emitting alpha particles shall be tested at intervals not to exceed three months;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> At any other time there is reason to suspect that a sealed source might have been damaged or might be leaking, it shall be tested for leakage before further use; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In the absence of a certificate from a transferor indicating that a test for leakage has been made within six months prior to the transfer, the sealed source shall not be put into use until tested and the results received.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Tests for leakage for all sealed sources, except those manufactured to contain radium, shall be capable of detecting the presence of 0.005 </span><span class="">µ</span><span class="">Ci (185 Bq) of radioactive material on a test sample. Test samples shall be taken from the sealed source or from the surfaces of the container in which the sealed source is stored or mounted on which one might expect contamination to accumulate. For sealed sources contained in a device, test samples are obtained when the source is in the "off" position.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Tests for leakage for sources manufactured to contain radium shall be capable of detecting an absolute leakage rate of 0.001 </span><span class="">µ</span><span class="">Ci (37 Bq) of radon-222 in a 24-hour period when the collection efficiency for radon-222 and its daughters has been determined with respect to collection method, volume, and time.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Test samples shall also be taken from the interior surfaces of the container in which sealed sources of radium are stored. This test shall be capable of detecting the presence of 0.005 </span><span class="">µ</span><span class="">Ci (185 Bq) of a radium daughter that has a half-life greater than four days.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(a)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Notwithstanding the periodic test for leakage required, any sealed source is exempt from such tests for leakage when the sealed source contains 100 </span><span class="">µ</span><span class="">Ci (3.7 MBq) or less of beta- or gamma-emitting material or ten </span><span class="">µ</span><span class="">Ci (370 kBq) or less of alpha-emitting material.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Tests for leakage or contamination shall be performed by persons specifically authorized by the Department, an Agreement State, a Licensing State, or the U.S. Nuclear Regulatory Commission to perform such services.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The following shall be considered evidence that the sealed source is leaking: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The presence of 0.005 </span><span class="">µ</span><span class="">Ci (185 Bq) or more of removable contamination on any test sample. If the test of a sealed source, other than radium, reveals the presence of 0.005 </span><span class="">µ</span><span class="">Ci (185 Bq) or more of removable contamination, the licensee shall immediately withdraw the sealed source from use, take action to prevent the spread of contamination, and cause the sealed source to be decontaminated and repaired or to be disposed of in accordance with this Rule.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Leakage of 0.001 </span><span class="">µ</span><span class="">Ci (37 Bq) of radon-222 per 24 hours for sealed sources manufactured to contain radium. If the test of a sealed source manufactured to contain radium reveals the presence of removable contamination resulting from the decay of 0.005 </span><span class="">µ</span><span class="">Ci (185 Bq) or more of radium-226, the licensee shall immediately withdraw the sealed source from use, take action to prevent the spread of contamination, and cause the sealed source to be decontaminated and repaired or to be disposed of in accordance with this Rule.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Records of test results for sealed sources shall be made pursuant to (14)(d).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(6)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Reports of test results for leaking or contaminated sealed sources shall be made pursuant to (15)(g) of this Rule.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)">(7)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Radiological Requirements for License Termination</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> General provisions and scope. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The requirements in this section apply to the decommissioning of facilities licensed under Rule </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Rules and Regulations/browse?ci=25&amp;id=gasos&amp;codesec=391-3-17-.02&amp;title=391#391-3-17-.02(8)(g)" target="_newtab">.02(8)(g)</a></span><span class="">, (Licensing of Radioactive Materials. Amended);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The requirements in this section do not apply to sites which: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(a)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Have been decommissioned prior to April 18, 2002 in accordance with requirements identified in.03(7) and Rule </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Rules and Regulations/browse?ci=25&amp;id=gasos&amp;codesec=391-3-17-.02&amp;title=391#" target="_newtab">.02</a></span><span class=""> of this Chapter; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(a)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Have previously submitted and received Department approval on a decommissioning plan by April 18, 2002.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> After a site has been decommissioned and the license terminated in accordance with the requirements in this section, the Department will require additional cleanup only if, based on new information, it determines that the requirements of this section were not met and residual radioactivity remaining at the site could result in significant threat to public health and safety.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(a)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> When calculating TEDE to the average member of the critical group the licensee shall determine the peak annual TEDE dose expected within the first 1,000 years after decommissioning.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Radiological requirements for unrestricted use. A site will be considered acceptable for unrestricted use if the residual radioactivity that is distinguishable from background radiation results in a TEDE to an average member of the critical group that does not exceed 25 mrem (0.25 mSv) per year, including that from groundwater sources of drinking water, and the residual radioactivity has been reduced to levels that are as low as reasonably achievable (ALARA). Determination of the levels which are ALARA must take into account consideration of any detriments, such as deaths from transportation accidents, expected to potentially result from decontamination and waste disposal.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Alternate requirements for license termination. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The Department may terminate a license using alternate requirements greater than the dose requirements of .03(7)(b) if the licensee: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Provides assurance that public health and safety would continue to be protected, and that it is unlikely that the dose from all man-made sources combined, other than medical, would be more than the 100 mrem/year (1 mSv/year) limit of .03(5)(i), by submitting an analysis of possible sources of exposure;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Reduces doses to ALARA levels, taking into consideration any detriments such as traffic accidents expected to potentially result from decontamination and waste disposal;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Has provided sufficient financial assurance in the form of a trust fund to enable an independent third party, including a governmental custodian of a site, to assume and carry out responsibilities for any necessary control and maintenance of the site; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Has submitted a decommissioning plan to the Department indicating the licensee's intent to decommission in accordance with requirements of Rule </span><span class=""> <a href="https://links.casemakerlegal.com/states/ga/books/Rules and Regulations/browse?ci=25&amp;id=gasos&amp;codesec=391-3-17-.02&amp;title=391#391-3-17-.02(18)(d)" target="_newtab">.02(18)(d)</a></span><span class="">, and specifying that the licensee proposes to decommission by use of alternate requirements. The licensee shall document in the decommissioning plan how the advice of individuals and institutions in the community who may be affected by the decommissioning has been sought and addressed, as appropriate, following analysis of that advice. In seeking such advice, the licensee shall provide for: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)1.(iv)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Participation by representatives of a broad cross section of community interests who may be affected by the decommissioning;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)1.(iv)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> An opportunity for a comprehensive, collective discussion on the issues by the participants represented; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)1.(iv)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A publicly available summary of the results of all such discussions, including a description of the individual viewpoints of the participants on the issues and the extent of agreement and disagreement among the participants on the issues.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The use of alternate requirements to terminate a license requires the approval of the Department after consideration of the Department's recommendations that will address any comments provided by the U.S. Environmental Protection Agency (EPA) and any public comments submitted in accordance with (7)(d) of this rule.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Public notification and public participation. Upon the receipt of a decommissioning plan from the licensee, or a proposal by the licensee for release of a site in accordance with (7)(c) of this Rule, or whenever the Department deems such notice to be in the public interest, the Department will: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Notify and solicit comments from: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(d)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Local and State governments in the vicinity of the site and any Indian Nation or other indigenous people that have treaty or statutory rights that could be affected by the decommissioning; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(d)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The EPA for cases where the licensee proposes to release a site in accordance with (7)(c).</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Publish a notice in the local newspaper(s), letters to State or local organizations, or other appropriate forum, that is readily accessible to individuals in the vicinity of the site, and solicit comments from affected parties.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Minimization of contamination. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Applicants for licenses, other than renewals, after April 18, 2002, shall describe in the application how facility design and procedures for operation will minimize, to the extent practical, contamination of the facility and the environment, facilitate eventual decommissioning, and minimize, to the extent practical, the generation of radioactive waste.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(7)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Licensees shall, to the extent practical, conduct operations to minimize the introduction of residual radioactivity into the site, including the subsurface, in accordance with the existing radiation protection requirements in.03(4) and radiological criteria for license termination in.03(7) of this Rule.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)">(8)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Surveys and Monitoring</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> General. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall make, or cause to be made, surveys of areas, including the subsurface, that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> May be necessary for the licensee to demonstrate compliance with this Rule; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Are reasonable under the circumstances to evaluate: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)1.(ii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The magnitude and extent of radiation levels;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)1.(ii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Concentrations or quantities of residual radioactivity; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)1.(ii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The potential radiological hazards of the radiation levels and residual radioactivity detected.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Notwithstanding.03(14)(c) 1, records from surveys describing the location and amount of subsurface residual radioactivity identified at the site must be kept with records important for decommissioning, and such records must be retained in accordance with.02(8)(g) 8, as applicable.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall ensure that instruments and equipment used for quantitative radiation measurements (e.g., dose rate and effluent monitoring) are calibrated periodically, at least annually, for the radiation measured except when a more frequent interval is specified in other applicable parts of these Rules or a license condition.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> All personnel dosimeters, except for direct and indirect reading pocket ionization chambers and those dosimeters used to measure the dose to any extremity, that require processing to determine the radiation dose and that are used by licensees to comply with (5)(a) of this Rule, with other applicable provisions of this Chapter, or with conditions specified in a license shall be processed and evaluated by a qualified dosimetry processor. A dosimetry processor is qualified if it: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Holds current personnel dosimetry accreditation from the National Voluntary Laboratory Accreditation Program (NVLAP) of the National Institute of Standards and Technology; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Is approved in this accreditation process for the type of radiation or radiations included in the NVLAP program that most closely approximates the type of radiation or radiations for which the individual wearing the dosimeter is monitored.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(a)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall ensure that adequate precautions are taken to prevent a deceptive exposure of an individual monitoring device.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Conditions Requiring Individual Monitoring of External and Internal Occupational Dose. Each licensee shall monitor exposures to sources of radiation and radioactive material at levels sufficient to demonstrate compliance with the occupational dose limits of this Rule. As a minimum: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall monitor occupational exposure to radiation and shall supply and require the use of individual monitoring devices by: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Adults likely to receive, in one year from sources external to the body, a dose in excess of ten percent of the limits in (5)(a)1. of this Rule;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Minors likely to receive, in one year from radiation sources external to the body, a deep dose equivalent in excess of 0.1 rem (1mSv), a lens dose equivalent in excess of 0.15 rem (1.5 mSv), or a shallow dose equivalent to the skin or to extremities in excess of 0.5 rem (5mSv);</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Declared pregnant women likely to receive during the entire pregnancy, from radiation sources external to the body, a deep dose equivalent in excess of 0.1 rem (1 mSv);</span><span class=""><sup>[<a name="fn-FR-391-3-17-.03-10" href="#ftn.fn-FR-391-3-17-.03-10">3</a>]</sup></span><span class=""> and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Individuals entering a high or very high radiation area.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall monitor, to determine compliance with (5)(d) of this Rule, the occupational intake of radioactive material by, and assess the committed effective dose equivalent to: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Adults likely to receive, in one year, an intake in excess of ten percent (10%) of the applicable ALI in Table I, Columns 1 and 2, of Appendix B of 10 CFR 20; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Minors likely to receive, in one year, a committed effective dose equivalent in excess of 0.05 rem (0.50 mSv).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(8)(b)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Declared pregnant women likely to receive, during the entire pregnancy, a committed effective dose equivalent in excess of 0.1 rem (1 mSv).</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)">(9)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Control Of Exposure From External Sources In Restricted Areas</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Control of Access to High Radiation Areas. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall ensure that each entrance or access point to a high radiation area has one or more of the following features: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A control device that, upon entry into the area, causes the level of radiation to be reduced below that level at which an individual might receive a deep dose equivalent of 0.1 rem (1 mSv) in one hour at 30 centimeters from the source of radiation or from any surface that the radiation penetrates;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A control device that energizes a conspicuous visible or audible alarm signal so that the individual entering the high radiation area and the supervisor of the activity are made aware of the entry; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Entryways that are locked, except during periods when access to the areas is required, with positive control over each individual entry.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In place of the controls required by (9)(a)1. of this Rule, the licensee may substitute continuous direct or electronic surveillance that is capable of preventing unauthorized entry.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee may apply to the Department for approval of alternative methods for controlling access to high radiation areas.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall establish the controls required by (9)(a)1. and (9)(a)3. of this Rule in a way that does not prevent individuals from leaving a high radiation area.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee is not required to control each entrance or access point to a room or other area that is a high radiation area solely because of the presence of radioactive materials prepared for transport and packaged and labeled in accordance with the regulations of the U.S. Department of Transportation provided that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The packages do not remain in the area longer than three days; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The dose rate at one meter from the external surface of any package does not exceed 0.01 rem (0.1 mSv) per hour.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee is not required to control entrance or access to rooms or other areas in hospitals solely because of the presence of patients containing radioactive material, provided that there are personnel in attendance who will take the necessary precautions to prevent the exposure of individuals to radiation or radioactive material in excess of the established limits in this Rule and to ensure operation within the ALARA provisions of the licensee's Radiation Protection Program.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(a)7.">7.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee is not required to control entrance or access to rooms or other areas containing sources of radiation capable of producing a high radiation area if the licensee has met all the specific requirements for access and control specified in other applicable Rules, such as </span><span class=""> <a title="391-3-17-.04" href="391-3-17-.04">391-3-17-.04</a></span><span class=""> for industrial radiography.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Control of Access to Very High Radiation Areas. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In addition to the requirements in (9)(a) of this Rule, the licensee shall institute additional measures to ensure that an individual is not able to gain unauthorized or inadvertent access to areas in which radiation levels could be encountered at 500 rads (5 Gy) or more in one hour at one meter from a source of radiation or any surface through which the radiation penetrates. This requirement does not apply to rooms or areas in which diagnostic x-ray systems are the only source of radiation, or to non-self-shielded irradiators.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(9)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee is not required to control entrance or access to rooms or other areas containing sources of radiation capable of producing a very high radiation area as defined in this Rule if the licensee has met all the specific requirements for access and control specified in other applicable Rules, such as </span><span class=""> <a title="391-3-17-.04" href="391-3-17-.04">391-3-17-.04</a></span><span class=""> for industrial radiography.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)">(10)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Respiratory Protection and Controls to Restrict Internal Exposure in Restricted Areas</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use of Process or Other Engineering Controls. The licensee shall use, to the extent practicable, process or other engineering controls (e.g., containment, decontamination, or ventilation) to control the concentrations of radioactive material in air.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use of Other Controls. When it is not practical to apply process or other engineering controls to control the concentrations of radioactive material in air to values below those that define an airborne radioactivity area, the licensee shall, consistent with maintaining the total effective dose equivalent ALARA, increase monitoring and limit intakes by one or more of the following means: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Control of access;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Limitation of exposure times;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use of respiratory protection equipment; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Other controls.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee performs an ALARA analysis to determine whether or not respirators should be used, the licensee may consider safety factors other than radiological factors. The licensee should also consider the impact of respirator use on workers' industrial health and safety.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Use of Individual Respiratory Protection Equipment. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> If the licensee uses respiratory protection equipment to limit intakes pursuant to (10)(b) of this Rule: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Except as provided in (10)(d)1.(ii) of this Rule, the licensee shall use only respiratory protection equipment that is tested and certified by or had certification extended by the National Institute for Occupational Safety and Health and the Mine Safety and Health Administration (NIOSH/MSHA).</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee may use equipment that has not been tested or certified by the National Institute for Occupational Safety and Health and the Mine Safety and Health Administration or had certification extended by NIOSH/MSHA or for which there is no schedule for testing or certification, provided the licensee has submitted to the Department and the Department has approved an application for authorized use of that equipment, including a demonstration by testing, or a demonstration on the basis of reliable test information, that the material and performance characteristics of the equipment are capable of providing the proposed degree of protection under anticipated conditions of use.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall implement and maintain a respiratory protection program that includes: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(iii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Air sampling sufficient to identify the potential hazard, permit proper equipment selection, and estimate exposures;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(iii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Surveys and bioassays, as appropriate, to evaluate actual intakes;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(iii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Testing of respirators for operability (user seal check for face sealing devices and functional check for others) immediately prior to each use;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(iii)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Written procedures regarding: respirator selection; fit testing; breathing air quality; inventory control; storage, issuance, maintenance, repair, and quality assurance of respiratory protection equipment, including testing for operability immediately prior to each use; supervision and training of personnel; monitoring, including air sampling and bioassays; and record-keeping; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(iii)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Determination by a physician prior to initial fitting of face sealing respirators; before the first use of non-face sealing respirators; and either every 12 months thereafter or periodically at a frequency determined by a physician, that the individual user is medically fit to use the respiratory protection equipment.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(iii)(VI)">(VI)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Fit testing, with fit factor "ten times the APF for negative pressure devices", and a fit factor" 500 for any positive pressure, continuous flow, and pressure-demand devices", before the first field use of tight fitting, face-sealing respirators and periodically thereafter at a frequency not to exceed one year. Fit testing must be performed with the facepiece operating in the negative pressure mode. </span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall advise each respirator user that the user may leave the area at any time for relief from respirator use in the event of equipment malfunction, physical or psychological distress, procedural or communication failure, significant deterioration of operating conditions, or any other conditions that might require such relief.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(v)">(v)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall also consider limitations appropriate to the type and mode of use. When selecting respiratory devices the licensee shall provide for vision correction, adequate communication, low temperature work environments, and the concurrent use of other safety or radiological protection equipment. The licensee shall use equipment in such a way as not to interfere with the proper operation of the respirator.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(vi)">(vi)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Standby rescue persons are required whenever one-piece atmosphere-supplying suits, or any combination of supplied air respiratory protection device and personnel protective equipment are used from which an unaided individual would have difficulty extricating himself. The standby persons must be equipped with respiratory protection devices or other apparatus appropriate for the potential hazards. The standby rescue persons shall observe or otherwise maintain continuous communication with the workers (visual, voice, signal line, telephone, radio, or other suitable means), and be immediately available to assist them in case of a failure of the air supply or for any other reason that requires relief from distress. A sufficient number of standby rescue persons must be immediately available to assist all users of this type of equipment and to provide effective emergency rescue if needed.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(vii)">(vii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Atmosphere-supplying respirators must be supplied with respirable air of grade D quality or better as defined by the Compressed Gas Association in publication G-7.1, "Commodity Specification for Air," 1997 and included in the regulations of the Occupational Safety and Health Administration ( 29 CFR 1910.134(i)(1)(ii)(A) through (E). Grade D quality air criteria include: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(vii)(I)">(I)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Oxygen content (v/v) of 19.5 -23.5 %;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(vii)(II)">(II)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Hydrocarbon (condensed) content of five (5) milligrams per cubic meter of air or less;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(vii)(III)">(III)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Carbon monoxide (CO) content of ten (10) ppm or less;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(vii)(IV)">(IV)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Carbon dioxide content of 1,000 ppm or less; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(vii)(V)">(V)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Lack of noticeable odor.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(viii)">(viii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall ensure that no objects, materials or substances, such as facial hair, or any conditions that interfere with the face to facepiece seal or valve function, and that are under the control of the respirator wearer, are present between the skin of the wearer's face and the sealing surface of a tight-fitting respirator facepiece.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(d)1.(ix)">(ix)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In estimating the dose to individuals from intake of airborne radioactive materials, the concentration of radioactive material in the air that is inhaled when respirators are worn is initially assumed to be the ambient concentration in air without respiratory protection, divided by the assigned protection factor. If the dose is later found to be greater than the estimated dose, the corrected value must be used. If the dose is later found to be less than the estimated dose, the corrected value may be used.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Further Restrictions on the Use of Respiratory Protection Equipment. The Department may impose restrictions in addition to those in (10)(b) and (10)(c) of this Rule and Appendix A to 10 CFR 20, in order to: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ensure that the respiratory protection program of the licensee is adequate to limit doses to individuals from intakes of airborne radioactive materials consistent with maintaining total effective dose equivalent ALARA; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Limit the extent to which a licensee may use respiratory protection equipment instead of process or other engineering controls.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Application for use of higher assigned protection factors. The licensee shall obtain authorization from the Department before using assigned protection factors in excess of those specified in Appendix A to 10 CFR Part 20. The Department may authorize a licensee to use higher assigned protection factors on receipt of an application that: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(f)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Describes the situation for which a need exists for higher protection factors; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(10)(f)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Demonstrates that the respiratory protection equipment provides these higher protection factors under the proposed conditions of use.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(11)">(11)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Storage and Control of Licensed Material</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(11)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Security and Control of Licensed Radioactive Material. The licensee shall secure licensed materials from unauthorized removal or access.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(11)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Control of material sources of radiation not in storage. The licensee shall maintain constant surveillance and use devices or administrative procedures to prevent unauthorized use of licensed radioactive material that is in an unrestricted area and that is not in storage or in a patient.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)">(12)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Precautionary Procedures</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Caution Signs. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Standard Radiation Symbol. Unless otherwise authorized by the Department, the symbol prescribed by (12)(a) of this Rule uses the colors magenta (or purple or black) on yellow background. The symbol prescribed is the three-bladed design as follows: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(a)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Cross-hatched area is to be magenta, purple, or black; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(a)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The background is to be yellow.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Exception to Color Requirements for Standard Radiation Symbol. Notwithstanding the requirements of (12)(a)1. of this Rule, licensees are authorized to label sources, source holders, or device components containing sources of radiation that are subjected to high temperatures with conspicuously etched or stamped radiation caution symbols without a color requirement. </span><span class=""><P> <P><img class="ImageLink" src="/pdf/ga/admin/2017/391-3-17-03.png" alt=" image: ga/admin/2017/391-3-17-03.png"></P> </P></span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(a)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> In addition to the contents of signs and labels prescribed in this Rule, the licensee shall provide, on or near the required signs and labels, additional information, as appropriate, to make individuals aware of potential radiation exposures and to minimize the exposures.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(b)">(b)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Posting Requirements. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(b)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Posting of Radiation Areas. The licensee shall post each radiation area with a conspicuous sign or signs bearing the radiation symbol and the words "CAUTION, RADIATION AREA."</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(b)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Posting of High Radiation Areas. The licensee shall post each high radiation area with a conspicuous sign or signs bearing the radiation symbol and the words "CAUTION, HIGH RADIATION AREA" or "DANGER, HIGH RADIATION AREA." The licensee may satisfy this requirement by posting the sign at the boundary of the high radiation area.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(b)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Posting of Very High Radiation Areas. The licensee shall post each very high radiation area with a conspicuous sign or signs bearing the radiation symbol and words "GRAVE DANGER, VERY HIGH RADIATION AREA."</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(b)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Posting of Airborne Radioactivity Areas. The licensee shall post each airborne radioactivity area with a conspicuous sign or signs bearing the radiation symbol and the words "CAUTION, AIRBORNE RADIOACTIVITY AREA" or "DANGER, AIRBORNE RADIOACTIVITY AREA."</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(b)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Posting of Areas or Rooms in which Licensed Material is Used or Stored. The licensee shall post each area or room in which there is used or stored an amount of licensed material exceeding ten times the quantity of such material specified in Appendix C of 10 CFR Part 20 with a conspicuous sign or signs bearing the radiation symbol and the words "CAUTION, RADIOACTIVE MATERIAL(S)" or "DANGER, RADIOACTIVE MATERIAL(S)".</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(c)">(c)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Exceptions to Posting Requirements. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(c)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A licensee is not required to post caution signs in areas or rooms containing sources of radiation for periods of less than eight hours, if all of the following conditions are met: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(c)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The sources of radiation are constantly attended during these periods by an individual who takes the precautions necessary to prevent the exposure of individuals to sources of radiation in excess of the limits established in this Rule; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(c)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The area or room is subject to the licensee's control.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(c)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Rooms or other areas in hospitals that are occupied by patients are not required to be posted with caution signs pursuant to (12)(b) of this Rule provided that the patient could be released from licensee control pursuant to Rule </span><span class=""> <a title="391-3-17-.05" href="391-3-17-.05">391-3-17-.05</a></span><span class="">.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(c)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A room or area is not required to be posted with a caution sign pursuant to (12)(b) of this Rule because of the presence of a sealed source provided that the radiation level at 30 centimeters from the surface of the source container or housing does not exceed 0.005 rem (0.05 mSv) per hour.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(d)">(d)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Labeling Containers and Radiation Machines. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(d)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall ensure that each container of licensed material bears a durable, clearly visible label bearing the radiation symbol and the words "CAUTION, RADIOACTIVE MATERIAL" or "DANGER, RADIOACTIVE MATERIAL." The label shall also provide information such as the radionuclides present, an estimate of the quantity of radioactivity, the date for which the activity is estimated, radiation levels, kinds of materials, and mass enrichment, to permit individuals handling or using the containers, or working in the vicinity of the containers, to take precautions to avoid or minimize exposures.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(d)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall, prior to removal or disposal of empty uncontaminated containers to unrestricted areas, remove or deface the radioactive material label or otherwise clearly indicate that the container no longer contains radioactive materials.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(e)">(e)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Exemptions to Labeling Requirements. A licensee is not required to label: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(e)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Containers holding licensed material in quantities less than the quantities listed in Appendix C of 10 CFR 20;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(e)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Containers holding licensed material in concentrations less than those specified in Table III of Appendix B of 10 CFR 20;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(e)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Containers attended by an individual who takes the precautions necessary to prevent the exposure of individuals in excess of the limits established by this Rule;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(e)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Containers when they are in transport and packaged and labeled in accordance with the regulations of the U.S. Department of Transportation</span><span class=""><sup>[<a name="fn-FR-391-3-17-.03-11" href="#ftn.fn-FR-391-3-17-.03-11">4</a>]</sup></span><span class="">;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(e)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Containers that are accessible only to individuals authorized to handle or use them or to work in the vicinity of the containers, if the contents are identified to these individuals by a readily available written record. Examples of containers of this type are containers in locations such as water-filled canals, storage vaults, or hot cells. The record shall be retained as long as the containers are in use for the purpose indicated on the record; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(e)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Installed manufacturing or process equipment, such as chemical process equipment, piping, and tanks.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)">(f)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Procedures for Receiving and Opening Packages. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee who is authorized to receive a package containing quantities of radioactive material in excess of a Type A quantity, as defined in Rule </span><span class=""> <a title="391-3-17-.06(3)" href="391-3-17-.06#391-3-17-.06(3)">391-3-17-.06(3)</a></span><span class="">, shall make arrangements to receive: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The package when the carrier offers it for delivery; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The notification of the arrival of the package at the carrier's terminal and to take possession of the package expeditiously.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Monitor the external surfaces of a labeled</span><span class=""><sup>[<a name="fn-FR-391-3-17-.03-12" href="#ftn.fn-FR-391-3-17-.03-12">5</a>]</sup></span><span class=""> package for radioactive contamination unless the package contains only radioactive material in the form of gas or in "special form" as defined in Rule </span><span class=""> <a title="391-3-17-.01(2)" href="391-3-17-.01#391-3-17-.01(2)">391-3-17-.01(2)</a></span><span class="">;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Monitor the external surfaces of a labeled package for radiation levels unless the package contains quantities of radioactive material that are less than or equal to the Type A quantity, as defined in Rule </span><span class=""> <a title="391-3-17-.06(3)" href="391-3-17-.06#391-3-17-.06(3)">391-3-17-.06(3)</a></span><span class="">, and the radioactive material is in the form of a gas or in special form as defined in Rule </span><span class=""> <a title="391-3-17-.01(2)" href="391-3-17-.01#391-3-17-.01(2)">391-3-17-.01(2)</a></span><span class="">; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)2.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Monitor all packages known to contain radioactive material for radioactive contamination and radiation levels if the package has evidence of potential contamination, such as packages that are crushed, wet, or damaged.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)3.">3.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall perform the monitoring required by (12)(f)2. of this Rule as soon as practicable after receipt of the package, but not later than three hours after the package is received at the licensee's facility if it is received during the licensee's normal working hours, or not later than three hours from the beginning of the next working day if it is received after working hours.</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)4.">4.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> The licensee shall immediately notify the final delivery carrier and the Department by telephone, telegram, mailgram, or facsimile, when: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)4.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Removable radioactive surface contamination exceeds the limits of Rule </span><span class=""> <a title="391-3-17-.06(16)(i)" href="391-3-17-.06#391-3-17-.06(16)(i)">391-3-17-.06(16)(i)</a></span><span class="">; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)4.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> External radiation levels exceed the limits of Rule </span><span class=""> <a title="391-3-17-.06(16)(j)" href="391-3-17-.06#391-3-17-.06(16)(j)">391-3-17-.06(16)(j)</a></span><span class="">.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)5.">5.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Each licensee shall: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)5.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Establish, maintain, and retain written procedures for safely opening packages in which radioactive material is received; and</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)5.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Ensure that the procedures are followed and that special instructions for the type of package being opened are followed.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(12)(f)6.">6.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Licensees transferring special form sources in vehicles owned or operated by the licensee to and from a work site are exempt from the contamination monitoring requirements of (12)(f)2. of this Rule, but are not exempt from the monitoring requirement in (12)(f)2. of this Rule for measuring radiation levels to ensure that the source is still properly lodged in its shield.</span></td> </tr> </table> </td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)">(13)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""><B>Waste Disposal</B></span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)">(a)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> General Requirements. </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)1.">1.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A licensee shall dispose of licensed material only:</span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)1.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> By transfer to an authorized recipient as provided in (13)(i) of this Rule and in Rule </span><span class=""> <a title="391-3-17-.02(19)" href="391-3-17-.02#391-3-17-.02(19)">391-3-17-.02(19)</a></span><span class="">, or to the U.S. Department of Energy;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)1.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> By decay in storage;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)1.(iii)">(iii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> By release in effluents within the limits in (5)(i) of this Rule; or</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)1.(iv)">(iv)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> As authorized pursuant to (13)(b), (13)(c), (13)(d), (13)(e), or (13)(k) of this Rule.</span></td> </tr> </table> </td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)2.">2.</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> A person shall be specifically licensed by the Department, the U.S. Nuclear Regulatory Commission, an Agreement State, or a Licensing State to receive waste containing licensed material from other persons for: </span> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)2.(i)">(i)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Treatment prior to disposal;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;" name="391-3-17-.03(13)(a)2.(ii)">(ii)</a></span></td> <td valign="top" style="text-align:left" class="leftalign"><span class=""> Treatment or disposal by incineration;</span></td> </tr> </table> <table border="0" width="100%" cellspacing="4" cellpadding="4"> <tr> <td valign="top" width="1%" style="white-space:nowrap;text-align:left;width:18px;"><span class=""><a style="white-space:nowrap;